mirtazapine has been researched along with mianserin in 1129 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (0.97) | 18.7374 |
| 1990's | 123 (10.89) | 18.2507 |
| 2000's | 554 (49.07) | 29.6817 |
| 2010's | 430 (38.09) | 24.3611 |
| 2020's | 11 (0.97) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Arnt, J; Cremers, TI; Mensonides-Harsema, MM; Moltzen, EK; Wikström, HV | 1 |
| Alonso, JM; Andrés, JI; Cid, JM; Díaz, A; Fernández, J; Gil, P; Iturrino, L; Megens, A; Sipido, VK; Trabanco, AA | 1 |
| Buck, LB; Petrascheck, M; Ye, X | 1 |
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gilvary, E; Glaudin, V; Panagides, J; Smith, WT | 1 |
| Groenhout, CM; Kamphuisen, HA; Kemp, B; Ruigt, GS | 1 |
| Checkley, S; Palazidou, E; Papadopoulos, A; Sitsen, A; Stahl, S | 1 |
| Kuitunen, T; Mattila, M; Mattila, MJ; Vrijmoed-de Vries, M | 1 |
| Smith, DF | 1 |
| Delbressine, LP; Jacobs, PL; Kaspersen, FM; Schmeits, GJ | 1 |
| de Boer, TH; de Vos, CJ; Maura, G; Pinder, RM; Raiteri, M; Wieringa, J | 1 |
| Ajeman, SA; Claghorn, JL; Johnstone, EE; Studebaker, SL | 1 |
| Paanakker, JE; van Hal, HJ | 1 |
| Leonard, BE; O'Connor, WT | 1 |
| Bettum, V; Dunbar, GC; Jørgensen, J; Steffensen, K; Sørensen, M; Viby-Mogensen, J | 1 |
| Nickolson, VJ; van Delft, AM; Wieringa, JH | 1 |
| Fink, M; Irwin, P | 1 |
| Claghorn, JL; Lesem, MD | 1 |
| Bremner, JD | 1 |
| de Wilde, J; Dierick, M; Evrard, JL; Mendlewicz, J; van Moffaert, M; Vereecken, A; Wilmotte, J | 1 |
| Gubbels, DG; Peeters, BW; van der Heijden, R; Vanderheyden, PM | 1 |
| De Boer, T; Nefkens, F; Van Helvoirt, A | 1 |
| Leinonen, E; Vartiainen, H | 1 |
| Delbressine, LP; Groothuis, GM; Meijer, DK; Sandker, GW; Slooff, MJ; Vos, RM | 1 |
| de Boer, TH; Nefkens, F; van Delft, AM; van Helvoirt, A | 1 |
| Blier, P; de Montigny, C; Haddjeri, N | 5 |
| Dinan, TG | 1 |
| de Boer, T | 2 |
| Bruijn, JA; de Man, KJ; Man in 't Veld, AJ; Pepplinkhuizen, L; Tulen, JH; van den Meiracker, AH | 1 |
| Ekdahl, P; Høyberg, OJ; Maragakis, B; Moksnes, KM; Mullin, J; Norum, D; Ose, E; Sennef, C; Stordall, E | 1 |
| Hoes, MJ; Zeijpveld, JH | 2 |
| Bruijn, JA; Moleman, P; Mulder, PG; van de Wetering, BJ; van den Broek, WW; van der Mast, RC; van Hulst, AM | 1 |
| Kasper, S | 2 |
| Montgomery, SA | 2 |
| Esteban, S; García-Sevilla, JA; Lladó, J | 1 |
| Ahlfors, U; Jääskeläinen, J; Järvi, R; Marttila, M; Miettinen, E; Romanov, M; Sorri, P; Zivkov, M | 1 |
| Paanakker, JE; Timmer, CJ; Vrijmoed-de Vries, M | 1 |
| Pinder, RM; Zivkov, M | 1 |
| Leonard, BE | 1 |
| Delbressine, LP; Vos, RM | 1 |
| Burrows, GD; Kremer, CM | 1 |
| Kasper, S; Pols, AG; Roes, KC; Zivkov, M | 1 |
| de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
| Klysner, R; Pedersen, L | 1 |
| Preskorn, SH | 1 |
| Frazer, A | 1 |
| Nelson, JC | 2 |
| Barkin, RL; Fawcett, J | 3 |
| Hesselink, JK; Panagides, J; Pinder, R; Sambunaris, A; Stahl, SM | 1 |
| Gerritsen, AW | 1 |
| De Boer, T; Delbressine, L; Funke, C; Kelder, J; Leysen, D; Nickolson, V | 1 |
| Farah, A | 3 |
| Pinder, RM | 2 |
| Hoff, W; Panagides, J; Reimitz, PE; Stahl, S; Zivkov, M | 1 |
| Nutt, D | 1 |
| Kasper, S; Praschak-Rieder, N; Tauscher, J; Wolf, R | 1 |
| Berendsen, HH; Broekkamp, CL | 1 |
| Rosenbaum, JF | 1 |
| Puzantian, T | 1 |
| Berger, M; Frauenknecht, S; Hesslinger, B; Normann, C; Walden, J | 1 |
| Berendsen, HH; Broekkamp, CL; Pinder, RM | 1 |
| Stahl, SM | 2 |
| Nutt, DJ | 3 |
| Nemeroff, CB; Owen, JR | 1 |
| Bremner, JD; Walshe, TA; Wingard, P | 1 |
| de Zeeuw, RA; Franke, JP; Liao, Y; Selditz, U; Wikström, H | 1 |
| Benazzi, F | 3 |
| Montgomery, SA; Reimitz, PE; Zivkov, M | 1 |
| Kremer, CM; Timmerman, L; van Moffaert, M; Wheatley, DP | 1 |
| Berigan, TR; Harazin, JS | 1 |
| Keck, PE; McElroy, SL; Soutullo, CA | 1 |
| Burrows, GD; McGrath, C; Norman, TR | 1 |
| Gray, R | 1 |
| Coupland, NJ; Zedkova, L | 1 |
| Holzbach, R; Jahn, H; Mähne, C; Pajonk, FG | 1 |
| Bailer, U; Kasper, S; Pezawas, L; Praschak-Rieder, N | 1 |
| Aerts, N; Clincke, G; Meert, TF; Melis, W | 1 |
| Maier, S; Maris, F; Retz, W; Rösler, M | 1 |
| Hartmann, PM | 1 |
| Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW | 3 |
| Aschauer, HN; de Zwaan, M; Kasper, S; Pezawas, L; Stamenkovic, M | 1 |
| De León, OA; Furmaga, KM; Kaltsounis, J | 1 |
| Dingler, E; Maris, FA; Niehues, S | 1 |
| Carpenter, LL; Hall, JM; Jocic, Z; Price, LH; Rasmussen, SA | 1 |
| Edwards, IR; Egberts, AC; Meyboom, RH | 1 |
| Ahearn, E; Connor, KM; Davidson, JR; Weisler, RH | 1 |
| Holm, KJ; Markham, A | 1 |
| Birkenhäger, TK; Moleman, P | 1 |
| Boyarsky, BK; Haque, W; Hirschfeld, RM; Rouleau, MR | 1 |
| Jensen, JB | 1 |
| Carpenter, LL; Leon, Z; Price, LH; Yasmin, S | 1 |
| Westenberg, HG | 1 |
| Gorman, JM | 1 |
| Roose, SP | 1 |
| Thompson, C | 2 |
| Thase, ME | 2 |
| Hirschfeld, RM | 2 |
| Falkai, P | 1 |
| Keller, MB | 1 |
| Baghai, T; Laakmann, G; Schüle, C; Waldvogel, E | 1 |
| DeVane, CL; Freund, BV; Goodnick, PJ; Puig, A | 1 |
| Fotiadou, A; Koutouvidis, N; Pratikakis, M | 1 |
| Giduz, T; Pact, V | 1 |
| Barkin, RL; Davis, J | 1 |
| Levine, B; Moore, KA; Saki, S; Schames, J; Smialek, JE; Smith, ML | 1 |
| Anderson, DT; Fritz, KL; Muto, JJ | 1 |
| Agren, H; Behnke, K; Helsdingen, JT; Leinonen, E; Skarstein, J | 1 |
| Bea, C; Budech, CB; Dunner, DL; Hendrickson, HE; O'Connor, E | 1 |
| Brown, MC; Guest, JF; Nimmerrichter, AA | 1 |
| Brannon, GE; Stone, KD | 1 |
| Carley, DW; Radulovacki, M | 1 |
| Nierenberg, AA; Wright, EC | 1 |
| Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM | 1 |
| Baghai, T; Bidlingmaier, M; Laakmann, G; Schüle, C; Strasburger, C; Waldvogel, E | 1 |
| Gorman, JM; Sullivan, G | 1 |
| Fava, M | 2 |
| Kent, JM | 1 |
| Clifford, EM; Cowen, PJ; Whale, R | 1 |
| Adhumeau-Auclair, A; Cussac, D; Dekeyne, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Nicolas, JP; Rivet, JM | 1 |
| Elliott, AJ; Roy-Byrne, PP | 1 |
| Moustgaard, G | 1 |
| Abo-Zena, RA; Bobek, MB; Dweik, RA | 1 |
| Callender, J; MacCall, C | 1 |
| Besson, A; Blier, P; de Montigny, C; Haddjeri, N | 1 |
| Häggström, L; Nordling, S; Norinder, A | 1 |
| Delgado, P; Gelenberg, AJ; Laukes, C; McGahuey, C; Moreno, F; Okayli, G; Zentner, L | 1 |
| Delbressine, LP; Sitsen, JM; Timmer, CJ | 1 |
| Sitsen, JM; Timmer, CJ; Voortman, G | 1 |
| Blass, DM; Pearson, VE | 1 |
| Thomas, SG | 1 |
| Bayles-Dazet, W; Gary, KA; Hayes, JB; MacDonald, MM; Sateia, MJ; Winokur, A | 1 |
| Arévalo, E; Claraco, LM; García-Campayo, J; Sanz Carrillo, C | 1 |
| Bailer, U; Fischer, P; Kasper, S; Küfferle, B; Stastny, J | 1 |
| Foster, RH; Holm, KJ; Jarvis, B | 1 |
| Fomari, V; Klesmer, J; Sarcevic, A | 1 |
| Greenblatt, DJ; Shader, RI; Störmer, E; von Moltke, LL | 1 |
| O'Hanlon, JF; Radhakishun, FS; Roes, KC; van den Bos, J; van der Heijden, BC | 1 |
| Borghi, J; Guest, JF | 1 |
| Maris, FA; Sitsen, JM; Timmer, CJ | 1 |
| Benkert, O; Kohnen, R; Szegedi, A | 1 |
| Greenblatt, DJ; Störmer, E; von Moltke, LL | 1 |
| Berendsen, HH; Schweitzer, DH; Waldinger, MD | 1 |
| Boetsch, T; Gallinat, J; Hampel, H; Hegerl, U; Herrmann, WM; Padberg, F | 1 |
| Burrows, GD; Dodd, S; Norman, TR | 1 |
| Altinöz, S; Karaşen, N | 1 |
| Bengtsson, HJ; Hjorth, S; Johansson, J; Kele, J | 1 |
| Biggio, G; Dazzi, L; Jentsch, JD; Ladu, S; Pira, L; Rivano, A; Spiga, F; Vacca, G | 1 |
| Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
| Blier, P | 3 |
| Berk, M; Brook, S; Ichim, C | 1 |
| Dekeyne, A; Iob, L; Millan, MJ | 1 |
| Mofsen, R | 1 |
| Law, J; Nutt, D | 1 |
| Good, C; Petersen, C | 1 |
| Poyurovsky, M; Weizman, A | 1 |
| Belinskiĭ, AV; Dorovskikh, IV; Iakovlev, VA; Zhbrykunov, VL | 1 |
| Kremer, C; Quitkin, FM; Taylor, BP | 1 |
| Ihde-Scholl, T; Jefferson, JW | 1 |
| Nierenberg, AA | 1 |
| Cohen, M; Dunner, DL; Fava, M; Greist, JH; Preskorn, SH; Trivedi, MH; Zajecka, J | 1 |
| Ansseau, M; Guelfi, JD; Kørsgaard, S; Timmerman, L | 1 |
| Biggio, G; Dazzi, L; Ladu, S; Pisu, MG; Serra, M; Vacca, G | 1 |
| Murphy, T; Nguyen, M | 1 |
| Dieterich, A; Krause, C; Rüther, E; Sommer, M; Wiltfang, J | 1 |
| Hutchison, LC | 1 |
| Brady, SR; Raji, MA | 1 |
| Kast, RE | 2 |
| Elliott, M; Koran, LM; Lorberbaum, JP; Quirk, T | 1 |
| Busnello, EA; Busnello, JV; Kapczinski, F; Kauer-Sant'Anna, M; Madruga, M; Quevedo, J; Ribeiro, L | 1 |
| Biggio, G; Dazzi, L; Jentsch, JD; Pisu, MG; Serra, M; Spiga, F | 1 |
| Anttila, SA; Leinonen, EV | 1 |
| Guenin, KD; Kohn, AE; McDougle, CJ; Posey, DJ; Swiezy, NB | 1 |
| Demers, JC; Malone, M | 1 |
| Anttila, AK; Leinonen, EV; Rasanen, L | 1 |
| Arko, M; Florjanc, TI | 1 |
| Boshuisen, ML; den Boer, JA; Slaap, BR; Vester-Blokland, ED | 1 |
| Anderson, IM | 1 |
| Hartman, BA; Kutscher, EC; Lund, BC | 1 |
| Biggio, G; Dazzi, L; Ladu, S; Pira, L; Rivano, A; Spiga, F; Vacca, G | 1 |
| Carlson, A; Leikin, JB; Stokes, KA; Velazquez, C | 1 |
| Bourin, M; Jolliet, P; Veyrac, G | 1 |
| Cohen, LS; Groninger, H; Joffe, H; Nonacs, R; Soares, C; Soares, CN | 1 |
| Barnas, C; Hilger, E; Kasper, S; Konstantinidis, A; Neumeister, A; Ptak-Butta, J; Stastny, J; Winkler, D | 1 |
| Dawson, AH; Isbister, GK; Whyte, IM | 1 |
| Bech, P | 1 |
| Ng, B | 1 |
| Keller, MB; Nierenberg, AA; Panagides, J; Thase, ME | 1 |
| Carpenter, LL; Price, LH; Yasmin, S | 1 |
| Cornil, C; Dumont, F; Fontaine, E; Machowski, R; Mendlewicz, J; Schittecatte, M; Wilmotte, J | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 2 |
| Boshuisen, ML; den Boer, JA; Slaap, BR; van Roon, AM | 1 |
| González-Macías, J; Hernández, JL; Infante, J; Ramos, FJ; Rebollo, M | 1 |
| Duggal, HS; Fetchko, J | 1 |
| Dallet, P; Dubost, JP; Kummer, E; Labat, L | 1 |
| Dlaboga, D; Dziedzicka-Wasylewska, M; Maj, J; Rogoz, Z; Wrobel, A | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Kim, KS; Pae, CU | 1 |
| Azzoni, A; Raja, M | 1 |
| Cresp, RM; Girishchandra, BG; Johnson, L; Orr, KG | 1 |
| Donaghy, K; Holtsclaw, E; Kirsh, KL; Passik, SD; Theobald, DE | 1 |
| Gourley, M; Hurley, AD; Lu, R | 1 |
| Kunwar, A; Masand, PS; Virk, S | 1 |
| Delgado, PL; Gelenberg, AJ; Moreno, FA; Onate, L | 1 |
| Camardese, G; Carli, V; DeRisio, S; Romano, L; Sarchiapone, M | 1 |
| Biggio, G; Dazzi, L; Pisul, MG; Purdy, RH; Serra, M | 1 |
| Spierings, EL | 1 |
| Begaud, B; Jarry, C; Matoga, M; Pehourcq, F; Romiguieres, T | 1 |
| Goldberg, RJ | 1 |
| Ahmed, A | 1 |
| Crijns, HJ; Honig, A; Lambert, FP; Ormel, J; Schene, AH; van den Brink, RH; van Melle, JP | 1 |
| Baghai, T; Bidlingmaier, M; Goy, J; Laakmann, G; Schüle, C; Strasburger, C | 1 |
| Hui, CK; Lai, CL; Lam, SK; Wong, WM; Yuen, MF | 1 |
| Bender, D; Gjedde, A; Marthi, K; Smith, DF | 1 |
| Abraham, G | 1 |
| Choi, SC; Lee, SY; Rho, SH | 1 |
| Aslan, S; Cosar, B; Isik, E | 1 |
| Chin-Kon-Sung, UG; Colbers, EP; Peeters, PA; Schnabel, PG; Sitsen, JM; Spaans, E; van den Heuvel, MW | 1 |
| Khouzam, HR | 2 |
| Aguglia, E; Amore, M; Delgado, PL; Gastpar, M; Hawley, C; Hirschfeld, RM; Kasper, S; Linden, M; Massana, J; Mendlewicz, J; Möller, HJ; Montgomery, SA; Nemeroff, CB; Saiz, J; Such, P; Torta, R; Versiani, M | 1 |
| Anghelescu, I; Dahmen, N; Klawe, C | 1 |
| Katz, Y; Pick, CG; Rigai, T; Schreiber, S | 1 |
| Cerniglia, CE; Freeman, JP; Fu, PP; Moody, JD | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Benkert, O; Muller, M; Szegedi, A | 1 |
| Van Veen, JF; Van Vliet, IM; Westenberg, HG | 1 |
| Bhanji, NH; Chouinard, G; Margolese, HC; Saint-Laurent, M | 1 |
| Lewis, JD | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Kim, KS; Pae, CU; Tsoh, J | 1 |
| Fahn, S; Frucht, SJ; Gordon, PH; Louis, ED; Pullman, SL | 1 |
| Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E | 1 |
| Dimellis, D | 1 |
| Amore, M; Balista, C; Camardese, G; Carli, V; De Risio, S; Faia, V; Ferrari, G; Poterzio, F; Sarchiapone, M | 1 |
| Baghai, T; Bidlingmaier, M; Laakmann, G; Schüle, C; Strasburger, C | 1 |
| Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A | 1 |
| D'Andreamatteo, G; Iacono, D; Luciano, AL; Onofrj, M; Thomas, A | 1 |
| Ağargün, MY; Kara, H; Ozbek, H; Ozer, OA; Tombul, T | 1 |
| Danileviciūte, V | 1 |
| Barnett, S; Butterfield, MI; Casat, CD; Connor, KM; Davidson, JR; van Meter, S; Weisler, RH | 1 |
| Baghai, T; Ella, R; Eser, D; Möller, HJ; Padberg, F; Rupprecht, R; Schüle, C; Zwanzger, P | 1 |
| Barros, FC; de Quadros, A; Teive, HA; Werneck, LC | 1 |
| Bannink, M; Stronks, DL; Van Gool, AR; Vos, MS | 1 |
| Cornil, C; Dumont, F; Lavergne, F; Machowski, R; Schittecatte, M; Wilmotte, J | 1 |
| Gupta, S; Masand, PS | 1 |
| Lima, L; Urbina, M | 1 |
| Baghai, T; Rupprecht, R; Schüle, C; Zwanzger, P | 1 |
| Kundhur, D; Lam, RW; Solomons, K; Wan, DD; Yatham, LN | 1 |
| Sennef, C; Sitsen, JM; Timmer, CJ | 1 |
| Lankisch, PG; Werner, HM | 1 |
| Baghai, T; Hennig, J; Laakmann, G; Schüle, C | 2 |
| Andresen, S; Davis, MP; Frandsen, JL; Taylor, S; Walsh, D | 1 |
| Bonelli, RM | 1 |
| Baghai, TC; Bondy, B; Minov, C; Möller, HJ; Rupprecht, R; Schüle, C; Schwarz, MJ; Zwanzger, P | 1 |
| Davis, MP; Khawam, E; Lagman, R; Pozuelo, L | 1 |
| Burrows, GD; Gupta, RK; Tiller, JW | 1 |
| Brüggemann, BR; Garlipp, P; Machleidt, W | 1 |
| Fisfalen, ME; Hsiung, RC | 1 |
| Biswas, PN; Shakir, SA; Wilton, LV | 1 |
| Angus, M; Crawford, GM; Hamilton, L; Wade, A; Wilson, R | 1 |
| Anghelescu, I; Benkert, O; Klawe, C; Kohnen, R; Müller, MJ; Szegedi, A | 1 |
| Lyons, KE; Pahwa, R | 1 |
| Aga, VM; Barklage, NE; Jefferson, JW | 1 |
| Hindmarch, I; Johnsen, S; Meadows, R; Ridout, F | 1 |
| Schillerstrom, JE; Seaman, JS | 1 |
| Dembinski, J; Dorn, C; Rohde, A | 1 |
| Epshtein, S; Fuchs, C; Poyurovsky, M; Schneidman, M; Weizman, A; Weizman, R | 1 |
| Chen, JL; Karwa, M; Spinowitz, N | 1 |
| Canale, A; Crucitti, D; D'Arrigo, C; Malara, G; Muscatello, MR; Spina, E; Torre, DL; Zoccali, R | 1 |
| Baccichet, E; Carreira, I; Lima, L; Obregón, F; Peña, S; Urbina, M | 1 |
| Lévy, E; Margolese, HC | 1 |
| Agren, H; Bäuml, J; Behnke, K; Martin, S; Ravindran, AV; Søgaard, J; Vester-Blokland, ED | 1 |
| Hegerl, U; Juckel, G; Laakmann, G; Pogarell, O; Rupp, D; Schüle, C | 1 |
| Ekstrom, RD; Esposito, SM; Ford, AL; Golden, RN; Nicholas, LM | 1 |
| Chen, CC; Hong, CJ; Hsiao, CC; Hu, WH; Ruwe, FJ; Tsai, SJ | 1 |
| Christodoulou, G; Liappas, J; Paparrigopoulos, T; Tzavellas, E | 1 |
| Klíma, J; Macek, J; Ptácek, P | 1 |
| Croft, HA; Labbate, LA; Oleshansky, MA | 1 |
| Kremer, C; Murphy, GM; Rodrigues, H; Schatzberg, AF | 1 |
| Kremer, C; Murphy, GM; Rodrigues, HE; Schatzberg, AF | 1 |
| Olivier, B; Waldinger, MD; Zwinderman, AH | 1 |
| Pinder, RM; Roose, SP | 1 |
| Frijlink, HW | 1 |
| Grauer, MT; Holsboer, F; Uhr, M | 1 |
| Roxanas, MG | 1 |
| Baghai, T; Laakmann, G; Rackwitz, C; Schule, C | 1 |
| Böhm, M; Hammer, B; Link, A; Weisgerber, K | 1 |
| Nash, JR; Nutt, DJ; Potokar, JP; Wilson, SJ | 1 |
| Benelli, A; Bertolini, A; Frigeri, C; Genedani, S | 1 |
| Biondi, M; Orlandi, V; Salviati, M; Speca, A | 1 |
| Alvarez, E; Andreoli, A; Ferrer-Alcón, M; García-Sevilla, JA; Guimón, J; Pérez, V; Puigdemont, D; Rubovszky, G; Ventayol, P | 1 |
| Morgan, PE; Spencer, EP; Tapper, J | 1 |
| Cormier, JL; DeMartinis, NA; Gary, EM; Gary, KA; McNally, DP; Winokur, A | 1 |
| Berendsen, HH; Kloosterboer, HJ | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Hollander, SB; Nelson, JC; Rodrigues, H; Roose, SP; Salzman, C | 1 |
| Elger, CE; Falkai, P; Kühn, KU; Maier, W; Quednow, BB; Thiel, M | 1 |
| Ferner, RE; Hamlyn, AN; Langford, NJ; Munyame, C; Patel, H | 1 |
| Bender, D; Hansen, SB; Hermansen, F; Jakobsen, S; Marthi, K; Rosenberg, R; Smith, DF; Smith, SB | 1 |
| Härtter, S; Hiemke, C; Shams, M | 1 |
| Baghai, T; Laakmann, G; Schüle, C | 1 |
| Alda Díez, M; Espuelas Monge, M; García-Campayo, J | 1 |
| Houlihan, DJ | 1 |
| Keller, MB; Kremer, C; Nierenberg, AA; Quitkin, FM; Thase, ME | 1 |
| Devoto, P; Flore, G; Gessa, GL; Longu, G; Pira, L | 1 |
| Gillman, PK | 3 |
| Norman, TR | 1 |
| Cedro, C; Di Rosa, AE; La Torre, D; Meduri, M; Muscatello, MR; Neri, P; Spina, E; Zoccali, R | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Bateman, DN; Dhaun, N; Good, AM; Kelly, CA; Laing, WJ; Strachan, FE | 1 |
| Lynch, A; Madjlessi, A | 1 |
| Christodoulou, G; Liappas, J; Malitas, P; Paparrigopoulos, T; Tzavellas, E | 1 |
| Knapp, M; Patel, A; Romeo, R; Thomas, C | 1 |
| Katsu, H; Nakayama, K; Sakurai, T | 1 |
| Hundley, JL; Yosipovitch, G | 1 |
| Bendtsen, L; Jensen, R | 1 |
| Brockmöller, J; Kress, I; Meineke, I; Poser, W; Rüther, E | 1 |
| Norman, TR; Olver, JS | 1 |
| Alamo, C; López-Muñoz, F; Rubio, G; San, L | 1 |
| Maier, W | 1 |
| Hartter, S | 1 |
| Baumann, P; Cochard, N; Eap, CB; Jonzier-Perey, M; Paus, E | 1 |
| Dragicevic, A; Grasmäder, K; Hiemke, C; Jaehde, U; Kühn, KU; Maier, W; Rao, ML; Rietschel, M; Verwohlt, PL; von Widdern, O; Zobel, A | 1 |
| Bailey, D; del Pilar Castillo Abadia, M; Gyenes, G; Le Mellédo, JM; Newman, S; Tsuyuki, R | 1 |
| Fabricio, AS; Navarra, P; Pozzoli, G; Tringali, G | 1 |
| Bonato, PS; Cesarino, EJ; de Santana, FJ | 1 |
| Haapasalo-Pesu, KM; Lahelma, L; Marttunen, M; Vuola, T | 1 |
| Lawrence, RW | 1 |
| Janka, Z; Kálmán, J; Kitajka, K; Molnár, J; Pákáski, M; Palotás, A; Palotás, M; Penke, B; Puskás, LG | 1 |
| Castillo, JL; Guilleminault, C; Menendez, P; Segovia, L | 1 |
| Abraham, G; Prost, E | 1 |
| Chung, MY; Jun, EM; Jun, YJ; Kim, SS; Kim, WC; Min, KH | 1 |
| Lezanska-Szpera, M; Rybakowski, JK; Samborski, W | 2 |
| Bruscoli, M; Pallanti, S; Quercioli, L | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Unsal, M; Yaris, E; Yaris, F | 1 |
| Hollander, SB; Kremer, C; Murphy, GM; Rodrigues, HE; Schatzberg, AF | 1 |
| Dahmen, N; Kohnen, R; Müller, MJ; Rujescu, D; Stassen, HH; Szegedi, A; Tadic, A | 3 |
| Bartoletti, C; Fanali, S; Mandrioli, R; Pucci, V; Raggi, MA; Sabbioni, C | 1 |
| Brockmöller, J; Henckel, HB; Kirchheiner, J; Meineke, I; Roots, I | 1 |
| Caldis, EV; Gair, RD | 1 |
| Crijns, H; Hamulyák, K; Honig, A; Lousberg, R; Scharpé, S; Schins, A; Van Melle, J | 1 |
| Aichhorn, W; Stuppaeck, C; Weiss, U; Whitworth, AB | 1 |
| de Bruijn, ER; Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ | 1 |
| Chae, JH; Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH | 1 |
| Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E | 1 |
| Petty, F; Ramaswmay, S; Siddiqui, Z | 1 |
| Bohrer, E; Heuser, I; Niedermaier, N; Schlattmann, P; Schulte, K | 1 |
| Blackburn-Munro, G; Bomholt, SF; Mikkelsen, JD | 1 |
| Moreno, R; Ramakers-van Moorsel, CJ; Schutte, AJ; Versiani, M | 1 |
| Berry, RB; Hayward, LF; Koch, GL | 1 |
| Carey, TS; Gartlehner, G; Gaynes, BN; Hansen, RA; Lohr, KN; Randolph, LC | 1 |
| Konitsiotis, S; Mantas, C; Mavreas, V; Pappa, S | 1 |
| Alevizos, B; Alevizos, E; Vaidakis, N | 1 |
| Robertson, VB; Wilson, MS | 1 |
| Backmund, M; Nickel, T; Pollmächer, T; Sonntag, A | 1 |
| Cassanelli, A; Gambarana, C; Raone, A; Rauggi, R; Tagliamonte, A | 1 |
| Gerschlager, W; Langosch, JM; Münchau, A; Orth, M; Rothwell, JC; Trimble, MR | 1 |
| Kuliwaba, A | 1 |
| Barbaud, A; Schmutz, JL; Trechot, P | 1 |
| Aghayan, S; Akhondzadeh, S; Amini, H; Jalili, SA; Pakravan-Nejad, M; Yahyazadeh, O | 1 |
| Bothmer, J; Langer, S; Ramaekers, JG; Wingen, M | 1 |
| Aboujaoude, EN; Choung, HW; Gamel, NN; Koran, LM; Smith, EH | 1 |
| Crockford, DN; White, WD | 1 |
| Biggio, G; Cherchi, G; Dazzi, L; Seu, E | 1 |
| Almási, J; Rihmer, Z | 1 |
| Baccichet, E; Carreira, I; Lima, L; Peña, S; Urbina, M | 1 |
| Bindslev-Jensen, C; Thormann, H | 1 |
| Chabolla, DR; Freeman, WD | 1 |
| Dragicevic, A; Frahnert, C; Grasmäder, K; Hiemke, C; Kühn, KU; Maier, W; Rao, ML; Verwohlt, PL; von Widdern, O; Zobel, A | 1 |
| Raji, MA | 1 |
| Schwertfeger, N; Szegedi, A | 1 |
| Breda, MF; Novaretti, TM; Pereira, PG; Pilon, B; Teixeira, FV | 1 |
| Campisi, J; Fleshner, M; Johnson, JD; Kennedy, SL; Nickerson, M; Sharkey, C; Smith, TP | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Ozcanli, T; Ozdemir, S; Ozmen, M; Unsalver, B | 1 |
| Heiser, P; Krieg, JC; Singh, S; Vedder, H | 1 |
| Buecking, A; Khazaal, Y; Vandeleur, CL; Zullino, DF | 1 |
| Dogan, E; Gol, M; Guclu, S; Saygili, U | 1 |
| Wilson, MS | 1 |
| Demet, MM; Esen-Danaci, A; Mizrak, S | 1 |
| Degner, D; Grohmann, R; Kropp, S; Porzig, J; Rüther, E | 1 |
| Baumann, P; Engel, R; Fähndrich, E; Greil, W; Hippius, H; Horvath, A; Mayland, G; Rüther, E; Schmidt, LG; Zullino, D | 1 |
| Biersack, HJ; Broich, K; Clusmann, H; Freymann, N; Joe, A; Maier, W; Reinhardt, M; Schramm, J; Zobel, A | 1 |
| Bäckström, M; Dahlqvist, R; Johansson, S; Kling, A; Mjörndal, T | 1 |
| Ahlner, J; Bengtsson, F; Prochazka, J; Reis, M; Sitsen, A | 1 |
| Aderjan, R; Mattern, R; Pedal, I; Skopp, G; Wenzel, S | 1 |
| Kongsakon, R; Papadopoulos, KI; Saguansiritham, R | 1 |
| Cobo, J; Gibert, K; Rodriguez-Cano, E; Rojo, JE; Vallejo, J | 1 |
| Arias, F; Carrasco, JL; Díaz, M; Ferrando, L; Ibáñez, A; Montes, JM; Pelegrín, C; Saiz-Ruiz, J; Vicente, F; Viñas, R | 1 |
| Birkenhäger, TK; Bruijn, JA; Moleman, P; van den Broek, WW; Vulto, AG | 1 |
| Campanella, D; Carano, A; Cicconetti, A; De Berardis, D; Ferro, FM; Gambi, F; Mezzano, D; Penna, L; Salerno, RM; Salini, G; Sepede, G | 1 |
| Cavanagh, J; Dempsey, MF; Dewar, D; Eersels, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Winters, NC | 1 |
| Aturki, Z; D'Orazio, G; Fanali, S; Kasicka, V; Raggi, MA | 1 |
| de Jong, GJ; Kranendijk, M; Somsen, GW; Waterval, JC | 1 |
| Passier, A; van Puijenbroek, E | 1 |
| Brunner, H; Held, K; Ising, M; Schmid, DA; Sonntag, A; Steiger, A; Uhr, M; Weikel, JC; Wichniak, A | 1 |
| Bigatà, X; Sais, G; Soler, F | 1 |
| Anvar, J; Bachler, E; Egger, C; Fartacek, R; Kaplan, P; Kettler, C; Lahmann, C; Leiberich, PK; Loew, TH; Mitterlehner, F; Muehlbacher, M; Nickel, C; Nickel, MK; Pedrosa Gil, F; Rother, N; Rother, WK; Tritt, K | 1 |
| Agüera, L; de la Gándara, J; de Pedro, JM; Rojo, JE; Ros, S | 1 |
| Chang, CC; Chang, HA; Mao, WC; Shiah, IS | 1 |
| Chou, YH; Shiah, IS; Wang, TS | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Baghai, TC; di Michele, F; Eser, D; Kempter, H; Pasini, A; Romeo, E; Rupprecht, R; Schüle, C; Schwarz, M; Uzunov, DP | 1 |
| Cumming, P; Hansen, SB; Jakobsen, S; Marthi, K; Munk, OL; Smith, DF | 1 |
| Beitinger, PA; Fulda, S; Himmerich, H; Pollmächer, T; Schaaf, L; Schuld, A | 1 |
| Apikoglu Rabus, S; Bilici, M; Izzettin, F; Rabus, M | 1 |
| Legutko, B; Rogóz, Z; Skuza, G | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Kim, W; Pae, CU | 1 |
| Berman, RM; Heuser, I; Neu, P; Schlattmann, P; Schwertfeger, N | 1 |
| Baker, RA; Benkert, O; Heinrich, C; Heukels, A; Kohnen, R; Philipp, M; Schutte, AJ; Simmons, JH; Szegedi, A; van der Vegte-Senden, M | 1 |
| Anderson, IM; Deakin, JF; Elliott, R; McKie, S; Richardson, P; Völlm, B | 1 |
| Ahlner, J; Bengtsson, F; Dahl, ML; Odén, A; Prochazka, J; Sjödin, I; Wålinder, J | 1 |
| Appel, H; Fiedler, U; Jockers-Scherübl, MC; Klein, JP; Quante, A | 1 |
| Freynhagen, R; Lipfert, P; Muth-Selbach, U; Stevens, MF; Tölle, TR; von Giesen, HJ; Zacharowski, K | 1 |
| Al-Adwani, A | 1 |
| Appleton, D; Chung, SA; Deb, P; Hossain, N; Huang, X; Kayumov, L; Moller, H; Novak, M; Shapiro, CM; Shen, J; Sun, F; Wang, X | 1 |
| Lakatos, L; Rihmer, Z | 1 |
| Almási, J; Fekete, S; Osváth, P; Vörös, V | 1 |
| Sauvageau, A | 1 |
| Fuchs, C; Pashinian, A; Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Herman, ZS; Huzarska, M; Zieliński, M | 1 |
| Egger, C; Eichberger, G; Hinterhuber, H; Hofmann, P; Kasper, S; Konstantinidis, A; Mühlbacher, M; Nickel, M; Nimmerrichter, A; Schubert, H; Stuppaeck, C | 1 |
| Kohen, I; Sarcevic, A | 1 |
| Albertazzi, P | 1 |
| Freynhagen, R; Lipfert, P; Muth-Selbach, U; Vogt, J | 1 |
| Cumming, P; Dyve, S; Jakobsen, S; Marthi, K; Minuzzi, L; Munk, OL; Smith, DF | 1 |
| Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
| Chandra, PS; Chaturvedi, SK; Gupta, A; Prabhu, SC; Ranjan, S | 1 |
| Silver, N | 2 |
| Bakker, PL; Gerrits, M; Koch, T; Ter Horst, GJ | 1 |
| Cho, SN; Choi, SB; Hwang, IB; Jeong, YC; Kim, DJ; Kim, JH; Lee, CT; Lee, E; Lee, HK; Lee, YS; Namkoong, K; Oh, DY; Pae, CU; Shin, DH; Shin, YC; Yoon, SJ | 1 |
| Guardiola, VD; Ladino, M; Paniagua, M | 1 |
| Pae, CU | 2 |
| Hennig, J; Laakmann, G; Schüle, C; Sighart, C | 1 |
| Albertini, G; Di Gennaro, G; Onorati, P; Polito, E; Sarà, M | 1 |
| Deisenhammer, EA; Ebenbichler, CF; Engl, J; Hinterhuber, H; Kramer-Reinstadler, K; Laimer, M; Lechner-Schoner, T; Patsch, JR; Rauchenzauner, M; Strauss, R | 1 |
| Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R | 1 |
| Baghai, TC; Buechs, R; Eser, D; Jordan, M; Rupprecht, R; Schüle, C; Zwanzger, P | 1 |
| Angle, JM; Dallimore, JE; Mackie, AR; McDaid, J; Mickiewicz, AL; Napier, TC; Shen, F; Tedford, CE | 1 |
| Alberdi-Leniz, A; Gené-Badia, J; Navarro-González, M | 1 |
| Dekeyne, A; Millan, MJ | 2 |
| Alpert, JE; Biggs, M; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Biondi, M; Cairoli, F; Costantini, A; Ferrarese, G; Pasquini, M; Picardi, A; Sternberg, C | 1 |
| Argiriou, S; Knopf, U; Kuwilsky, A; Zink, M | 1 |
| Clayton, AH; Montejo, AL | 1 |
| Dawn, A; Yosipovitch, G | 1 |
| Demierre, MF; Taverna, J | 1 |
| Bogousslavsky, J; Borruat, FX; Delavelle, J; Du Pasquier, RA; Koralnik, IJ; Kuntzer, T; Landis, T; Lurati-Ruiz, F; Picard, F; Vulliemoz, S | 1 |
| Dätwyler, S; Eschen, A; Künig, G; Schreiter Gasser, U | 1 |
| Valenstein, M | 1 |
| Biggs, MM; Davis, L; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Betzel, J; Hollander, SB; Nelson, JC; Smolen, P | 1 |
| Bouckaert, F; Peuskens, J; van den Bosch, S | 1 |
| De Santis, M; Diav-Citrin, O; Djulus, J; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Shakir, S; Voyer Lavigne, S; Wilton, L | 1 |
| Adler, LA; Morrill, MS; Reingold, LS; Wilens, TE | 1 |
| Hackett, LP; Ilett, KF; Kohan, R; Kristensen, JH; Rampono, J | 1 |
| Steinmann, C | 1 |
| Fountoulakis, KN; Iacovides, A; Kaprinis, GS; Koumaris, V; Siamouli, M | 1 |
| Akcay, A; Bavbek, N; Kargili, A; Kaya, A | 1 |
| Langer, S; Ramaekers, JG; Wingen, M | 1 |
| Huerta, S; Siddiqui, A | 1 |
| Dilley, JW; Harrison, G; Loeb, L; Nelson, K | 1 |
| Alfinito, PD; Cosmi, S; Deecher, DC; Maswood, N; Pawlyk, AC | 1 |
| Almási, J; Tajti, J | 1 |
| Hulstijn, W; Ruigt, GS; Sabbe, BG; Verkes, RJ; Wezenberg, E | 1 |
| Czell, D; Kaps, M; Manzl, G; Mutschler, J | 1 |
| Zirwas, MJ | 1 |
| Brockmöller, J; Kirchheiner, J; Meineke, I; Steinmetz, H | 1 |
| Carboni, V; Cortesi, M; Fusar-Poli, P; Luca, de M; Matteo, L; Politi, P | 1 |
| Arana-Lechuga, Y; Prospero-Garcia, KA; Ramirez-Bermudez, J; Teran-Perez, G; Torres-Ruiz, A; Velazquez-Moctezuma, J | 1 |
| Basta-Kaim, A; Budziszewska, B; Holan, V; Jagła, G; Kubera, M; Lasoń, W; Leśkiewicz, M; Nowak, W; Regulska, M; Rogóz, Z; Roman, A; Skuza, G; Zajicova, A | 1 |
| Adomaitiene, V; Danileviciūte, V; Kadusevicius, E; Maciulaitis, R; Sveikata, A; Volbekas, V | 1 |
| Baumann, P; Jonzier-Perey, M; Nikisch, G; Paus, E | 1 |
| Adetunji, B; Basil, B; Mathews, M; Osinowo, T | 1 |
| Ashina, S; Bendtsen, L; Buchgreitz, L; Jensen, R | 1 |
| Klier, CM; Lee, A; Mossaheb, N; Zernig, G | 1 |
| Doraiswamy, PM; Gersing, K; Hellegers, C; Varia, I; Venkataraman, S | 1 |
| Carley, DW; Olopade, C; Radulovacki, M; Ruigt, GS | 1 |
| Burian, R; Diefenbacher, A; Elstner, S | 1 |
| Akinpeloye, HO; Hamzah, Z; Hannan, N; Meagher, D | 1 |
| Brockmöller, J; Kirchheiner, J; Meineke, I | 1 |
| Bateman, DN; Good, AM; Waring, WS | 1 |
| Chang, HT; Chen, IS; Chen, JS; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Liu, SI; Lu, YC; Pan, CC | 1 |
| Brunn, A; Hallek, M; Hilker, R; Owczarczyk, K; Rubbert, A | 1 |
| Ghaemi, SN; Wingo, AP | 1 |
| Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J | 1 |
| Biederman, J; de Moor, C; DeMaso, DR; Forbes, P; Gonzalez-Heydrich, J; Hsin, O; Masek, B; Mrakotsky, C; Raches, D | 1 |
| Dietl, T; Friess, E; Koethe, D; Leweke, FM | 1 |
| Betzel, JV; Holden, K; Hollander, SB; Nelson, JC; Roose, S; Salzman, C | 1 |
| Baghai, TC; Born, C; Eser, D; Häfner, S; Hecht, S; Hermisson, I; Nothdurfter, C; Rupprecht, R; Schüle, C | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Martin, AL; Park, B; Wallace, D | 1 |
| Kayir, H; Sezer, Z; Uzbay, TI; Yilmaz, I | 1 |
| Jagsch, C; Marksteiner, J; Seiringer, E; Windhager, E | 1 |
| Baghai, TC; di Michele, F; Eser, D; Pasini, A; Romeo, E; Rupprecht, R; Schüle, C; Schwarz, M | 1 |
| Foley, KF; Kast, RE | 1 |
| Aturki, Z; D'Orazio, G; Fanali, S; Raggi, MA; Rocco, A; Scotti, V | 1 |
| Dubarek, W; Kucia, K | 1 |
| Choi, MJ; Kang, RH; Lee, MS; Paik, JW; Wong, ML | 1 |
| Barnum, PD; Freeman, J; Markowitz, AB; Raji, MA | 1 |
| Gembruch, U; Heep, A; Rohde, A; Schwarzer, V | 1 |
| Tuya, AC | 1 |
| Audrain, H; Bender, D; Hansen, SB; Jakobsen, S; Jensen, SB; Rodell, A; Rosenberg, R; Smith, DF; Stork, BS; Wegener, G | 1 |
| Bergmann, C; Cikurel, K; Cunningham-Rundles, C; Koralnik, IJ; Morgello, S; Simpson, DM; Verma, S; Weinstein, ZR | 1 |
| Baharudin, A; Daud, TI; Jaafar, NR; Rahman, FN | 1 |
| Bares, M; Brunovsky, M; Kopecek, M; Krajca, V; Sos, P; Stopkova, P | 1 |
| de Jonge, P; Honig, A; Kuyper, AM; Ormel, J; Schene, AH; Schins, A; Tulner, D; van Melle, JP | 1 |
| Fava, M; Papakostas, GI; Thase, ME | 1 |
| Choi, MJ; Hahn, SW; Kang, RH; Lee, MS | 1 |
| Brown, M; LoVecchio, F; Pizon, A; Riley, B | 1 |
| Källén, B; Lennestål, R | 1 |
| Choung, RS; Cremonini, F; Talley, NJ; Thapa, P; Zinsmeister, AR | 1 |
| Bonato, PS; de Santana, FJ | 1 |
| Anderson, JJ; Berry, RB; Chou, YL; Davenport, PW; Hayward, LF; Stanley, JT; Vujisic, K | 1 |
| Chen, CC; Hsu, YW; Hung, YC; Ko, YP; Lao, HC; Lin, CS | 1 |
| Biondi, M; Delle Chiaie, R; Fiorentini, S; Salviati, M | 1 |
| Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
| Ceccherini-Nelli, L; Focosi, D; Kast, RE; Lauria, G; Maggi, F; Petrini, M | 1 |
| Eisfeld, BS; Kennedy, SH; Ravindran, LN | 1 |
| Burke, J; Hussain, A | 1 |
| Ben-Zion, I; Shalev, H; Shiber, A | 1 |
| Arnold, P; Deriaz, O; Gobelet, C; Kuntzer, T; Vuadens, P | 1 |
| Elbi, H; Ersoy, MA; Noyan, AM | 1 |
| Kinkul'kina, MA; Shchukina, EP | 1 |
| Feng, X; Hu, Y; Song, J; Wei, X; Xu, J; Zhu, J | 1 |
| Bozkurt, A; Cansever, A; Doruk, A; Karlidere, T; Ozgen, F; Ozmenler, NK; Ozsahin, A; Sutcigil, L; Uzun, O; Yetkin, S | 1 |
| Kim, JM; Kim, KM; Kim, KS; Kim, SW; Kim, YC; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Akbiyik, DI; Alkis, N; Cankurtaran, ES; Ozalp, E; Soygur, H; Turhan, L | 1 |
| Dimopoulos, NP; Mitsonis, CI; Psarra, VV | 1 |
| Fava, M; Homberger, CH; Papakostas, GI | 1 |
| Eriksen, HR; Lie, SA; Stubhaug, B; Ursin, H | 1 |
| Choi, MJ; Hahn, SW; Kang, RH; Lee, MS; Paik, JW | 1 |
| Akdeniz, F; Altintoprak, AE; Coskunol, H; Kitapcioglu, G; Zorlu, N | 1 |
| McGregor, C; Mitchell, A; Srisurapanont, M; White, JM; Wickes, W | 1 |
| Berk, M; Malhi, GS; Ng, F | 1 |
| Akhtar, S; Prakash, R; Zia Ul Haq, M | 1 |
| Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Benyamina, A; Blecha, L; Lecacheux, M; Lukasiewcz, M; Reynaud, M | 1 |
| Beranova, I; Hrdlicka, M; Urbanek, T; Zamecnikova, R | 1 |
| Blaszczyk, J; Cruickshank, CC; Dyer, KR; Montebello, ME; Quigley, A; Shand, D; Tomkins, S | 1 |
| Brunner, H | 1 |
| Borkowska, A; Drozdz, W; Rybakowski, J; Ziółkowska-Kochan, M | 1 |
| Coskun, M; Mukaddes, NM | 1 |
| Dellenbaugh, T; Hieber, R; Nelson, LA | 1 |
| Gallwitz, T; Kirch, MH; Messer, T; Rottach, KG; Schaner, BM; Teufel, LM; Zivotofsky, AZ | 1 |
| Gourion, D | 1 |
| Liang, KY; Liao, SC; Liu, CC | 1 |
| Klinger, G; Merlob, P; Sokolover, N | 1 |
| Buchanan, PR; Crompton, R; Desai, AV; Gendreau, RM; Grunstein, RR; Kranzler, J; Marshall, NS; Melehan, KL; Rao, SG; Wong, KK; Yee, BJ; Zack, N | 1 |
| Ashkanian, M; Audrain, H; Bender, D; Hall, H; Hansen, SB; Jakobsen, S; Minuzzi, L; Rosenberg, R; Smith, DF; Stork, BS | 1 |
| Fusar-Poli, P; Hobson, R; Martinelli, V; Politi, P | 1 |
| Chandrasekaran, PK | 1 |
| Haag, C; Linden, M; Schmidt, LG; Westram, A | 1 |
| Baghai, TC; Eser, D; Nothdurfter, C; Rupprecht, R; Schüle, C | 1 |
| Christof, T; Linden, M; Rentzsch, C | 1 |
| Hu, M; Kang, L; Li, B; Li, J; Wang, D; Zhang, P | 1 |
| Bergander, B; Deter, HC; Meissner, K; Zimmermann-Viehoff, F | 1 |
| Doruk, A; Gulsun, M | 1 |
| Ho, ST; Sheen, MJ | 1 |
| Golewale, MH; Kahn, DA; Khan, AY | 1 |
| Jia, L; Li, YY; Shang, YY | 1 |
| Cheah, CY; Fegan, PG; Ladhams, B | 1 |
| Andrzejczak, D; Kocon, K; Zieba, R | 1 |
| Linden, M | 1 |
| Baghai, TC; Bondy, B; Eser, D; Rupprecht, R; Schüle, C; Schwarz, M | 1 |
| Chang, FL; Ho, ST; Huang, ST; Lee, CH; Sheen, MJ; Tsung, YC | 1 |
| Kim, JM; Kim, SW; Park, KH; Shin, IS; Yoon, JS; Youn, T | 1 |
| Kálmán, J | 1 |
| Gendreau, M; Kranzler, J; Levendowski, DJ; Rao, S; Westbrook, PR; Wong, K; Zack, N; Zavora, T | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B | 1 |
| Barbini, B; Benedetti, F; Bernasconi, A; Colombo, C; Dallaspezia, S; Fulgosi, MC; Gavinelli, C; Marino, E; Pirovano, A; Radaelli, D; Smeraldi, E | 1 |
| Cahill, CM; Jhamandas, K; Milne, B; Sutak, M | 1 |
| Cunha, FT; Ladeira, RB; Nicolato, R; Salgado, JV; Teixeira, AL | 1 |
| Bonato, PS; de Santana, FJ; Lanchote, VL | 1 |
| Dose, T; Hennings, J; Holsboer, F; Horstmann, S; Ising, M; Kloiber, S; Lucae, S; Menke, A; Spieler, D; Uhr, M | 1 |
| Graham, MP; Harper, LK; Herrold, AA; Napier, TC; Shen, F; Specio, SE; Tedford, CE | 1 |
| Chen, R; Lopes, J | 1 |
| Conrad, R; Geiser, F; Imbierowicz, K; Liedtke, R; Wegener, I | 1 |
| Dang, A; Garg, G; Rataboli, PV | 1 |
| Chaput, C; Mannoury La Cour, C; Millan, MJ; Touzard, M | 1 |
| Arnone, D; Cowen, PJ; Harmer, CJ; Horder, J | 1 |
| Goyal, N; Sinha, VK | 1 |
| Albayrak, F; Bilici, M; Dursun, H; Gulaboglu, M; Ozturk, C; Saglam, MB; Tekin, SB; Uyanik, A | 1 |
| Hiemke, C; Kircher, T; Leube, D; Milenovic, S; Schlotterbeck, PM; Vehren, T | 1 |
| Ahlner, J; Baumann, P; Bengtsson, F; Dahl, ML; Jonzier-Perey, M; Lind, AB; Powell Golay, K; Reis, M | 1 |
| Howland, RH | 1 |
| Burkin, M; Joffe, G; Joffe, M; Stenberg, JH; Terevnikov, V; Tiihonen, J | 1 |
| Carney, PR; Davis, L; Dillard, SC; Geyer, JD; Ward, LC | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS | 1 |
| Chen, ZX; Jin, WD; Wang, HQ | 1 |
| Driehsen, C; Freynhagen, R; Hermanns, H; Lipfert, P; Muth-Selbach, U | 1 |
| Imanishi, T; Inoue, T; Kakui, N; Kitamura, K; Koyama, T; Yamauchi, M; Yokoyama, F | 1 |
| Chung, SA; Li, X; Moller, HJ; Shapiro, CM; Shapiro, GK; Shen, J; Wang, X | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; McGuire, H; Nakagawa, A; Omori, IM; Watanabe, N | 2 |
| Laroia, R; Samuels, D; Spiegel, DR | 1 |
| Brunnauer, A; David, I; Fric, M; Hermisson, I; Laux, G; Möller, HJ | 1 |
| Iacovides, A; Kaprinis, G; Nimatoudis, J; Sokolaki, S; Spyridi, S | 1 |
| Cettomai, D; McArthur, JC | 1 |
| Jansen, WT; Stassen, HH; Szegedi, A; Thase, ME; van der Meulen, E; van Willigenburg, AP | 1 |
| Darvishi, R; Kunik, ME; Shub, D | 1 |
| Ahned, N; Pearce, S; Varas, GM | 1 |
| Raju, AN; Rao, RN | 1 |
| Baumann, P; Walder, A | 1 |
| Blaszczyk, AT; Fox, CB; Sleeper, RB; Treadway, AK | 1 |
| Berk, M; Bole, F; D'Souza, R; Dodd, S; Gama, CS; Hustig, H; Koopowitz, L; Malloy, H; Monkhouse, A; Piskulic, D; Rowland, C; Sathiyamoorthy, S; Sundram, S | 1 |
| Alvarez, M; Corbacho, L; Fraile, P; Garcia, T; Garcia-Cosmes, P; Tabernero, JM | 1 |
| Blier, P; Boucher, N; de Montigny, C; Debonnel, G; Gobbi, G; Hébert, C; Turcotte, JE | 1 |
| Concia, E; Corsini, F; Deganello, R; Ferrari, S; Lanzafame, M; Lattuada, E; Vento, S | 1 |
| Coskun, M; Karakoc, S; Kircelli, F; Mukaddes, NM | 1 |
| Ito, T; Okubo, Y; Roth, A | 1 |
| Chien, CC; Lung, FW; Tzeng, DS; Yang, CY | 1 |
| Bloch, KE; Kohler, M; Stradling, JR | 1 |
| Chang, HS; Han, SW; Jeong, YJ; Kang, RH; Lee, HY; Lee, MS; Paik, JW | 1 |
| Inamdar, A; Mendhekar, D | 1 |
| Hassan, M; Marcus, SC; Olfson, M | 1 |
| Abad-Santos, F; Borobia, AM; Carcas, AJ; Guerra-López, P; López-Rodríguez, R; Novalbos, J; Rodríguez, V; Tabares, B | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| De Virgilio, A; Famularo, G; Gasbarrone, L; Minisola, G | 1 |
| Croom, KF; Perry, CM; Plosker, GL | 1 |
| Bertram, L; Grözinger, M; Liss, Y | 1 |
| Chang, HS; Choi, MJ; Ham, BJ; Han, CS; Joe, SH; Jung, IK; Kang, RH; Kim, L; Kim, SH; Kim, YK; Ko, YH; Lee, HJ; Lee, HY; Lee, MS; Park, JY; Wong, ML | 1 |
| Arellano, J; Baird, J; Benedict, A; De Cock, E | 1 |
| Dahmen, N; Hiemke, C; Reuter, SC; Tonn, P | 1 |
| Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N | 1 |
| Ashkanian, M; Audrain, H; Bender, D; Hansen, SB; Jakobsen, S; Rosenberg, R; Smith, DF; Stork, BS; Vase, KH; Videbech, P; Wegener, G | 1 |
| Lin, D; Lin, GY; Pan, XJ; Wang, XB; Wang, XQ; Wu, JZ; Xiang, Z | 1 |
| Alderman, CP; Condon, JT; Gilbert, AL | 1 |
| Hu, Y; Liu, J; Wei, X; Xu, J; Zhu, J | 1 |
| Auffarth, IS; Kropp, S | 1 |
| Heres, S; Laika, B; Leucht, S; Schneider, H; Steimer, W | 1 |
| Nakayama, K | 1 |
| Lazzeroni, LC; Murphy, GM; Ryan, HS; Sarginson, JE; Schatzberg, AF | 1 |
| Chung, SK; Hong, JP; Kang, EH; Kim, EJ; Kim, S; Lee, IS; Lee, SY; Oh, KS; Park, JE; Woo, JM; Yu, BH | 1 |
| Frazee, C; Garg, U; Johnson, L; Turner, JW | 1 |
| Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G | 1 |
| Belkahia, A; Dereure, O; Guillot, B; Hillaire-Buys, D; Raison-Peyron, N | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Lewicka, S; Onken, V; Römer, B; Schilling, C | 1 |
| Purebl, G; Rihmer, Z | 1 |
| Burman, D; Riechelmann, RP; Rodin, G; Tannock, IF; Zimmermann, C | 1 |
| Birkenhäger, TK; Bruijn, JA; Mulder, PG; Sukul, YR; van den Broek, WW | 1 |
| Bergin, C; Rock, C | 1 |
| Fernandez-Fernandez, FJ; Fuente-Aguado, Jde L; Montero-Tinnirello, J; Rodriguez-Pecci, MS | 1 |
| Arnheim, K | 1 |
| Grautoff, S; Hennings, JM; Himmerich, H; Ising, M; Pollmächer, T; Schaaf, L | 1 |
| Jachymova, M; Jirak, R; Tvrzicka, E; Vecka, M; Zak, A; Zeman, M | 1 |
| Grønli, O; Olstad, R; Stensland, GØ; Wynn, R | 1 |
| Burkin, M; Joffe, G; Joffe, M; Stenberg, JH; Tchoukhine, E; Terevnikov, V; Tiihonen, J | 4 |
| Abbasi, SH; Akhondzadeh, S; Behpournia, H; Ghoreshi, A; Raznahan, M; Rezaei, F; Rezazadeh, SA; Salehi, B | 1 |
| Aguilera Celorrio, L; Freijo Guerrero, J; Gómez, JJ; Tardón Ruiz de Gauna, L | 1 |
| Adomaitiene, V; Danileviciūte, V; Fokas, V; Gumbrevicius, G; Sveikata, A; Sveikatiene, R | 1 |
| Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE | 1 |
| Linden, M; Westram, A | 2 |
| Deuschle, M; Gilles, M; Hamann-Weber, B; Kopf, D; Lederbogen, F; Luppa, P; Paslakis, G | 1 |
| Akbayram, S; Aktar, F; Başaranoğlu, M; Çağan, E; Çaksen, H; Doğan, M; Kaya, A; Peker, E | 1 |
| Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R; Meyer, PT | 1 |
| Bonato, PS; Cesarino, EJ; de Santana, FJ; Jabor, VA; Lanchote, VL | 1 |
| Angermeier, T; Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B; Westphal, S | 1 |
| Poyurovsky, M | 1 |
| Darcy, AM; Lock, J; Safer, DL | 1 |
| Chen, CL; Chen, CY; Kuo, SC; Wang, HY; Wang, TY; Yeh, YW | 1 |
| Jan Schutte, A; Kasper, S; Möller, HJ; Montgomery, SA; van der Meulen, EA; van Oers, HJ; Vrijland, P | 1 |
| Bayer, U; Habermeyer, B; Müller-Spahn, F | 1 |
| Bach, A; Deuschle, M; Feuerhack, A; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C | 1 |
| Rush, AJ | 1 |
| Kiss, A; Mischo, M; Nigg, C | 1 |
| Beauclair, L; Desmarais, JE; Margolese, HC; Wolf, Y | 1 |
| Baghai, TC; di Michele, F; Eser, D; Pasini, A; Romeo, E; Rupprecht, R; Schüle, C | 1 |
| Felthous, AR; Hoevet, R; Wenger, PJ | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C; Weber-Hamann, B | 1 |
| Christodoulou, C; Douzenis, A; Lykouras, L; Moussas, G | 1 |
| Butler, MC; Di Battista, M; Warden, M | 1 |
| Burke, WJ; Malloy, T; Padala, KP; Padala, PR | 1 |
| Chen, JD; Wang, W; Winston, JH; Yin, J; Zhang, R | 1 |
| Egberts, TC; Grube, AM; Heerdink, ER; Mulder, H; Risselada, AJ; Wilmink, FW | 1 |
| Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Hart, CL; Reed, SC; Vosburg, SK | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Nierenberg, AA; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C | 1 |
| Fotopoulos, A; Ingelman-Sundberg, M; Johanson, I; Konstandi, M; Kotsovolou, O; Lang, MA; Marselos, M; Overstreet, DH; Papadopoulou-Daifoti, Z | 1 |
| Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Konstantakopoulos, G; Koulouris, GC; Leonardos, A; Oulis, P | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Arias, LH; Carvajal, A; del Pozo, JG; Lobato, CT; Ortega, S; Velasco, A | 1 |
| Denys, DA; Schutters, SI; Van Megen, HJ; Van Veen, JF; Westenberg, HG | 1 |
| Cowen, PJ; Harmer, CJ; Norbury, R; Rawlings, NB | 1 |
| Fonseca, C; Laino, CH; Reinés, A; Slobodianik, N; Sterin-Speziale, N | 1 |
| Bokde, AL; Brückmann, H; Frodl, T; Hampel, H; Koutsouleris, N; Linn, J; Meisenzahl, E; Möller, HJ; Scheuerecker, J; Schoepf, V; Wiesmann, M | 1 |
| Navarro, V | 1 |
| Bellodi, L; Calati, R; Chiesa, A; De Ronchi, D; Perna, G; Serretti, A | 1 |
| Gustafson, DL; Lunn, KF; Quimby, JM; Samber, BJ | 1 |
| Ahmad, YJ; Dholakia, R; Narang, IS; Schleifer, SJ | 1 |
| Hsu, CW; Lane, HY; Lin, CH | 1 |
| Bourne, PE; Dunkel, M; Koerner, S; Murgueitio, MS; Preissner, R; von Eichborn, J | 1 |
| Graves, SM; Napier, TC | 1 |
| Cho, SJ; Choi, TK; Kim, B; Kim, YW; Lee, JE; Lee, KS; Lee, SH; Suh, S; Yook, K; Yook, KH | 1 |
| Guerdjikova, A; Keck, PE; McElroy, SL; Mori, N | 1 |
| Rueda-Villar, T; Ruiz-Doblado, S; Sanz-Cortes, S; Zurita-Gotor, P | 1 |
| Hasselstrøm, J | 1 |
| Bateman, DN; Graham, A; Gray, J; Howell, C; Waring, WS; Wilson, AD | 1 |
| Chang, FL; Ho, ST; Sheen, MJ | 1 |
| Hubickova, L; Kostalova, J; Manakova, E; Zemanova, Z | 1 |
| Abe, M; Nakagawa, M; Ochi, S; Okada, M; Ueno, S; Yamamura, S | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Chaney, A; Frodl, T; Lisiecka, D; Meisenzahl, E; Moeller, HJ; Scheuerecker, J; Schoepf, V; Whitty, P; Wiesmann, M | 1 |
| Crijns, HJ; de Jonge, P; Delanghe, JR; den Boer, JA; Honig, A; Korf, J; Quere, M; Schins, A; Smith, OR; Tulner, DM | 1 |
| Braat, S; Conen, S; de Kam, PJ; Ivgy-May, N; Peeters, P; Ramaekers, JG; Theunissen, EL | 1 |
| Angermeier, T; Deuschle, M; Gilles, M; Hummel, J; Kopf, D; Lederbogen, F; Luley, C; Weber-Hamann, B; Westphal, S | 1 |
| Brissos, S; Dias, VV; Paiva, T; Palhavã, F | 1 |
| Chiu, HW; Li, TC | 1 |
| Dolev, Z | 1 |
| Cho, HB; Jeong, HS; Jung, JY; Kim, J; Kim, JE; Kim, TS; Lyoo, IK; Shin, E; Yoon, SJ | 1 |
| Bech, P; Bendsen, BB; Larsen, JK | 1 |
| Keltner, NL; McGuiness, TM; Steele, D | 1 |
| Petrascheck, M; Solis, GM | 1 |
| Morita, M; Nakayama, K | 1 |
| Guruprasad, K; Maurya, PK; Rao, RN | 1 |
| Baghai, TC; Jacoby, D; Lieb, M; Palm, U; Severus, E | 1 |
| Akechi, T; Furukawa, TA; Inagaki, M; Miki, K; Shimodera, S; Watanabe, N; Yamada, M; Yonemoto, N | 1 |
| Bhatia, KS; Fowler, JC; Lee, TH; Szabo, ST; Wetsel, WC | 1 |
| Dubois, J; Vanrullen, R | 1 |
| Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF | 1 |
| Akalay, A; Hanson, B; Ost, M | 1 |
| Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Benjamin, S; Doraiswamy, PM | 1 |
| Kumar, KN; Ramakrishna, S; Rao, RN | 1 |
| Giorgi, M; Yun, H | 1 |
| Kang, SG; Park, YM; Yoon, BM | 1 |
| Baydemir, C; Dogan, AE; Erol, K; Kilic, FS | 1 |
| Basavraj, V; Chandra, PS; Nanjundappa, GB | 1 |
| de la Serna, J; Fernández-Ruiz, M; López-Medrano, F; Ruiz, J | 1 |
| Escudero, J; Fernández, A; Gómez, C; Hornero, R; Méndez, MA; Ortiz, T; Rodríguez-Palancas, A; Zuluaga, P | 1 |
| Fitzgerald, P; Hannon, B; Murphy, M | 1 |
| Bahk, WM; Jun, TY; Jung, YE; Kim, KS | 1 |
| Anderson, IM; Deakin, JF; Dolan, MC; Elliott, R; McKie, S; Richardson, P; Völlm, BA; Williams, SR | 1 |
| Brodaty, H | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Orrell, M; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 2 |
| Mickiewicz, AL; Napier, TC; Voigt, RM | 1 |
| Fridman, V; Jacobs, D; Koralnik, IJ; McGuire, JL; Wüthrich, C | 1 |
| Davis, MP; Karafa, M; Kirkova, J; Lagman, R; Walsh, D | 1 |
| Wichniak, A; Wierzbicka, A | 1 |
| Di Corcia, D; Gerace, E; Salomone, A; Vincenti, M | 1 |
| Brett, F; Dodd, JD; Farrell, M; Hall, WW; Keane, MP; McCreery, K; O'Brien, D; O'Sullivan, C; Pallin, M; Tubridy, NJ | 1 |
| Agius, M; Butler, S; Holt, C; Zaman, R | 2 |
| Brandão, CO; Damasceno, A; Damasceno, BP; Deus-Silva, L; Longhini, AL; Martinez, AR; Santos, LM; von Glehn, F | 1 |
| Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Kreys, TJ; Phan, SV | 1 |
| Akcay, F; Albayrak, A; Cetin, N; Polat, B; Sener, E; Suleyman, B; Suleyman, H; Tok, A | 1 |
| Christoffersen, RK; Høimark, L; Vesterby, A; Vestergård, LD | 1 |
| Colfax, GN; Das, M; Gasper, J; Matheson, T; Santos, DM; Santos, GM; Shoptaw, S; Vittinghoff, E | 1 |
| Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Arumugam, K; Averineni, RK; Meka, SR; Nayak, UY; Ranjan, OP; Shavi, GV; Sureshwar, P | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Nakagawa, A; Omori, IM; Watanabe, N | 1 |
| Clark, MS; Jamieson, B; Smith, PO | 1 |
| Lee, KU; Lee, YM | 1 |
| Davis, JM; Torrey, EF | 1 |
| Enomoto, T; Hirayama, S; Horiuchi, H; Ikegami, D; Inada, E; Iseki, M; Nagase, H; Nakahara, K; Narita, M; Sakai, H; Suzuki, T; Torigoe, K; Yamashita, A; Yanase, M | 1 |
| Afshar, M; Ciraulo, DA; Colaneri, LS; Devine, E; Knapp, CM; Putnam, MA; Sarid-Segal, O; Tozier, L; Waters, ME | 1 |
| Lai, CH | 2 |
| Imai, E; Ito, T; Nishimura, D; Shibahara, H; Uematsu, N | 1 |
| Ikemoto, G; Mogi, T; Nomura, S; Yoshino, A | 1 |
| Cabral, A; Ferreira, LS; Izídio, GS; Macedo, PT; Melo, TG; Ribeiro, AM; Silva, RH; Sousa, DS | 1 |
| Imanishi, T; Koyama, T; Yamauchi, M | 1 |
| Barrientos-Astigarraga, RE; Borges, NC; Donato, JL; Felix, L; Galvinas, PA; Moreno, P; Moreno, RA; Sverdloff, CE | 1 |
| Jett, RA; Moenster, RP | 1 |
| Hackenbroch, M; Hallek, M; Rath, T; Rubbert, A; Saech, J | 1 |
| Abuissa, H; Airey, K; Alla, V; Deshmukh, A; Ulveling, K | 1 |
| Panderi, I; Pligoropoulou, H; Vonaparti, A | 1 |
| Larrauri, JA; Levin, ED | 1 |
| Agarwal, A; Bansal, M; Conner, K | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Niki, T; Oishi, R; Shirakawa, A | 1 |
| Miao, J; Xiang, J; Xu, N; Yu, Q; Zheng, L | 1 |
| Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G | 1 |
| Estabrook, KR; Pheister, M | 1 |
| Lenze, EJ | 1 |
| Artigas, F; Bortolozzi, A; Castañé, A; Masana, M; Santana, N | 1 |
| Boessen, R; Grobbee, DE; Groenwold, RH; Knol, MJ; Roes, KC | 1 |
| Akechi, T; Fujita, H; Furukawa, TA; Ikeda, Y; Inagaki, M; Kato, T; Kondo, M; Miki, K; Morokuma, I; Sato, H; Shimodera, S; Shinagawa, Y; Watanabe, N; Yamada, M; Yonemoto, N | 1 |
| Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Cerón, I; Lasso, M | 1 |
| Himmerich, H; Schmidt, FM; Tennert, C; Teupser, D | 1 |
| Brustia, D; Cantello, R; Comi, C; Conconi, A; De Paoli, L; Gaidano, G; Monaco, F; Mula, M; Nasuelli, N; Ripellino, P; Savio, K; Stecco, A; Varrasi, C | 1 |
| Johansen, SS; Nielsen, MK | 1 |
| Jia, L; Jiang, SM; Wu, JH | 1 |
| Koch, H; Nanev, D | 1 |
| Abad-Santos, F; Carcas-Sansuan, A; Dorado, P; Estévez-Carrizo, F; González-Vacarezza, N; Llerena, A; Peñas-Lledó, E | 1 |
| Bachli, E; Günthard, HF; Hohlfeld, SK; Locher, P; Zeitz, J | 1 |
| Burkin, M; Chukhin, E; Joffe, G; Joffe, M; Stenberg, JH; Terevnikov, V; Tiihonen, J | 2 |
| De Winter, S; Decoutere, L; Fagard, K; Schrooten, M; Spriet, I; Tournoy, J; Vander Weyden, L | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Kopf, D; Lecei, O; Lederbogen, F; Roth, HJ; Scharnholz, B; Schilling, C; Terhardt, J; Weber-Hamann, B | 1 |
| Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
| Delicata, M; McGuinness, J | 1 |
| Chen, CC; Chen, HW; Chiang, IT; Fang, CK; Hwang, JJ; Liao, JF; Su, TP; Tung, CY; Uchitomi, Y | 1 |
| Akcay, F; Cinar, I; Polat, B; Polat, H; Sener, E; Sener, MT; Suleyman, H; Tok, A | 1 |
| Graves, SM; Napier, TC; Persons, AL; Riddle, JL | 1 |
| Martínez-Ramírez, JA; Peters, FT; Voigt, K | 1 |
| Aleksic, B; Hagikura, M; Iwamoto, K; Ozaki, N | 1 |
| Fuzikawa, C; Hara, C; Lopes Rocha, F; Ramos, MG; Riera, R | 1 |
| Dolder, CR; Iler, CA; Nelson, MH | 1 |
| Grubb, MF; Humphreys, WG; Josephs, JL | 1 |
| Atake, K; Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Iwata, N; Katsuki, A; Kishi, T; Nakamura, J; Umene-Nakano, W; Yoshimura, R | 1 |
| Fresan, A; Jiménez-Genchi, A; Muñoz-Delgado, J; Roche, A; Rothschild-Fuentes, B; Sánchez-Ferrer, JC | 1 |
| Baumann, P; Brocard, M; Crettol, S; Eap, CB; Golay, KP; Harenberg, S; Hilleret, H; Jaquenoud Sirot, E; Jonzier-Perey, M; Kemmerling, K; Lima, CA; Perrenoud, P; Vandel, P; Zullino, DF | 1 |
| Graves, SM; Napier, TC; Rafeyan, R; Watts, J | 1 |
| Deuschle, M; Gilles, M; Hellweg, R; Lang, UE; Lederbogen, F; Scharnholz, B | 1 |
| Kojima, H; Kojima, K; Masuzawa, M; Matsumoto, S; Shingu, K; Sugimoto, T; Taguchi, H | 1 |
| Gash, A; Udo, I | 1 |
| Aleksic, B; Iidaka, T; Iwamoto, K; Katayama, H; Kawano, N; Kohmura, K; Noda, A; Noda, Y; Ozaki, N; Sasada, K | 1 |
| Schruers, KR; Schutters, SI; van Megen, HJ; Van Veen, JF; Westenberg, HG | 1 |
| Egami, M; Imamura, Y; Mizoguchi, Y; Nabeta, H; Yamada, S | 1 |
| Knud Larsen, J | 1 |
| Nagata, T; Nakayama, K; Shinagawa, S; Tagai, K | 1 |
| Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Avena-Woods, C; Hilas, O | 2 |
| Moffatt, A; Ticehurst, S | 1 |
| Albayrak, A; Bilici, M; Cayir, K; Erdemci, B; Gundogdu, C; Ozogul, B; Suleyman, B; Suleyman, H; Tekin, SB | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 1 |
| Furukawa, M; Irie, W; Kurihara, K; Maeda, K; Murakami, C; Nakamaru, N; Nakamura, S; Sasaki, C; Shinozuka, T; Watanabe, T | 1 |
| Sagdinc, SG; Sahinturk, AE | 1 |
| Conradi, HJ; de Jonge, P; Ormel, J; van Melle, JP; Zuidersma, M | 1 |
| Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA | 1 |
| Akcay, F; Dursun, OB; Gulec, M; Hacimuftuoglu, A; Oral, E; Suleyman, H; Yucel, A | 1 |
| Counsell, H; Johnson, S | 1 |
| Uguz, F | 1 |
| Fazel, M; Goldring, L; Reed, RV | 1 |
| Arterburn, D; Bogart, A; Boudreau, DM; Haneuse, S; Simon, G; Theis, MK; Westbrook, E | 1 |
| Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W | 1 |
| Rogóż, Z | 2 |
| Koval, CE; Loyaga-Rendon, RY; Taylor, DO | 1 |
| Chiapelli, J; Fischer, BA; Himelhoch, S; Reese, C; Vidal, C | 1 |
| Engel, D; Gabilan, NH; Lieberknecht, V; Rodrigues, AL; Zomkowski, AD | 1 |
| Højer, AM; Ramaekers, JG; Street, D; Theunissen, EL; van Oers, A; Vermeeren, A | 1 |
| Bernhard, JD; Yosipovitch, G | 1 |
| Dose, T; Fulda, S; Hennings, J; Holsboer, F; Kloiber, S; Lucae, S; Schaaf, L | 1 |
| Fukuyama, K; Hamaguchi, T; Motomura, E; Nakagawa, M; Okada, M; Shiroyama, T; Tanahashi, S | 1 |
| Aleksic, B; Ebe, K; Iwamoto, K; Kawano, N; Kohmura, K; Noda, Y; Ozaki, N; Sasada, K; Yamamoto, M | 1 |
| Huber, CG; Jahn, H; Schroeder, K | 1 |
| Anzivino, E; Bellizzi, A; Ciardi, MR; D'Abramo, A; D'Agostino, C; d'Ettorre, G; Iannetta, M; Lo Menzo, S; Oliva, A; Pietropaolo, V; Vullo, V | 1 |
| Funaki, Y; Hiraoka, K; Ito, C; Iwata, R; Matsuoka, H; Sato, H; Shibuya, K; Tashiro, M; Yanai, K | 1 |
| Altuner, D; Cetin, N; Gulaboglu, M; Yapca, OE | 1 |
| Eifler, S; Schirmbeck, F; Waltereit, R; Zink, M | 1 |
| Acharya, S; Acharya, T; Huang, J; Tringali, S | 1 |
| Atigari, OV; Healy, D; Jabeen, Q; Kelly, AM | 1 |
| Ebe, K; Iwamoto, K; Kawano, N; Kohmura, K; Noda, Y; Ozaki, N; Sasada, K; Yamamoto, M | 1 |
| Dong, L; Li, W; Liu, X; Shen, J; Sun, H; Wang, X; Xu, J; Zhang, G | 1 |
| Lunn, KF; Quimby, JM | 1 |
| Hao, W; Li, L; Li, Z; Wang, D | 1 |
| Nagata, T; Nakayama, K; Ozone, M; Shinagawa, S; Tagai, K; Tsuno, N | 1 |
| Clarke, G; Cryan, JF; Dinan, TG; Griffin, BT; O'Brien, FE | 1 |
| Arteta, B; Basta-Kaim, A; Budziszewska, B; Curzytek, K; Duda, W; Grygier, B; Kubera, M; Lasoń, W; Leśkiewicz, M; Maes, M | 1 |
| Bhogle, M; Holland, J | 1 |
| Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M | 1 |
| Kontny, U; Meiss, F; Möller, J; Puzik, A; Rössler, J | 1 |
| Bognár, Z; Gazdag, G; Vonyik, G | 1 |
| Bertolino, A; Blasi, G; Caforio, G; De Simeis, G; Di Giorgio, A; Fazio, L; Mancini, M; Nardini, M; Rampino, A; Rizzo, M; Romano, R; Taurisano, P; Ursini, G | 1 |
| Chang, SN; Chang, YJ; Kao, CH; Liang, JA; Lin, MC; Muo, CH; Sun, LM; Sung, FC | 1 |
| Purslow, C | 1 |
| Berling, I; Isbister, GK | 1 |
| Bartsch, S; Bauer, K; Himmerich, H; Kirkby, KC; Mergl, R; Munzer, A; Petersein, C; Sack, U; Schönherr, J | 1 |
| Ishikawa, J; Kusakabe, S; Masaie, H; Ohshima, K; Toda, J; Yagi, T; Yoshida, H | 1 |
| Saddichha, S | 1 |
| Bernard, SA; Hamer, RM; Mayer, DK; Nelson, KM; Park, EM; Raddin, RS; Rosenstein, DL | 1 |
| An, Y; Chen, C; Inoue, T; Izumi, T; Kitaichi, Y; Koyama, T; Kusumi, I; Li, X; Nakagawa, S; Song, N | 1 |
| Hashimoto, R; Hosokawa, K; Mashimo, T; Nakae, A; Nakai, K | 1 |
| Boks, MP; de Wit, NJ; Ng, CG; Roes, KC; Sulaiman, AH; Tan, SB; Zainal, NZ | 1 |
| Godschalx-Dekker, JA; Siegers, HP | 1 |
| Künzel, H | 1 |
| Chen, JD; Lei, Y; Song, J; Xu, X; Yin, J | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| Bergman, J; Pashinian, A; Poyurovsky, M; Weizman, A | 1 |
| Deuschle, M; Gilles, M; Hamann, B; Lederbogen, F; Paslakis, G; Westphal, S | 1 |
| Imai, E; Nishimura, D; Shibahara, H; Tokura, Y; Uematsu, N | 1 |
| Cao, WQ; Fan, GR; Gao, FY; Li, J; Wen, J; Yang, N; Zhang, WT | 1 |
| Aryal, SR; Khan, MA; Rajpurohit, N; Stys, AT; Stys, TP | 1 |
| Martínez-Ramírez, JA; Peters, FT; Walther, G | 1 |
| Cha, JH; Chang, HS; Ham, BJ; Kim, B; Lee, HY; Lee, MS; Won, ES | 1 |
| Alam, A; Kundu, S; Levinthal, DJ; Rogal, S | 1 |
| Berger, T; Di Pauli, F; Maier, H; Rhomberg, P; Steurer, M; Stockhammer, G; Uprimny, C; Walder, A | 1 |
| Baba, T; Fushimi, K; Kasamatsu, A; Ogawara, K; Saito, Y; Sakamoto, Y; Sakuma, K; Shiiba, M; Shimizu, T; Tanzawa, H; Uzawa, K | 1 |
| Fukano, T; Kadoguchi, N; Kasahara, J; Okabe, S; Shono, M; Tanabe, A; Yamamura, Y; Yokoyama, H | 1 |
| Ansermot, N; Eap, CB; Hodel, PF | 1 |
| Bahk, WM; Jun, TY; Shim, IH; Song, HR; Wang, HR; Woo, YS | 1 |
| Benecke, R; Großmann, A; König, FB; Meister, S; Winkelmann, A; Zettl, UK | 1 |
| Tak, S | 1 |
| Jang, JH; Kim, DK; Lee, SY; Myung, W; Yoon, H | 1 |
| Alisky, J; Malesic, I; Stuhec, M | 1 |
| Groppe, SE; Gründer, G; Hiemke, C; Paulzen, M; Tauber, SC; Veselinovic, T | 1 |
| Callado, LF; Díez-Alarcia, R; González-Maeso, J; Meana, JJ; Miranda-Azpiazu, P; Morentin, B; Muguruza, C | 1 |
| Coffin, P; Colfax, G; Hermanstyne, KA; Santos, D; Santos, GM; Vittinghoff, E | 1 |
| Norizadeh Tazehkand, M; Topaktas, M | 1 |
| Bahk, WM; Jeong, JH | 1 |
| Buggenhout, S; Sienaert, P; Vandenberghe, J | 1 |
| Beck, J; Brand, S; Eckert, A; Giese, M; Hatzinger, M; Hemmeter, U; Holsboer-Trachsler, E; Muheim, F | 1 |
| Smith, JH | 1 |
| Chang, HS; Ham, BJ; Kim, YG; Lee, HY; Lee, MS; Won, ES | 1 |
| Holyoak, AL; Prematuranga, S; Senthuran, S; Trout, MJ; White, RP | 1 |
| Bengesser, SA; Birner, A; Kapfhammer, HP; Lackner, N; Reininghaus, B; Reininghaus, E | 1 |
| Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Stephansson, O; Valdimarsdottir, U; Zoega, H | 1 |
| Tanidir, C; Tanidir, IC; Tuzcu, V | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Lederbogen, F; Paslakis, G; Schilling, C; Weber-Hamann, B | 1 |
| An, Y; Chen, C; Inoue, T; Kitaichi, Y; Kusumi, I; Nakagawa, S; Song, N; Wang, C | 1 |
| Gołembiowska, K; Kamińska, K; Rogóż, Z | 1 |
| Alampay, MM; Flanagan, MC; Grammer, GG; Haigney, MC; Love, KM; Perito, RM | 1 |
| Roth, T; van de Loo, AJ; Verster, JC | 1 |
| Chiba, Y; Miura, J; Murayama, N; Okubo, M; Yamazaki, H | 1 |
| Beneš, L; Doležel, P; Dvořáčková, K; Kejdušová, M; Košťál, V; Vysloužil, J | 1 |
| Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR | 1 |
| Carlberg, VM; Girouard, SD; Lee, JJ; Mostaghimi, A | 1 |
| de Bejczy, A; Söderpalm, B | 1 |
| Helmreich, I; Hiemke, C; Kohnen, R; König, J; Szegedi, A; Tadić, A; Wagner, S | 1 |
| Dolman, KM; Heres, M; Honig, A; Smit, M; Wennink, H | 1 |
| Kato, S; Makiguchi, A; Nishida, M; Nisijima, K; Shioda, K; Suda, S | 1 |
| Gärtner, M; Krhut, J | 1 |
| Li, Y; Lin, N; Song, J; Tian, F | 1 |
| Epperla, N; Mazza, JJ; Medina-Flores, R; Yale, SH | 1 |
| Khedr, NF | 1 |
| Goyal, P; Singh, P; Tomar, LR; Tripathi, P | 1 |
| Rohani, S; Sarkar, A | 1 |
| Arnon, J; Buclin, T; Clementi, M; Eleftheriou, G; Kaplan, YC; Klinger, G; Malm, H; Maňáková, E; Merlob, P; Panchaud, A; Pistelli, A; Rothuizen, LE; Stephens, S; Te Winkel, B; Winterfeld, U | 1 |
| Fekete, S; Karesova, I; Mzik, M; Palicka, V; Pavlíková, L; Simko, J; Zivna, H | 1 |
| Dedoni, S; Olianas, MC; Onali, P | 1 |
| Bassetti, CL; Du Pasquier, R; Furrer, H; Hirsch, HH; Kardas, P; Krestel, H; Kurmann, R; Lämmle, B; Sturzenegger, M; Weisstanner, C; Wiest, R | 1 |
| Abe, T; Mimura, M; Nakajima, S; Sato, Y; Suzuki, T; Uchida, H; Ueno, F | 1 |
| Hegerl, U; Kratzsch, J; Nowak, C; Sander, C; Schmidt, FM; Schönknecht, P | 1 |
| Ehler, E; Meleková, A | 1 |
| Abe, M; Mori, Y; Nakata, S; Ochi, S; Ueno, S; Yamazaki, K; Yoshino, Y | 1 |
| Feld, JJ; Shah, H; Sheehan, K; Sockalingam, S | 1 |
| Ivgy-May, N; Roth, T; Ruwe, F; Walsh, J | 1 |
| Ivgy-May, N; Krystal, A; Roth, T; Ruwe, F | 1 |
| Chang, HS; Ham, BJ; Lee, HY; Lee, MS; Won, E | 1 |
| Campeas, R; Carcamo, J; Glass, A; Lewis-Fernandez, R; Neria, Y; Sanchez-Lacay, A; Schneier, FR; Vermes, D; Wall, MM | 1 |
| Deuschle, M; Gilles, M; Kahl, KG; Scharnholz, B | 1 |
| Bates, JA; Ferguson, LE; McLean, MK; Quimby, JM | 1 |
| Andersson, SI; Broaddus, CD; Gomez-Amaro, RL; Kardakaris, R; Niculescu, AB; Petrascheck, M; Rangaraju, S; Solis, GM | 1 |
| Abe, M; Fukudo, S; Ichie, M; Machida, T; Otera, M | 1 |
| Durmaz, O; Durna, MM; Kahraman, N | 1 |
| Hattori, Y; Hirose, T; Matsumoto, H; Ohnishi, M; Shimazu, T; Takegawa, R | 1 |
| Chiu, HF; Correll, CU; Feng, L; Feng, Y; Geng, Y; Guo, T; Hu, CQ; Lai, KY; Ungvari, GS; Wang, G; Xiang, YT; Xiao, L | 1 |
| Basavaraju, V; Bondade, S; Singh, N | 1 |
| Bahk, WM; Kwon, YJ; Song, HR; Woo, YS | 1 |
| Clemens, B; Dömötör, J | 1 |
| Gentile, S | 1 |
| Avasthi, A; Chee, KY; Chiu, HF; Chong, MY; Grover, S; He, YL; Kanba, S; Kuga, H; Lee, MS; Sartorius, N; Shen, WW; Shinfuku, N; Si, TM; Sim, K; Tan, CH; Tanra, AJ; Tripathi, A; Udormatn, P; Xiang, YT; Yang, SY | 1 |
| Akechi, T; Furukawa, TA; Guyatt, GH; Hayasaka, Y; Inagaki, M; Kato, T; Mantani, A; Miki, K; Ogawa, Y; Shimodera, S; Shinohara, K; Tajika, A; Takeshima, N; Tanaka, S; Watanabe, N; Yamada, M; Yonemoto, N | 1 |
| Kamińska, K; Rogóż, Z | 1 |
| Hergüner, S; Tanıdır, C | 1 |
| Aytekin, E; Bozdağ Pehlivan, S; Ünlü, N; Yavuz, B; Yıldız, S | 1 |
| Arts, J; Boeckxstaens, G; Caenepeel, P; Carbone, F; Holvoet, L; Ly, HG; Tack, J; Van Oudenhove, L; Vanheel, H; Vanuytsel, T | 1 |
| Ekelund, J; Harmer, CJ; Heikkilä, R; Isometsä, E; Jylhä, P; Komulainen, E; Lahti, J; Melartin, T; Meskanen, K; Nummenmaa, L; Raij, TT | 1 |
| Akiyama, K; Aoki, A; Hayashi, Y; Inoue, Y; Ishiguro, S; Kato, K; Shimoda, K; Tsuchimine, S; Ueda, M; Watanabe, T; Yasui-Furukori, N | 1 |
| Clifford, KM; Duncan, NA; Shvarts, OM | 1 |
| Dolman, KM; Honig, A; Smit, M | 1 |
| Loignon, M; Toma, E | 1 |
| Messer, T | 1 |
| Baj, G; Bernareggi, A; Bittolo, T; Deiana, C; Ferrazzo, S; Raminelli, CA; Tongiorgi, E; Vaghi, V | 1 |
| Funaki, K; Mimura, M; Nakajima, S; Suzuki, T; Uchida, H | 1 |
| Camargos, EF; Louzada, LL; Naves, JO; Nóbrega, OT; Quintas, JL; Scoralick, FM | 1 |
| Kawakami, M; Nishimura, H | 1 |
| Anderson, IM; Campbell, J; Chew-Graham, C; Davies, S; Dickens, C; Gilbody, S; Hollingworth, W; Kessler, D; Lewis, G; Macleod, U; Peters, TJ; Tallon, D; Wiles, N | 1 |
| Bhatia, MS; Gupta, K; Gupta, LK; Gupta, R; Tripathi, AK | 1 |
| Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A | 1 |
| Arora, S; Vohora, D | 1 |
| Chou, WH; Lin, CP; Lin, FS; Lin, WY; Sun, WZ; Yie, JC | 1 |
| Antón, B; Barbosa-Méndez, S; Hernández-Miramontes, R; Jurado, N; Leff, P; Salazar-Juárez, A | 1 |
| Alessi-Severini, S; Bolton, J; Chateau, D; Enns, MW; Leong, C; Prior, HJ; Sareen, J | 1 |
| Martínez-Ramírez, JA; Peters, FT; Strien, J; Walther, G | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| An, Y; Chen, C; Inoue, T; Izumi, T; Kitaichi, Y; Kusumi, I; Nakagawa, S; Wang, C | 1 |
| An, Y; Chen, C; Inoue, T; Kitaichi, Y; Kusumi, I; Nakagawa, S; Wang, C | 1 |
| Bielefeldt, K; Szigethy, E; Thorkelson, G | 1 |
| Arbus, C; Schmitt, L; Yrondi, A | 1 |
| Antoniou, K; Dalla, C; Kokras, N; Polissidis, A | 1 |
| Andersen, SE; Gislasson, G; Hansen, AH; Holm, EA; Leth-Møller, KB; Torp-Pedersen, C; Torstensson, M; Ødum, L | 1 |
| Grasso, SA; Holtz, NA; Napier, TC; Persons, AL; Tedford, SE | 1 |
| Miki, K; Murakami, M; Oka, H; Onozawa, K; Osada, K; Yoshida, S | 1 |
| Binder, W; Miller, ES; Welsh, L | 1 |
| Datka, W; Dudek, D; Gurwitz, D; Kmiotek, K; Obuchowicz, M; Oved, K; Pilc, A; Rzezniczek, S; Shomron, N; Siwek, M | 1 |
| Akerman, SC; Brunette, MF; Dawson, R; Green, AI; O'Keefe, CD | 1 |
| García-Fuster, MJ; García-Sevilla, JA | 1 |
| Hergüner, S; Hoşoğlu, E | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Jia, L; Jiang, SM; Liu, J; Shi, MM; Xu, MZ | 1 |
| Chung, T; Cornelius, JR; Douaihy, AB; FitzGerald, D; Glance, J; Kirisci, L; Kmiec, J; Salloum, I; Wesesky, MA | 1 |
| Ong, CT; Sung, SF; Tong, SH; Wu, CS | 1 |
| Hasegawa, Y; Ito, D; Katsuno, M; Nakamichi, K; Takahashi, A; Yasui, K | 1 |
| Broussolle, C; Ferry, T; Honnorat, J; Jamilloux, Y; Kerever, S; Sève, P | 1 |
| Angeles, MR; Bucelli, RC; Clifford, DB; Dang, X; Koralnik, IJ; Kuhlmann, FM; Major, EO; Ryschkewitsch, CF; Schmidt, RE; Schwetye, KE; Soleimani-Meigooni, DN | 1 |
| Berdel, WE; Grauer, OM; Kerkhoff, A; Keßler, T; Lenz, G; Lutz, M; Rebber, E; Schulze, AB; Wiebe, S; Zoubi, T | 1 |
| IJzerman-Boon, P; Ivgy-May, N; Roth, T; Ruwe, F; Zammit, G | 1 |
| de Witte, LD; Dekker, D; Kaasjager, K; Kromkamp, M; Veraart, J; Vinkers, CH | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Aghamohammadhasani, M; Chamsaz, M; Ghorbani, M; Lahoori, NA; Rounaghi, GH; Seyedin, O | 1 |
| Reich, A; Szepietowski, JC | 1 |
| Rowe, B; Yosipovitch, G | 1 |
| Brzezinski, M; Cason, B; Gregersen, M; Kukreja, J; Nouri, KF; Schuch, LG; Wozniak, C; Yip, A | 1 |
| Benson, KK; Brown, SR; Gustafson, DL; Hansen, RJ; Lunghofer, PJ; Morgan, PK; Quimby, JM; Wittenburg, LA; Zajic, LB | 1 |
| Asayama, S; Asayama, T; Kosaka, S; Nakamichi, K; Ohnuki, E; Saijo, M | 1 |
| Lai, FY; Ritz, S; Shankar, K | 1 |
| Burkin, M; Joffe, G; Stenberg, JH; Terevnikov, V; Tiihonen, J | 1 |
| Mai, SM; Xiang, YT; Yang, XH; Zhang, YF; Zheng, W; Zhong, HQ | 1 |
| Greenspan, SL; Hanlon, JT; Kotlarczyk, MP; Naples, JG; Perera, S | 1 |
| Boumba, VA; Rallis, GN; Vougiouklakis, T | 1 |
| Abramowitz, A; Miller, ES; Wisner, KL | 1 |
| Hagenauw, LA; Kamphuis, J; Karsten, J; Lancel, M | 1 |
| Frouni, I; Gourdon, JC; Hamadjida, A; Harraka, MJ; Huot, P; Kwan, C; Nuara, SG; Sid-Otmane, L; Veyres, N | 1 |
| Bandou, H; Hatashita, Y; Kato, M; Kinoshita, T; Koshikawa, Y; Nishida, K; Onohara, A; Sakai, S; Serretti, A; Sunada, N; Takekita, Y | 1 |
| Chekroud, AM; Gueorguieva, R; Krumholz, HM; Krystal, JH; McCarthy, G; Trivedi, MH | 1 |
| Iga, JI; Nakata, S; Ochi, S; Ueno, SI; Yamazaki, K; Yoshino, Y | 1 |
| Harada, T; Hirosawa, T; Morinaga, K; Shimizu, T | 1 |
| Berenato, F; Chan, YH; Grossman, SK; Korbutov, J; Lavery, MJ; Lee, HG; Valdes-Rodriguez, R; Yosipovitch, G | 1 |
| Buschkamp, JA; Frohn, C; Juckel, G | 1 |
| Ekelund, J; Glerean, E; Heikkilä, R; Isometsä, E; Jylhä, P; Komulainen, E; Lahti, J; Melartin, T; Meskanen, K; Nummenmaa, L; Raij, TT | 1 |
| Aytekin, E; Bozdağ Pehlivan, S; Ünlü, N; Vural, İ; Yavuz, B; Yıldız, S | 1 |
| Arías-Caballero, A; Barbosa-Méndez, S; Heinze, G; Hernández-Miramontes, R; Leff, P; Salazar-Juárez, A | 1 |
| Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J | 1 |
| Kataria, R; Malamood, M; Parkman, HP; Roberts, A; Schey, R | 1 |
| Celeste, T; Persons, AL; Tedford, SE | 1 |
| Ch'ng, CL; Haboubi, H; Lloyd, A; Thomas, E; Williams, N | 1 |
| Hastings, M; May, T; Urbina, TM | 1 |
| Barbosa-Méndez, S; Flores-Zamora, A; Jurado, N; Matus-Ortega, M; Salazar-Juárez, A | 1 |
| Goto, T; Ikeda, J; Ikeda, SI; Ishii, W; Matsushima, A; Nakamichi, K; Saijo, M; Sekijima, Y; Takahashi, K | 1 |
| de Oliveira, AA; de Sousa, CNS; de Sousa, LC; Honório Júnior, JER; Macedo, D; Maes, M; Medeiros, IDS; Oliveira, TQ; Patrocínio, CFV; Vasconcelos, GS; Vasconcelos, SMM | 1 |
| Avato, FM; Brandolini, F; Gaudio, RM; Groppi, A; Morini, L; Talarico, A; Vignali, C | 1 |
| El-Tanbouly, DM; Sayed, RH; Wadie, W | 1 |
| Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M | 1 |
| Ardakani, YH; Jamshidfar, S; Lavasani, H; Rouini, M | 1 |
| Barbosa-Méndez, S; Heinze, G; Jurado, N; Martiñon, S; Matus-Ortega, M; Salazar-Juárez, A | 1 |
| Carbone, F; Tack, J; Vanuytsel, T | 1 |
| Gadad, BS; Greer, TL; Jha, MK; Mayes, TL; Minhajuddin, A; Trivedi, MH | 1 |
| Bervoets, AC; Bouwmeester, NH; der Ark, PV; Fedgchin, M; Garssen, J; Mooren, L; Morrison, R; Singh, J; van Amerongen, G; van de Loo, AJAE; van Gerven, J; Verster, JC; Wajs, E; Zuiker, R | 1 |
| Cho, SE; Cho, SJ; Jung, HY; Na, KS | 1 |
| Barbosa-Méndez, S; Matus-Ortega, M; Salazar-Juárez, A | 1 |
| Abdelsalam, NM; El-Sayad, ME; El-Sisi, AE | 1 |
| Jacobs, B; Kralt, P; Scholten, P | 1 |
| Engel, RR; Fennema, H; Kaspers-Janssen, M; Leucht, S; Szegedi, A | 1 |
| Fay, B; Gründer, G; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G; Unholzer, S | 1 |
| García-Colunga, J; Hernández-Abrego, A; Vázquez-Gómez, E | 1 |
| Johansen, SS; Linnet, K; Nedahl, M | 1 |
| Barbosa-Méndez, S; Jacinto-Gutiérrez, S; Matus-Ortega, M; Salazar-Juárez, A | 1 |
| Arshad, MF; Bekhit, M; Javed, N | 1 |
| Dronamraju, N; Greer, TL; Jha, MK; Minhajuddin, A; Trivedi, MH; Wakhlu, S | 1 |
| Almishri, W; Frolkis, AD; Kaplan, GG; Patten, S; Shaheen, AA; Swain, MG; Vallerand, I | 1 |
| Papazisis, G; Siafis, S; Tzachanis, D | 1 |
| Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Ratnam, C; Saguin, E | 1 |
| Akagawa, Y; Ikeda, J; Ishii, W; Sekijima, Y; Shishido-Hara, Y; Ueno, A | 1 |
| Perry, LA; Ramson, D; Stricklin, S | 1 |
| Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Plantamura, J; Ratnam, C; Saguin, E | 1 |
| Calip, GS; Kim, S; Lee, TA; Leow, AD; Schumock, GT; Touchette, DR; Xing, S | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Bernardy, K; Derry, S; Häuser, W; Moore, RA; Welsch, P | 1 |
| Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A | 1 |
| Akiyama, K; Hayashi, Y; Inoue, Y; Kato, K; Komahashi-Sasaki, H; Ozeki, Y; Pierce, J; Sasaki, T; Shimoda, K; Shinozaki, M; Tsuchimine, S; Watanabe, T; Yasui-Furukori, N | 1 |
| Boesen, MS; Lindelof, M; Sagar, M | 1 |
| Ameline, A; Kintz, P; Raul, JS | 1 |
| Finch, CK; March, KL; McGowan, KE | 1 |
| Danilov, DS | 1 |
| Herrmann, N; Lanctôt, KL | 1 |
| Joffe, G; Terevnikov, V | 1 |
| Burke, H; Hernandez, M; Jiang, S; Ruth, L | 1 |
| Osler, M; Rosenqvist, TW; Wium-Andersen, IK; Wium-Andersen, MK | 1 |
| Janković, SM; Kostić, MJ; Milosavljević, MN; Pejčić, AV | 1 |
| Gajić, Z; Greš, A; Šakić, B | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
139 review(s) available for mirtazapine and mianserin
| Article | Year |
|---|---|
Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
Topics: Antidepressive Agents, Tricyclic; Brain; Depressive Disorder; Growth Hormone; Humans; Hydrocortisone; Life Change Events; Mianserin; Mirtazapine; Norepinephrine; Receptors, Adrenergic; Receptors, Glucocorticoid; Receptors, Serotonin; Serotonin; Stress, Physiological; Stress, Psychological | 1996 |
The pharmacologic profile of mirtazapine.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Autoreceptors; Behavior, Animal; Depressive Disorder; Dioxanes; Drug Evaluation, Preclinical; Humans; Idazoxan; Imidazoles; Mianserin; Mirtazapine; Rats; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin Antagonists; Synaptic Transmission | 1996 |
Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Brain; Depressive Disorder; Dose-Response Relationship, Drug; Hippocampus; Humans; Long-Term Care; Mianserin; Mirtazapine; Neurons; Norepinephrine; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin; Synaptic Transmission | 1995 |
The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents, Tricyclic; Arousal; Autoreceptors; Brain; Depressive Disorder; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Serotonin | 1995 |
Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Humans; Meta-Analysis as Topic; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Treatment Outcome | 1995 |
Safety of mirtazapine: a review.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Overdose; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 1995 |
Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Humans; Mianserin; Mirtazapine | 1997 |
The clinical relevance of preclinical data: mirtazapine, a model compound.
Topics: Animals; Antidepressive Agents, Tricyclic; Area Under Curve; Biological Availability; Biotransformation; Brain; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Half-Life; Humans; Liver; Metabolic Clearance Rate; Mianserin; Mirtazapine; Polymorphism, Genetic; Protein Binding | 1997 |
Mirtazapine: clinical advantages in the treatment of depression.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Feeding and Eating Disorders; Humans; Mianserin; Mirtazapine; Sleep Stages; Weight Gain | 1997 |
Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 1997 |
Selection of an antidepressant: mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Biotransformation; Clinical Trials as Topic; Decision Making; Depressive Disorder; Humans; Mianserin; Mirtazapine; Patient Selection; Receptors, Neurotransmitter | 1997 |
Antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Efficacy issues with antidepressants.
Topics: Absenteeism; Age Factors; Amitriptyline; Antidepressive Agents; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Follow-Up Studies; Humans; Imipramine; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Psychotherapy; Severity of Illness Index; Treatment Outcome; Work | 1997 |
Development of new antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 1997 |
A risk-benefit assessment of mirtazapine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Depressive Disorder; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Receptors, Neurotransmitter; Synaptic Transmission | 1997 |
Mirtazapine, an antidepressant.
Topics: Animals; Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Mianserin; Mirtazapine | 1998 |
A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychomotor Agitation; Randomized Controlled Trials as Topic; Somatoform Disorders | 1998 |
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Dopamine; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Triazoles; Venlafaxine Hydrochloride | 1998 |
Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Serotonin; Treatment Outcome | 1998 |
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Safety of mirtazapine in overdose.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Biopharmaceutics; Charcoal; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Overdose; Female; Fluid Therapy; Gastric Lavage; Humans; Ipecac; Male; Mianserin; Middle Aged; Mirtazapine; Product Surveillance, Postmarketing; United States | 1998 |
Mirtazapine: a newer antidepressant.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Interactions; Humans; Mianserin; Mirtazapine | 1999 |
Mirtazapine: a review of its use in major depression.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic | 1999 |
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Epinephrine; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychotic Disorders; Receptors, Serotonin; Serotonin; Sex Factors; Synaptic Transmission; Treatment Outcome | 1998 |
[Two new antidepressants: mirtazapine and venlafaxine].
Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 1999 |
New developments in the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Placebos; Severity of Illness Index; Treatment Outcome | 1999 |
Pharmacology of antidepressants: selectivity or multiplicity?
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Receptors, Adrenergic, alpha-2; Receptors, Histamine; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin | 1999 |
Mirtazapine: clinical overview.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Mianserin; Middle Aged; Mirtazapine; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Tolerability and patient compliance.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 1999 |
Mirtazapine versus selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Care of depressed patients with anxiety symptoms.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Care of the sexually active depressed patient.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles | 1999 |
Mirtazapine: other indications.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Dysthymic Disorder; Female; Humans; Male; Menopause; Mianserin; Mirtazapine; Panic Disorder; Psychiatric Status Rating Scales; Recurrence; Stress Disorders, Post-Traumatic; Treatment Outcome | 1999 |
The long-term treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Humans; Imipramine; Mianserin; Mirtazapine; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 1999 |
Mirtazapine--another new class of antidepressant.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Depression; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
Evolution of remission as the new standard in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Noradrenergic approaches to antidepressant therapy.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Norepinephrine; Reboxetine; Receptors, Adrenergic; Selective Serotonin Reuptake Inhibitors | 2000 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2000 |
[Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective].
Topics: Adrenergic alpha-Agonists; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost of Illness; Cost-Benefit Analysis; Depression; Drug Costs; Fluoxetine; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Models, Economic; Socioeconomic Factors; Sweden | 2000 |
Clinical pharmacokinetics of mirtazapine.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine | 2000 |
Treatment issues related to sleep and depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Humans; Mianserin; Mirtazapine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Sleep, REM | 2000 |
Mirtazapine. A pharmacoeconomic review of its use in depression.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depression; Humans; Mianserin; Mirtazapine; Quality of Life; Selective Serotonin Reuptake Inhibitors | 2000 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pharmacology of rapid-onset antidepressant treatment strategies.
Topics: Antidepressive Agents, Tricyclic; Autoreceptors; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Hippocampus; Humans; Mianserin; Mirtazapine; Norepinephrine; Pindolol; Pyramidal Cells; Raphe Nuclei; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Do some antidepressants work faster than others?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
A review of the pharmacological and clinical profile of mirtazapine.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Interactions; Humans; Mianserin; Mirtazapine | 2001 |
Meta-analytical studies on new antidepressants.
Topics: Adult; Aged; Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Evidence-Based Medicine; Humans; Lofepramine; Meta-Analysis as Topic; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2001 |
Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
Topics: Adult; Affect; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
Topics: Antidepressive Agents; Congresses as Topic; Cyclopropanes; Decision Trees; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lithium; Mianserin; Milnacipran; Mirtazapine; Morpholines; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
An overview of the clinical efficacy of mirtazapine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Onset of action of antidepressants: results of different analyses.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome | 2002 |
The use of mirtazapine in difficult-to-treat patient populations.
Topics: Adrenergic alpha-Antagonists; Age Factors; Antidepressive Agents; Depressive Disorder; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Treatment Outcome | 2002 |
Tolerability and safety aspects of mirtazapine.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents; Body Weight; Depressive Disorder; Humans; Mianserin; Mirtazapine; Serotonin Antagonists; Sexual Behavior; Sleep | 2002 |
[Pharmacological justification for the use of new antidepressant drugs].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain | 2002 |
Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Humans; Mianserin; Mirtazapine; Neoplasms; Olanzapine; Palliative Care; Pirenzepine | 2002 |
Dual action antidepressants and some important considerations.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Histamine H1 Antagonists; Humans; Mianserin; Milnacipran; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Weight Gain | 2003 |
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; Drug Tolerance; Erectile Dysfunction; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Orgasm; Piperazines; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles | 2003 |
Benefits of different drug formulations in psychopharmacology.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Circadian Rhythm; Cystic Fibrosis; Drug Administration Routes; Drug Delivery Systems; Humans; Mianserin; Mirtazapine; Patient Compliance; Proton Pump Inhibitors; Proton Pumps; Psychopharmacology | 2003 |
New formulations of existing antidepressants: advantages in the management of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride | 2004 |
[Genetics of depression. Current knowledge and perspectives].
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Diseases in Twins; Environment; Female; Genetic Markers; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Polymorphism, Genetic; Prevalence; Promoter Regions, Genetic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socialization; Time Factors; Twins, Dizygotic; Twins, Monozygotic | 2004 |
Daytime sleepiness and insomnia as correlates of depression.
Topics: Antidepressive Agents; Benzhydryl Compounds; Bupropion; Comorbidity; Depressive Disorder; Disorders of Excessive Somnolence; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Modafinil; Monoamine Oxidase Inhibitors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Trazodone | 2004 |
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Outpatients; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Refusal; Venlafaxine Hydrochloride | 2005 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Mirtazapine: a review of its clinical efficacy and tolerability.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Mental Disorders; Mianserin; Mirtazapine; Serotonin Antagonists | 2005 |
Are antidepressants safe for adolescents?
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder; Humans; Mianserin; Mirtazapine; Safety; Selective Serotonin Reuptake Inhibitors; Suicide | 2005 |
Mirtazapine-induced arthralgia.
Topics: Adult; Antidepressive Agents, Tricyclic; Arthralgia; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2005 |
A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Receptor, Serotonin, 5-HT1A; Serotonin | 2006 |
[1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Cyclohexanols; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2005 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
Headache (chronic tension-type).
Topics: Acupuncture Therapy; Amitriptyline; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Humans; Mianserin; Mirtazapine; Tension-Type Headache | 2005 |
Major depressive disorder, antidepressants, and sexual dysfunction.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles | 2006 |
Treating itch in psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipruritics; Capsaicin; Coal Tar; Emollients; Histamine H1 Antagonists; Humans; Immunologic Factors; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Mianserin; Mirtazapine; Morpholines; Phototherapy; Pruritus; Psoriasis; Quality of Life; Salicylates; Skin Care; Vitamin D | 2006 |
[Suspected depression].
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Female; Humans; Male; Mianserin; Mirtazapine; Neurology; Psychiatry; Referral and Consultation; Suicide; Time Factors | 2006 |
[Effects of mirtazapine in patients with chronic tension-type headache. Literature review].
Topics: Age Factors; Analgesics; Chronic Disease; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Receptors, Opioid; Tension-Type Headache | 2006 |
[Depression in family practice].
Topics: Age Factors; Aged; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Depressive Disorder; Dysthymic Disorder; Family Practice; Female; Humans; Interview, Psychological; Male; Mianserin; Mirtazapine; Prevalence; Recurrence; Referral and Consultation; Sex Factors; Surveys and Questionnaires; Time Factors; World Health Organization | 2007 |
[Applications and safety of modern antidepressants in patients with liver diseases].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2007 |
Headache (chronic tension-type).
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents; Biofeedback, Psychology; Chronic Disease; Cognitive Behavioral Therapy; Humans; Incidence; Massage; Mianserin; Mirtazapine; Prevalence; Prognosis; Randomized Controlled Trials as Topic; Relaxation Therapy; Risk Factors; Tension-Type Headache | 2007 |
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Topics: Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2008 |
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence.
Topics: Behavior Therapy; Buspirone; Cannabinoids; Cognitive Behavioral Therapy; Combined Modality Therapy; Dronabinol; Humans; Marijuana Abuse; Mianserin; Mirtazapine; Motivation; Piperidines; Psychotherapy; Psychotropic Drugs; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Substance Withdrawal Syndrome | 2008 |
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
Topics: Affect; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Mianserin; Mirtazapine; Patient Satisfaction; Personality Inventory; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Suicide Prevention; Thiophenes; Time Factors; Treatment Refusal; Venlafaxine Hydrochloride | 2008 |
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4; Benzodiazepines; Citalopram; Cyclohexanols; Disease Models, Animal; Gene Expression Regulation; Humans; Hungary; Mianserin; Mirtazapine; Oxidative Stress; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Understanding the clinical profile of a drug on the basis of its pharmacology: mirtazapine as an example.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Patient Selection; Psychiatric Nursing; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
[Selective serotonin reuptake inhibitor is more likely to induce sexual dysfunction than mirtazapine in treating depression].
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Erectile Dysfunction; Humans; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 2008 |
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Personality Inventory; Prognosis; Time Factors; Treatment Outcome | 2009 |
Non-pharmacologic treatment of insomnia in persons with dementia.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antidepressive Agents, Tricyclic; Circadian Rhythm; Dementia; Drug Therapy, Combination; Evidence-Based Medicine; Geriatrics; Humans; Hypnotics and Sedatives; Mianserin; Mirtazapine; Motor Activity; Phototherapy; Practice Guidelines as Topic; Pyridines; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Walking; Zolpidem | 2009 |
Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
Topics: Aged; Antidepressive Agents, Tricyclic; Appetite Stimulants; Cachexia; Case-Control Studies; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Megestrol Acetate; Mianserin; Mirtazapine; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Wasting Syndrome; Weight Loss | 2009 |
Pharmacological approaches to the treatment of obstructive sleep apnoea.
Topics: Animals; Cholinesterase Inhibitors; Humans; Mianserin; Mirtazapine; Protriptyline; Pulmonary Ventilation; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Treatment Outcome | 2009 |
Mirtazapine: a review of its use in major depression and other psychiatric disorders.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Databases, Bibliographic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales | 2009 |
[Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].
Topics: Antidepressive Agents; Citalopram; Dopamine; Duloxetine Hydrochloride; Humans; Japan; Mianserin; Mirtazapine; Synaptic Transmission; Thiophenes | 2009 |
Seizures associated with levofloxacin: case presentation and literature review.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cytochrome P-450 CYP1A2; Dopamine Antagonists; Drug Administration Schedule; Drug Synergism; Female; Humans; Klebsiella Infections; Levofloxacin; Male; Metoclopramide; Mianserin; Middle Aged; Mirtazapine; Ofloxacin; Phosphodiesterase Inhibitors; Seizures; Theophylline | 2009 |
[Mirtazapine--pharmacologic action and clinical advantages].
Topics: Adrenergic alpha-Antagonists; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Depression; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Suicide; Treatment Outcome | 2009 |
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Regression Analysis | 2010 |
[Depression].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Female; HIV Infections; Humans; Hypericum; Mianserin; Middle Aged; Mirtazapine; Phytotherapy; Psychotherapy; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Socioeconomic Factors | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Improving medication compliance in patients with depression: Use of orodispersible tablets.
Topics: Administration, Oral; Antidepressive Agents; Citalopram; Deglutition Disorders; Depressive Disorder, Major; Dosage Forms; Humans; Medication Adherence; Mianserin; Mirtazapine | 2010 |
Novel antidepressants and panic disorder: evidence beyond current guidelines.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Morpholines; Panic Disorder; Practice Guidelines as Topic; Reboxetine; Thiophenes | 2011 |
Therapeutic potential of new second generation antipsychotics for major depressive disorder.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic | 2010 |
Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Headache; Humans; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Nausea; Psychotic Disorders; Retrospective Studies; Schizophrenia | 2011 |
Review of the use of mirtazapine in the treatment of depression.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Quality of Life; Stereoisomerism | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
[The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine].
Topics: Amitriptyline; Antidepressive Agents; Depression; Doxepin; Humans; Mianserin; Mirtazapine; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Trazodone | 2011 |
Adjunct mirtazapine for negative symptoms of schizophrenia.
Topics: Antidepressive Agents; Antipsychotic Agents; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Schizophrenia; Treatment Outcome | 2011 |
Mirtazapine versus other antidepressive agents for depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2011 |
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aspirin; Benzothiazoles; Bipolar Disorder; Celecoxib; Chemotherapy, Adjuvant; Cyclooxygenase 2 Inhibitors; Dopamine Agonists; Estrogens; Fatty Acids, Omega-3; Folic Acid; Humans; Mianserin; Minocycline; Mirtazapine; Pramipexole; Pregnenolone; Pyrazoles; Randomized Controlled Trials as Topic; Schizophrenia; Sulfonamides; Treatment Outcome; Vitamin B Complex | 2012 |
[Mirtazapine and antiretroviral therapy in the treatment of progressive multifocal leukoencephalopathy associated with HIV-1 infection: report of a case and review of literature].
Topics: Adult; AIDS Dementia Complex; Antidepressive Agents, Tricyclic; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Mirtazapine; Treatment Outcome | 2012 |
Antidepressant combination for major depression in incomplete responders--a systematic review.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
The effects of mirtazapine on sleep in patients with major depressive disorder.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sleep | 2012 |
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside.
Topics: Animals; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Conditioning, Psychological; Humans; Methamphetamine; Mianserin; Mirtazapine; Receptors, Serotonin; Substance-Related Disorders | 2012 |
[Posttraumatic stress disorder].
Topics: Adolescent; Adult; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Cultural Comparison; Cross-Sectional Studies; Diagnosis, Differential; Eye Movement Desensitization Reprocessing; Female; Guideline Adherence; Humans; Life Change Events; Male; Mianserin; Mirtazapine; Paroxetine; Stress Disorders, Post-Traumatic | 2013 |
Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia | 2015 |
Clinical practice. Chronic pruritus.
Topics: Amines; Antidepressive Agents, Tricyclic; Behavior Therapy; Chronic Disease; Cyclohexanecarboxylic Acids; Emollients; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Histamine Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pruritus | 2013 |
Sertraline and mirtazapine as geriatric antidepressants.
Topics: Aged; Antidepressive Agents; Depression; Geriatric Psychiatry; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Sertraline | 2013 |
Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability.
Topics: Antidepressive Agents, Tricyclic; Automobile Driving; Computer Simulation; Depression; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Mianserin; Mirtazapine; Reference Standards; Sleep Stages | 2015 |
Mirtazapine in pregnancy and lactation - A systematic review.
Topics: Antidepressive Agents, Tricyclic; Breast Feeding; Depressive Disorder; Female; Humans; Lactation; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk | 2016 |
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Coinfection; Cytarabine; Cytosine; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mianserin; Mirtazapine; Organophosphonates; Ritanserin; Serotonin Antagonists | 2016 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Topics: Adolescent; Adult; Affect; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Bupropion; Buspirone; Depression; Gastrointestinal Tract; Humans; Immunity; Inflammatory Bowel Diseases; Mianserin; Mirtazapine; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Young Adult | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Benzodiazepines; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Pulmonary Edema; Rhabdomyolysis; Serotonin Syndrome | 2015 |
Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.
Topics: Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Natalizumab | 2016 |
Itch in Psoriasis Management.
Topics: Adaptation, Psychological; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Doxepin; Histamine Antagonists; Humans; Mianserin; Mirtazapine; Paroxetine; Pruritus; Psoriasis; Social Support; Thalidomide; Ultraviolet Therapy | 2016 |
Paraneoplastic Itch Management.
Topics: Acantholysis; Acanthosis Nigricans; Analgesics, Opioid; Anticonvulsants; Antidepressive Agents; Aprepitant; Dermatitis, Exfoliative; Dermatomyositis; Histone Deacetylase Inhibitors; Humans; Ichthyosis; Immunosuppressive Agents; Keratosis, Seborrheic; Mianserin; Mirtazapine; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Paraneoplastic Syndromes; Pruritus; Selective Serotonin Reuptake Inhibitors; Thalidomide | 2016 |
Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Depressive Disorder, Major; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Sertraline; Treatment Outcome; Young Adult | 2016 |
Treatment options for hyperemesis gravidarum.
Topics: Adrenergic alpha-Antagonists; Adult; Antiemetics; Dopamine Agonists; Female; Humans; Hyperemesis Gravidarum; Mianserin; Mirtazapine; Pregnancy | 2017 |
Can we recommend mirtazapine and bupropion for patients at risk for bleeding?: A systematic review and meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Databases, Factual; Depressive Disorder, Major; Gastrointestinal Hemorrhage; Humans; Mianserin; Mirtazapine; Risk Factors | 2018 |
Mirtazapine adjunct for people with schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chemotherapy, Adjuvant; Humans; Mianserin; Mirtazapine; Patient Dropouts; Quality of Life; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Weight Gain | 2018 |
Mirtazapine for fibromyalgia in adults.
Topics: Adult; Antidepressive Agents, Tricyclic; Fibromyalgia; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic | 2018 |
Mirtazapine in schizophrenia - an undeservedly overlooked option?
Topics: Antidepressive Agents; Antipsychotic Agents; Humans; Mianserin; Mirtazapine; Schizophrenia | 2022 |
Mirtazapine-induced Acute Pancreatitis in Patients With Depression: A Systematic Review.
Topics: Acute Disease; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pancreatitis | 2023 |
272 trial(s) available for mirtazapine and mianserin
| Article | Year |
|---|---|
Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Psychiatric Status Rating Scales | 1990 |
Effect of the antidepressant Org 3770 on human sleep.
Topics: Adult; Antidepressive Agents; Double-Blind Method; Electroencephalography; Humans; Male; Mianserin; Mirtazapine; Psychomotor Performance; Sleep; Sleep Stages | 1990 |
Actions and interactions of psychotropic drugs on human performance and mood: single doses of ORG 3770, amitriptyline, and diazepam.
Topics: Adult; Affect; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cognition; Diazepam; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Placebos; Psychomotor Performance; Random Allocation | 1989 |
The effectiveness of 6-azamianserin (Org 3770) in depressed outpatients.
Topics: Adult; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine | 1987 |
A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery.
Topics: Adult; Anxiety; Blood Pressure; Diazepam; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Mianserin; Mirtazapine; Premedication; Random Allocation; Sleep Initiation and Maintenance Disorders | 1985 |
Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
Topics: Adult; Antidepressive Agents, Tricyclic; Arousal; Attention; Blood Pressure; Dibenzazepines; Electroencephalography; Evoked Potentials; Flicker Fusion; Flurazepam; Heart Rate; Humans; Male; Mianserin; Mirtazapine; Stereoisomerism | 1982 |
A double-blind placebo-controlled study of Org 3770 in depressed outpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Treatment Outcome | 1995 |
A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Constipation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Treatment Outcome; Xerostomia | 1995 |
Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Trazodone | 1995 |
Double-blind study of mirtazapine and placebo in hospitalized patients with major depression.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Single-Blind Method | 1994 |
Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770).
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arousal; Blood Pressure; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Imipramine; Male; Mianserin; Middle Aged; Mirtazapine; Parasympathetic Nervous System; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Vagus Nerve | 1996 |
A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Treatment Outcome | 1996 |
A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales | 1996 |
A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales | 1995 |
Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations.
Topics: Adult; Antidepressive Agents, Tricyclic; Biological Availability; Circadian Rhythm; Cross-Over Studies; Humans; Male; Mianserin; Mirtazapine | 1997 |
Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 1997 |
Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Survival Analysis | 1998 |
Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Headache; Health Status; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sleep | 1998 |
Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Confidence Intervals; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipramine; Lithium; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Research Design; Survival Analysis; Treatment Outcome | 1998 |
High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma.
Topics: Antidepressive Agents, Tricyclic; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Humans; Indicators and Reagents; Mianserin; Mirtazapine; Quality Control; Reference Standards; Reproducibility of Results; Solvents; Spectrometry, Fluorescence | 1999 |
Mirtazapine augmentation in the treatment of refractory depression.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sleep; Treatment Outcome; Weight Gain | 1999 |
Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
A pilot study of mirtazapine in post-traumatic stress disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic | 1999 |
Clinical experience with mirtazapine in the treatment of panic disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Administration Schedule; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain | 1999 |
Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Human Growth Hormone; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Prolactin; Reference Values | 1999 |
Mirtazapine in major depression with comorbid generalized anxiety disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome | 1999 |
Depressed in-patients respond differently to imipramine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Anxiety; Chi-Square Distribution; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Likelihood Functions; Male; Mianserin; Middle Aged; Mirtazapine; Sleep Wake Disorders; Treatment Outcome | 1999 |
The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Patient Compliance; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological | 1999 |
Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales | 1999 |
Dysthymic disorder: treatment with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome | 1999 |
Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion.
Topics: Adult; Antidepressive Agents; Growth Hormone; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Prolactin | 2000 |
Mirtazapine for depression in patients with human immunodeficiency virus.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; HIV Seropositivity; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sick Role | 2000 |
Mirtazapine substitution in SSRI-induced sexual dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Depressive Disorder; Female; Humans; Irritable Mood; Male; Mianserin; Middle Aged; Mirtazapine; Muscular Diseases; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Behavior; Sexual Dysfunctions, Psychological; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2000 |
Pharmacokinetics of mirtazapine and lithium in healthy male subjects.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Cognition; Cross-Over Studies; Double-Blind Method; Humans; Lithium; Male; Mianserin; Middle Aged; Mirtazapine; Psychometrics | 2000 |
Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Topics: Affect; Antidepressive Agents, Tricyclic; Attention; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Telephone | 2000 |
Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Cimetidine; Cross-Over Studies; Double-Blind Method; Drug Interactions; Half-Life; Histamine H2 Antagonists; Humans; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine | 2000 |
Mirtazapine compared with paroxetine in major depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2000 |
Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Topics: Adult; Affect; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Mianserin; Mirtazapine; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2001 |
[Comparative efficacy of remeron (mirtazapine) and amitriptyline in treatment of patients with depression of moderate intensity].
Topics: Adrenergic alpha-Antagonists; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Depression; Histamine H1 Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2000 |
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Health Status; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Treatment Outcome; Weight Gain | 2001 |
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2001 |
Mirtazapine treatment of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Female; Humans; Male; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Severity of Illness Index | 2001 |
Mirtazapine versus fluoxetine in the treatment of panic disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mianserin; Mirtazapine; Panic Disorder; Selective Serotonin Reuptake Inhibitors | 2001 |
A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents, Tricyclic; Anxiety Disorders; Appetite; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Depressive Disorder; Disorders of Excessive Somnolence; Female; Humans; Irritable Mood; Male; Mianserin; Mirtazapine; Self-Injurious Behavior; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Weight Gain | 2001 |
The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Mirtazapine; Panic Disorder; Pilot Projects; Psychiatric Status Rating Scales; Single-Blind Method | 2001 |
An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy.
Topics: Adult; Antidepressive Agents; Depression; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Menopause; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2001 |
Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients.
Topics: Adult; Chronic Disease; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Recurrence; Risk Factors; Treatment Outcome | 2001 |
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2002 |
Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study.
Topics: Adult; Agoraphobia; Antidepressive Agents, Tricyclic; Electrocardiography; Female; Heart Rate; Humans; Male; Mianserin; Mirtazapine; Panic Disorder; Pilot Projects; Predictive Value of Tests; Psychiatric Status Rating Scales; Single-Blind Method | 2002 |
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.
Topics: Antidepressive Agents, Tricyclic; Cross-Over Studies; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Pilot Projects; Quality of Life | 2002 |
Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Second-Generation; Catecholamines; Depressive Disorder; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Mirtazapine; Norepinephrine; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 2002 |
Mirtazapine in the treatment of panic disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Female; Gyrus Cinguli; Hippocampus; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Panic Disorder; Parietal Lobe; Psychiatric Status Rating Scales; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Myocardial Infarction; Prognosis; Quality of Life | 2002 |
The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects.
Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Tricyclic; Blood Pressure; Heart Rate; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Pituitary Hormones, Anterior; Prolactin | 2002 |
The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers.
Topics: Adolescent; Adult; Double-Blind Method; Electroencephalography; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Polysomnography; Sleep Stages; Sleep, REM; Surveys and Questionnaires | 2002 |
Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Area Under Curve; Drug Interactions; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Phenytoin | 2002 |
Mirtazapine in social anxiety disorder: a pilot study.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Mirtazapine; Patient Dropouts; Phobic Disorders; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2002 |
Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Korea; Male; Mianserin; Mirtazapine; Pilot Projects; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic | 2002 |
Mirtazapine in the treatment of panic disorder: an open-label trial.
Topics: Adult; Comorbidity; Depressive Disorder; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Panic Disorder; Psychometrics; Treatment Outcome | 2003 |
Endocrinological effects of mirtazapine in healthy volunteers.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder; Endocrine System; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Placebos; Prolactin | 2002 |
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2002 |
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic | 2003 |
Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Tricyclic; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Mirtazapine; Pituitary-Adrenal System; Psychiatric Status Rating Scales | 2003 |
Effects of mirtazapine on sleep polygraphic variables in major depression.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Sleep | 2002 |
Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Attention; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mental Processes; Mianserin; Mirtazapine; Psychomotor Performance; Single-Blind Method | 2003 |
Influence of mirtazapine on salivary cortisol in depressed patients.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Histamine H1 Antagonists; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Saliva; Treatment Outcome | 2003 |
Substance P serum levels are increased in major depression: preliminary results.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance P; Time Factors | 2003 |
A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Fatigue; Female; Headache; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Paroxetine; Primary Health Care; Severity of Illness Index; Sweating; Treatment Outcome | 2003 |
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome | 2003 |
Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
Topics: Aged; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Essential Tremor; Female; Humans; Male; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Psychomotor Performance; Severity of Illness Index; Surveys and Questionnaires | 2003 |
A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Automobile Driving; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Surveys and Questionnaires | 2003 |
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Pilot Projects | 2003 |
Migraine headache prophylaxis and treatment with low-dose mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Mianserin; Migraine Disorders; Mirtazapine; Receptors, Serotonin, 5-HT1; Recurrence | 2003 |
Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 2003 |
The effects of mirtazapine on plasma lipid profiles in healthy subjects.
Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Mianserin; Mirtazapine; Placebos; Risk Factors; Triglycerides | 2003 |
A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Ethnicity; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Taiwan; Treatment Outcome | 2003 |
Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration.
Topics: Adrenergic alpha-Antagonists; Adult; Alcoholism; Combined Modality Therapy; Female; Humans; Inactivation, Metabolic; Incidence; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine; Phobic Disorders; Psychotherapy | 2003 |
The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.
Topics: Aged; Aged, 80 and over; Alleles; Antidepressive Agents; Apolipoproteins E; Chromatography, High Pressure Liquid; Cognition; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genotype; Geriatric Psychiatry; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Paroxetine; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2003 |
Pharmacogenetics of antidepressant medication intolerance.
Topics: Aged; Alleles; Antidepressive Agents; Cytochrome P-450 CYP2D6; Cytosine; Double-Blind Method; Drug Tolerance; Female; Genetic Markers; Genotype; High-Temperature Requirement A Serine Peptidase 2; Humans; Male; Mianserin; Mirtazapine; Mitochondrial Proteins; Paroxetine; Polymorphism, Single Nucleotide; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serine Endopeptidases; Thymine | 2003 |
Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Confidence Intervals; Double-Blind Method; Ejaculation; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Sexual Dysfunction, Physiological | 2003 |
Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2003 |
Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Homes for the Aged; Humans; Male; Mianserin; Mirtazapine; Nursing Homes; Tablets | 2003 |
Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Chi-Square Distribution; Citalopram; Demography; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Interactions; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Patient Dropouts; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Reboxetine; Time Factors | 2003 |
[N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Brain; Humans; Mianserin; Mirtazapine; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Adrenocorticotropic Hormone; Adult; Area Under Curve; Drug Combinations; Drug Interactions; Growth Hormone; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Morpholines; Prolactin; Reboxetine; Time Factors | 2004 |
Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse.
Topics: Adult; Aged; Antidepressive Agents; Chronic Disease; Depressive Disorder; Female; Humans; Long-Term Care; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Secondary Prevention; Survival Analysis | 2004 |
The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.
Topics: Adrenergic alpha-Antagonists; Adult; Antipsychotic Agents; Clozapine; Double-Blind Method; Drug Synergism; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Schizophrenia; Serotonin Antagonists; Time Factors; Treatment Outcome | 2004 |
Mirtazapine improves alcohol detoxification.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Psychotherapy; Substance Withdrawal Syndrome; Temperance; Treatment Outcome | 2004 |
The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Primary Health Care; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome | 2004 |
Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Area Under Curve; Chronic Disease; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurotransmitter Agents; Pain Measurement; Receptors, Presynaptic; Tension-Type Headache; Treatment Outcome; Weight Gain | 2004 |
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomers of mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine by LC-MS.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Humans; Male; Mass Spectrometry; Mianserin; Middle Aged; Mirtazapine; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2004 |
Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Mirtazapine; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome | 2004 |
Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.
Topics: Adult; Aged; Humans; Korea; Male; Mianserin; Middle Aged; Mirtazapine; Sertraline; Stress Disorders, Post-Traumatic; Veterans | 2004 |
Open trial of mirtazapine in patients with fibromyalgia.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Drug Administration Schedule; Female; Fibromyalgia; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index | 2004 |
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
Topics: Adult; Age of Onset; Antidepressive Agents, Tricyclic; Citalopram; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Nausea; Obsessive-Compulsive Disorder; Pilot Projects; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Weight Gain | 2004 |
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Topics: Adrenergic alpha-Antagonists; Aged; Ambulatory Care; Depressive Disorder, Major; Female; Genetic Markers; Genotype; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mianserin; Mirtazapine; Nerve Tissue Proteins; Paroxetine; Pharmacogenetics; Polymorphism, Genetic; Proportional Hazards Models; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2004 |
Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; CD40 Antigens; Depressive Disorder; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ligands; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Platelet Activation; Platelet Factor 4; Psychiatric Status Rating Scales; Serotonin | 2004 |
Drug-induced stimulation and suppression of action monitoring in healthy volunteers.
Topics: Adult; Cerebral Cortex; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Evoked Potentials; Female; Gyrus Cinguli; Humans; Lorazepam; Male; Mianserin; Mirtazapine; Psychomotor Performance; Reaction Time | 2004 |
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
Effects of antidepressant mirtazapine on fibromyalgia symptoms.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Fibromyalgia; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Time Factors; Treatment Outcome | 2004 |
Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Prognosis; Psychiatric Status Rating Scales; Stroke; Treatment Outcome | 2004 |
Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Male; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Saliva | 2004 |
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 2005 |
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Topics: Adolescent; Adult; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Oxazepam; Treatment Outcome | 2005 |
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
Topics: Adult; Affect; Antidepressive Agents, Tricyclic; Automobile Driving; Circadian Rhythm; Citalopram; Computer Simulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Placebos; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2005 |
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Topics: Adult; Antidepressive Agents, Tricyclic; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome | 2005 |
Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Topics: Adult; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Chromatography, High Pressure Liquid; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrochemistry; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Body Size; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Diazepam; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Outpatients; Oxazepam; Prospective Studies; Sex Factors; Smoking; Time Factors; Treatment Refusal | 2005 |
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Female; Humans; Male; Mianserin; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 2005 |
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2005 |
Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Appetite; Constipation; Female; Humans; Male; Mianserin; Mirtazapine; Outpatients; Psychiatric Status Rating Scales; Sleep Stages; Treatment Outcome; Weight Gain; Xerostomia | 2005 |
Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Topics: Adrenocorticotropic Hormone; Adult; Animals; Antidepressive Agents, Tricyclic; Area Under Curve; Body Weight; Circadian Rhythm; Depression; Dexamethasone; Dose-Response Relationship, Drug; Electroencephalography; Endocrine System; Female; Ghrelin; Growth Hormone; Hormones; Humans; Hydrocortisone; Immunoradiometric Assay; Leptin; Male; Melatonin; Mianserin; Middle Aged; Mirtazapine; Peptide Hormones; Prolactin; Psychometrics; Sleep; Time Factors | 2006 |
Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Health Status; Health Surveys; Humans; Mianserin; Mirtazapine; Phobic Disorders; Psychological Tests; Quality of Life; Treatment Outcome | 2005 |
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Steroids; Treatment Outcome | 2006 |
The effectiveness of mirtazapine in the treatment of post-traumatic stress disorder: a 24-week continuation therapy.
Topics: Adult; Antidepressive Agents; Female; Humans; Long-Term Care; Male; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic | 2005 |
Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study.
Topics: Adult; Antidepressive Agents, Tricyclic; Blood Flow Velocity; Cerebrovascular Circulation; Double-Blind Method; Humans; Male; Mianserin; Mirtazapine; Ultrasonography, Doppler, Transcranial | 2006 |
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Psychiatric Status Rating Scales; Tablets; Time Factors; Venlafaxine Hydrochloride | 2006 |
Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers.
Topics: Adolescent; Adult; Antidepressive Agents; Brain Mapping; Carbamide Peroxide; Double-Blind Method; Drug Combinations; Frontal Lobe; Functional Laterality; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Neuropsychological Tests; Peroxides; Reaction Time; Reinforcement, Psychology; Serotonin; Urea | 2006 |
Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Body Mass Index; Depression; Dose-Response Relationship, Drug; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Sweden; Time Factors; Treatment Outcome | 2006 |
Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
Topics: Adult; Affect; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Polysomnography; Reaction Time; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Treatment Outcome | 2006 |
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Placebos; Propranolol; Prospective Studies; Treatment Outcome | 2006 |
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Fatigue; Female; Headache; Humans; Injections, Intravenous; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Vertigo | 2006 |
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Topics: Adult; Alcoholism; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Pain Measurement; Severity of Illness Index; Time Factors | 2006 |
Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Body Mass Index; Bulimia; Data Interpretation, Statistical; Female; Humans; Hydrocortisone; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Saliva | 2006 |
Effect of mirtazapine treatment on body composition and metabolism.
Topics: Adipose Tissue; Adult; Antidepressive Agents, Tricyclic; Blood Glucose; Body Composition; Body Fat Distribution; Body Weight; Depressive Disorder; Female; Follow-Up Studies; Homeostasis; Humans; International Classification of Diseases; Leptin; Lipoproteins; Mianserin; Mirtazapine; Obesity; Prospective Studies; Receptors, Cell Surface; Receptors, Leptin; Treatment Outcome | 2006 |
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antidepressive Agents; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Pituitary-Adrenal System; Psychiatric Status Rating Scales; Reboxetine; Time Factors | 2006 |
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Cross-Over Studies; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
Topics: Administration, Oral; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Homes for the Aged; Humans; Male; Mianserin; Mirtazapine; Nursing Homes; Psychiatric Status Rating Scales; Tablets; Treatment Outcome | 2006 |
Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Citalopram; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory; Mianserin; Mirtazapine; Neuropsychological Tests; Photic Stimulation; Time Factors; Verbal Learning | 2006 |
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
Topics: Adult; Affect; Antipsychotic Agents; Arousal; Benzodiazepines; Choice Behavior; Cross-Over Studies; Double-Blind Method; Female; Haloperidol; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Memory Disorders; Mianserin; Mirtazapine; Olanzapine; Psychological Tests; Psychomotor Performance; Reaction Time; Reference Values; Saccades; Surveys and Questionnaires; Verbal Learning | 2007 |
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Gene Frequency; Genetic Linkage; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase; Paroxetine; Polymorphism, Single Nucleotide; Sex Characteristics; Time Factors; Treatment Outcome | 2007 |
Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders | 2006 |
Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Liver; Liver Function Tests; Male; Mianserin; Mirtazapine | 2007 |
Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ibuprofen; Male; Mianserin; Middle Aged; Mirtazapine; Tension-Type Headache; Treatment Failure | 2007 |
Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Sleep Apnea, Obstructive | 2007 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid | 2007 |
Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.
Topics: Adolescent; Age Factors; Antidepressive Agents, Tricyclic; Child; Dose-Response Relationship, Drug; Humans; Mianserin; Mirtazapine; Phobic Disorders; Pilot Projects | 2008 |
Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Homes for the Aged; Humans; Male; Mianserin; Mirtazapine; Nursing Homes; Predictive Value of Tests; Psychiatric Status Rating Scales; Tablets; Treatment Outcome | 2007 |
Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Personality Inventory; Piperazines; Quinolones | 2007 |
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Mianserin; Middle Aged; Mirtazapine; Pregnanolone; Progesterone; Steroids; Tranquilizing Agents | 2007 |
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Depressive Disorder, Major; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins | 2007 |
A monoamine oxidase B gene variant and short-term antidepressant treatment response.
Topics: Adult; Alleles; Antidepressive Agents; Data Interpretation, Statistical; Depressive Disorder, Major; DNA; Double-Blind Method; Female; Humans; Introns; Male; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase; Paroxetine; Psychiatric Status Rating Scales; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors | 2007 |
Receptor occupancy of mirtazapine determined by PET in healthy volunteers.
Topics: Adult; Amygdala; Antidepressive Agents, Tricyclic; Brain; Carbon Radioisotopes; Cerebellum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hippocampus; Humans; Injections, Intravenous; Male; Mianserin; Middle Aged; Mirtazapine; Positron-Emission Tomography; Radioligand Assay; Receptors, Cell Surface; Tablets; Time Factors; Trimipramine | 2007 |
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Placebos; Prognosis; Proportional Hazards Models; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Treatment Failure | 2007 |
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Breath Tests; Caprylates; Double-Blind Method; Female; Gastric Emptying; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nortriptyline; Postprandial Period; Sample Size; Satiation | 2008 |
Premedication with mirtazapine reduces preoperative anxiety and postoperative nausea and vomiting.
Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Antiemetics; Anxiety; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Mianserin; Middle Aged; Mirtazapine; Morphine; Pain Measurement; Pain, Postoperative; Postoperative Nausea and Vomiting; Preanesthetic Medication; Serotonin Antagonists; Time Factors; Treatment Outcome | 2008 |
Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clozapine; Cognition; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Drug Synergism; Female; Humans; Male; Mianserin; Mirtazapine; Schizophrenia; Time Factors | 2007 |
Mirtazapine decreases the pain feeling in healthy participants.
Topics: Adult; Analgesics; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electric Stimulation; Female; Humans; Leg; Male; Mianserin; Middle Aged; Mirtazapine; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Peripheral Nerves; Peripheral Nervous System Diseases; Placebo Effect; Reaction Time; Reflex; Treatment Outcome | 2008 |
An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.
Topics: Administration, Oral; Adult; Aged; Anorexia; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors.
Topics: Adult; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 2008 |
Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Topics: Adjustment Disorders; Administration, Oral; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Neoplasms; Prospective Studies; Sick Role; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2008 |
Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
Topics: Adaptation, Psychological; Adjustment Disorders; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder, Major; Female; Histamine H1 Antagonists; Humans; Imipramine; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Pain; Pain Measurement; Psychometrics; Self-Assessment; Single-Blind Method; Sleep; Sleep Wake Disorders; Stress, Psychological | 2008 |
Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Double-Blind Method; Fatigue Syndrome, Chronic; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurasthenia; Psychiatric Status Rating Scales; Psychometrics; Treatment Outcome | 2008 |
Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Topics: Adult; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Surveys and Questionnaires | 2008 |
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
Topics: Adult; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Central Nervous System Stimulants; Female; Humans; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine; Modafinil; Phenothiazines; Severity of Illness Index; Sleep Wake Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2008 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Topics: Adult; Ambulatory Care; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methamphetamine; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors | 2008 |
Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-a preliminary open trial.
Topics: Adrenergic alpha-Antagonists; Aged; Body Mass Index; Continuous Positive Airway Pressure; Electromyography; Female; Humans; Male; Mianserin; Mirtazapine; Polysomnography; Severity of Illness Index; Sleep Apnea Syndromes; Sleep, REM; Stroke; Treatment Outcome | 2008 |
Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Female; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Male; Mianserin; Mirtazapine; Polysomnography; Sleep Apnea, Obstructive; Sleep, REM; Treatment Outcome | 2008 |
Neuroimaging of mirtazapine enantiomers in humans.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Autoradiography; Binding Sites; Binding, Competitive; Brain; Carbon Radioisotopes; Clonidine; Double-Blind Method; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Positron-Emission Tomography; Radioligand Assay; Radiopharmaceuticals; Stereoisomerism; Tissue Distribution; Young Adult | 2008 |
Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.
Topics: Adult; Affect; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Germany; Humans; Inservice Training; Male; Mianserin; Middle Aged; Mirtazapine; Practice Guidelines as Topic; Psychiatry; World Health Organization | 2008 |
Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents, Tricyclic; Antimanic Agents; Biological Availability; Carbamazepine; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine; Young Adult | 2009 |
Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus.
Topics: Adult; Analgesics, Opioid; Anesthesia, Spinal; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Injections, Spinal; Lower Extremity; Male; Mianserin; Mirtazapine; Morphine; Preanesthetic Medication; Prospective Studies; Pruritus; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2008 |
Assessment of the test-retest reliability of laboratory polysomnography.
Topics: Adrenergic alpha-Antagonists; Adult; Body Mass Index; Continuous Positive Airway Pressure; Female; Humans; Laboratories; Male; Mandibular Advancement; Mianserin; Mirtazapine; Plethysmography; Polysomnography; Reproducibility of Results; Sleep Apnea, Obstructive; Sleep Stages; Thorax; Young Adult | 2009 |
Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal Function Tests; Sex Characteristics; Time Factors | 2009 |
Early effects of mirtazapine on emotional processing.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Emotions; Facial Expression; Humans; Male; Mental Recall; Mianserin; Middle Aged; Mirtazapine; Reaction Time; Recognition, Psychology; Reflex, Startle | 2009 |
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Drug Synergism; Female; Humans; Hypoglycemic Agents; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2009 |
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2009 |
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
Topics: Accidents, Traffic; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Attention; Automobile Driving; Computer Simulation; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychomotor Performance; User-Computer Interface; Wakefulness | 2009 |
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention; Automobile Driving; Computer Simulation; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Psychomotor Performance; Reaction Time; Reboxetine | 2008 |
Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
Topics: Adult; Blood-Brain Barrier; Brain; Drug Administration Schedule; Early Diagnosis; Female; HIV Infections; Humans; Immunocompromised Host; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Receptors, Serotonin; Serotonin Antagonists; Treatment Outcome | 2009 |
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 2009 |
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Compliance; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrochemistry; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
[Efficacy of mirtazapine for appetite loss and nausea of the cancer patient--from clinical experience in Memorial Sloan-Kettering Cancer Center].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Appetite; Appetite Stimulants; Female; Hospitals; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Neoplasms; New York; Quality of Life; Surveys and Questionnaires | 2009 |
Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Mass Spectrometry; Mianserin; Mirtazapine; Sex Factors; Spain; Therapeutic Equivalency; Young Adult | 2009 |
Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.
Topics: Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polymorphism, Genetic; Republic of Korea; Severity of Illness Index; Treatment Outcome | 2010 |
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Serotonin; Treatment Outcome | 2009 |
FKBP5 polymorphisms and antidepressant response in geriatric depression.
Topics: Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Genetic Variation; Geriatrics; Humans; Male; Mianserin; Mirtazapine; Paroxetine; Polymorphism, Genetic; Sequence Analysis, DNA; Tacrolimus Binding Proteins; Treatment Outcome | 2010 |
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatosensory Disorders; Venlafaxine Hydrochloride | 2009 |
Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
Topics: Aged; Aged, 80 and over; Anorexia; Antidepressive Agents, Tricyclic; Appetite; Body Weight; Cachexia; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Quality of Life | 2010 |
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Cognition; Double-Blind Method; Drug Therapy, Combination; Executive Function; Female; Humans; Male; Memory; Mianserin; Middle Aged; Mirtazapine; Nootropic Agents; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology | 2010 |
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2010 |
Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Chlorprothixene; Controlled Clinical Trials as Topic; Data Collection; Data Interpretation, Statistical; Depression; Female; Humans; Lithuania; Male; Mental Health Services; Mianserin; Middle Aged; Mirtazapine; Observation; Olanzapine; Primary Health Care; Psychiatric Status Rating Scales; Remission Induction; Tablets; Time Factors; Treatment Outcome | 2009 |
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride | 2010 |
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antidepressive Agents; Case-Control Studies; Cyclohexanols; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Saliva; Secondary Prevention; Sex Factors; Venlafaxine Hydrochloride | 2010 |
Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retinol-Binding Proteins, Plasma; Venlafaxine Hydrochloride | 2010 |
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mianserin; Mirtazapine; Placebo Effect; Severity of Illness Index; Suicide, Attempted | 2010 |
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Desoxycorticosterone; Female; Humans; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2010 |
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Saliva; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Topics: Adrenergic alpha-Antagonists; Adult; Affect; Baclofen; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Eating; GABA Agonists; Humans; Male; Marijuana Abuse; Mianserin; Mirtazapine; Secondary Prevention; Smoking; Substance Withdrawal Syndrome; Young Adult | 2010 |
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Phobic Disorders; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2010 |
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 2010 |
A single dose of mirtazapine modulates neural responses to emotional faces in healthy people.
Topics: Adolescent; Adrenergic alpha-2 Receptor Antagonists; Adult; Affect; Analysis of Variance; Antidepressive Agents, Tricyclic; Brain Mapping; Double-Blind Method; England; Expressed Emotion; Facial Expression; Fear; Female; Happiness; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Neural Pathways; Placebo Effect; Serotonin Antagonists; Young Adult | 2010 |
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder, Major; Emotions; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Prefrontal Cortex; Psychiatric Status Rating Scales; Time Factors; Venlafaxine Hydrochloride | 2011 |
Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats.
Topics: Adrenergic alpha-Antagonists; Animals; Appetite; Appetite Stimulants; Cats; Chromatography, Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Feeding Behavior; Female; Male; Mianserin; Mirtazapine; Random Allocation; Tandem Mass Spectrometry | 2011 |
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cognition Disorders; Double-Blind Method; Drug Synergism; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia | 2011 |
Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery*.
Topics: Adult; Analgesics, Opioid; Anesthesia, Spinal; Antiemetics; Double-Blind Method; Humans; Lower Extremity; Mianserin; Middle Aged; Mirtazapine; Morphine; Orthopedic Procedures; Pain, Postoperative; Postoperative Nausea and Vomiting; Postoperative Period; Preanesthetic Medication; Treatment Outcome; Young Adult | 2010 |
Neural correlates of treatment outcome in major depression.
Topics: Adult; Affect; Antidepressive Agents; Biomarkers; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Face; Female; Frontal Lobe; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Net; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Inflammation Mediators; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Receptors, Tumor Necrosis Factor, Type I | 2011 |
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Topics: Adult; Automobile Driving; Azabicyclo Compounds; Cognition; Cross-Over Studies; Cytochrome P-450 CYP2D6; Dextromethorphan; Dose-Response Relationship, Drug; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Odds Ratio; Phenotype; Piperazines; Psychometrics; Psychomotor Performance; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2011 |
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prospective Studies; Triglycerides; Venlafaxine Hydrochloride | 2011 |
Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Mianserin; Mirtazapine; Paroxetine; Prospective Studies; Treatment Outcome; Young Adult | 2011 |
More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cognition; Cross-Sectional Studies; Double-Blind Method; Drug Therapy, Combination; Executive Function; Female; Humans; Male; Memory; Mianserin; Mirtazapine; Neuropsychological Tests; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Stroop Test; Trail Making Test; Verbal Behavior; Visual Perception; Wechsler Scales | 2011 |
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Schizophrenia; Schizophrenic Psychology; Young Adult | 2011 |
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cluster Analysis; Depressive Disorder, Major; Drug Administration Schedule; Drug Substitution; Female; Humans; Japan; Male; Mianserin; Middle Aged; Mirtazapine; Patient Selection; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2011 |
Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study.
Topics: Adult; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Double-Blind Method; Hormones; Humans; Hydrocortisone; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Oxygen; Piperazines; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists; Young Adult | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Mirtazapine to reduce methamphetamine use: a randomized controlled trial.
Topics: Adrenergic alpha-Antagonists; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Directive Counseling; Double-Blind Method; Drug Monitoring; Homosexuality, Male; Humans; Male; Medication Adherence; Methamphetamine; Mianserin; Middle Aged; Mirtazapine; Risk Factors; Sexual Behavior; Sexual Partners; Treatment Outcome; Urine Specimen Collection | 2011 |
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Cocaine; Cocaine-Related Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Self Report; Treatment Outcome | 2012 |
A fast, sensitive and simple method for mirtazapine quantification in human plasma by HPLC-ESI-MS/MS. Application to a comparative bioavailability study.
Topics: Adult; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Dibenzothiazepines; Drug Stability; Female; Humans; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Quetiapine Fumarate; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Bioequivalence study of two mirtazapine oral tablet formulations in healthy Chinese male volunteers.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cross-Over Studies; Humans; Male; Mianserin; Mirtazapine; Tablets; Therapeutic Equivalency; Young Adult | 2012 |
The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Informed Consent; Japan; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome | 2012 |
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6.
Topics: Antidepressive Agents, Tricyclic; Cross-Over Studies; Cytochrome P-450 CYP2D6; Female; Genotype; Healthy Volunteers; Humans; Male; Mianserin; Mirtazapine; Pharmacogenetics; Sample Size; Therapeutic Equivalency | 2013 |
Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Antipsychotic Agents; Cognition; Cognition Disorders; Double-Blind Method; Drug Monitoring; Female; Histamine Antagonists; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Molecular Targeted Therapy; Nootropic Agents; Psychiatric Status Rating Scales; Schizophrenia; Spatial Behavior; Statistics as Topic; Vision Disorders | 2013 |
Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Norepinephrine; Venlafaxine Hydrochloride | 2012 |
Effects of mirtazapine on the sleep wake rhythm of geriatric patients with major depression: an exploratory study with actigraphy.
Topics: Actigraphy; Age Factors; Aged; Aged, 80 and over; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Motor Activity; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Disorders, Circadian Rhythm | 2013 |
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Drug Monitoring; Female; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Psychiatric Status Rating Scales; Sex Factors; Smoking; Stereoisomerism; Treatment Outcome; Young Adult | 2012 |
Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Double-Blind Method; Functional Neuroimaging; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Oxyhemoglobins; Prefrontal Cortex; Sleep; Spectroscopy, Near-Infrared; Speech Production Measurement; Task Performance and Analysis; Trazodone | 2013 |
Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.
Topics: Adrenergic alpha-Antagonists; Adult; Anxiety Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome | 2011 |
Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metabolic Diseases; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Schizophrenia; Statistics as Topic; Time Factors; Young Adult | 2013 |
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.
Topics: Antidepressive Agents; Caregivers; Cost-Benefit Analysis; Dementia; Depression; Health Care Costs; Health Services for the Aged; Humans; Intention to Treat Analysis; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Time Factors | 2013 |
Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial.
Topics: Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Myocardial Infarction; Patient Readmission; Personality Inventory; Psychometrics; Psychotherapy; Risk; Secondary Prevention; Survival Rate | 2013 |
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult | 2013 |
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Dementia; Depression; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2013 |
A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition.
Topics: Adult; Antidepressive Agents; Automobile Driving; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Psychomotor Performance; Sulfides; Vortioxetine | 2013 |
Mirtazapine provokes periodic leg movements during sleep in young healthy men.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Body Mass Index; Cohort Studies; Drug Administration Schedule; Health Status; Humans; Male; Mianserin; Mirtazapine; Nocturnal Myoclonus Syndrome; Risk Factors; Sex Factors; Young Adult | 2013 |
Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Automobile Driving; Cognition; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sleep Stages; Trazodone | 2013 |
Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers.
Topics: Administration, Oral; Adult; Antidepressive Agents; Area Under Curve; Brain; Chromatography, Liquid; Double-Blind Method; Doxepin; Fluvoxamine; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Positron-Emission Tomography; Receptors, Histamine H1; Sleep Stages; Tandem Mass Spectrometry; Young Adult | 2013 |
Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
Topics: Animals; Anorexia; Antiemetics; Appetite Stimulants; Cat Diseases; Cats; Cross-Over Studies; Female; Male; Mianserin; Mirtazapine; Renal Insufficiency, Chronic; Vomiting | 2013 |
Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2013 |
Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.
Topics: Academic Medical Centers; Aged; Antidepressive Agents; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaysia; Male; Methylphenidate; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Palliative Care; Patient Dropouts; Psychiatric Status Rating Scales; Terminally Ill | 2014 |
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Unstimulated and glucose-stimulated ghrelin in depressed patients and controls.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite Regulation; Biomarkers; Blood Glucose; Depression; Female; Ghrelin; Glucose Tolerance Test; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Bupropion; Female; Humans; Logistic Models; Male; Medication Adherence; Methamphetamine; Mianserin; Middle Aged; Mirtazapine; Motivation; Substance Abuse Detection; Young Adult | 2014 |
Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Platelet Count; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2015 |
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2015 |
The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial.
Topics: Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents, Tricyclic; Double-Blind Method; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Single-Blind Method; Treatment Outcome | 2015 |
Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Remission Induction; ROC Curve; Time Factors; Treatment Outcome | 2015 |
Whether to increase or maintain dosage of mirtazapine in early nonimprovers with depression.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Psychometrics; Treatment Failure | 2015 |
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
Topics: Adult; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Mianserin; Middle Aged; Mirtazapine; Patient Satisfaction; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult | 2015 |
Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Mianserin; Middle Aged; Mirtazapine; Patient Satisfaction; Polysomnography; Recurrence; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2015 |
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
Topics: Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Young Adult | 2015 |
Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters.
Topics: Adult; Antidepressive Agents; Clinical Decision-Making; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2015 |
Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan.
Topics: Antidepressive Agents, Tricyclic; Clinical Protocols; Data Interpretation, Statistical; Depressive Disorder, Major; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Humans; Japan; Mianserin; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Research Design; Sample Size; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2015 |
Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anxiety; Double-Blind Method; Dyspepsia; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Placebos; Quality of Life; Satiation; Treatment Outcome; Weight Loss; Young Adult | 2016 |
A single dose of mirtazapine attenuates neural responses to self-referential processing.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Cerebral Cortex; Depression; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Young Adult | 2016 |
Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Predictive Value of Tests; Remission Induction; Treatment Outcome; Young Adult | 2016 |
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study.
Topics: Actigraphy; Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Brazil; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Pilot Projects; Sleep Wake Disorders; Treatment Outcome | 2017 |
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Topics: Antidepressive Agents, Tricyclic; Clinical Protocols; Depression; Drug Resistance; Humans; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Qualitative Research; Sample Size; Selective Serotonin Reuptake Inhibitors | 2016 |
Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Fibromyalgia; Humans; Japan; Male; Mianserin; Middle Aged; Mirtazapine; Pain Measurement; Psychiatric Status Rating Scales; Quality of Life; Retrospective Studies; Young Adult | 2016 |
Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
Topics: Adiposity; Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Checklist; China; Depression; Dyspepsia; Female; Hormones; Humans; Intra-Abdominal Fat; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Weight Loss | 2016 |
Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents; Comorbidity; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Treatment Outcome | 2016 |
A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia.
Topics: Adult; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Sleep Initiation and Maintenance Disorders | 2016 |
Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study.
Topics: Administration, Cutaneous; Animals; Appetite; Cats; Cross-Over Studies; Double-Blind Method; Mianserin; Mirtazapine; Pilot Projects | 2017 |
Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Cognition; Cross-Over Studies; Double-Blind Method; Humans; Male; Mianserin; Mirtazapine; Quetiapine Fumarate; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Wakefulness; Young Adult | 2017 |
Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2017 |
Single dose of mirtazapine modulates whole-brain functional connectivity during emotional narrative processing.
Topics: Adrenergic alpha-Antagonists; Adult; Arousal; Brain; Brain Mapping; Emotions; Fear; Female; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Narration; Nerve Net; Young Adult | 2017 |
The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Compliance; Female; Gastric Emptying; Healthy Volunteers; Humans; Male; Manometry; Mianserin; Mirtazapine; Stomach; Young Adult | 2017 |
The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Attention; Automobile Driving; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketamine; Male; Mianserin; Middle Aged; Mirtazapine; Orientation, Spatial; Psychomotor Performance; Young Adult | 2017 |
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Body Mass Index; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Overweight; Patient Selection; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
721 other study(ies) available for mirtazapine and mianserin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Binding Sites; Hippocampus; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Mianserin; Microdialysis; Mirtazapine; Norepinephrine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Histamine; Receptors, Serotonin; Serotonin; Stereoisomerism; Structure-Activity Relationship | 2002 |
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Mice; Psychotropic Drugs; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship | 2005 |
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
An alpha 2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man.
Topics: Adrenergic alpha-Antagonists; Adult; Circadian Rhythm; Humans; Male; Melatonin; Mianserin; Mirtazapine | 1989 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
A mass spectrometric approach to the identification of conjugated drug metabolites.
Topics: Animals; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Bepridil; Bile; Glucuronates; Glycine; Humans; Mass Spectrometry; Mianserin; Mirtazapine; Pyrrolidines; Rabbits; Sulfuric Acids; Taurine | 1987 |
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.
Topics: Animals; Antidepressive Agents, Tricyclic; Autonomic Nervous System; Binding, Competitive; Cerebral Cortex; Corpus Striatum; In Vitro Techniques; Male; Mianserin; Mirtazapine; Norepinephrine; Prazosin; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Serotonin; Spiperone; Stereoisomerism; Synaptosomes; Yohimbine | 1988 |
Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasma.
Topics: Chromatography, Gas; Female; Humans; Kinetics; Male; Mianserin; Mirtazapine; Monitoring, Physiologic | 1987 |
Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Biogenic Amines; Dibenzazepines; Male; Methoxyhydroxyphenylglycol; Mianserin; Mirtazapine; Norepinephrine; Olfactory Bulb; Rats; Rats, Inbred Strains; Stereoisomerism | 1986 |
Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
Topics: Absorption; Aggression; Animals; Behavior, Animal; Brain; Cell Membrane; Clonidine; Dibenzazepines; Diuresis; Dopamine; Humans; In Vitro Techniques; Male; Mianserin; Mice; Mirtazapine; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Histamine; Serotonin | 1982 |
Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Body Weight; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Imipramine; Kinetics; Male; Mianserin; Mirtazapine; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Reference Values | 1994 |
The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Hippocampus; Injections, Subcutaneous; Male; Mianserin; Microdialysis; Mirtazapine; Rats; Rats, Wistar; Serotonin; Synaptic Transmission | 1994 |
Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo.
Topics: Anabolic Agents; Animals; Antidepressive Agents, Tricyclic; Biotransformation; Cell Survival; Cells, Cultured; Dibenzoxazepines; Humans; Liver; Male; Mianserin; Mirtazapine; Norpregnenes; Rats; Rats, Wistar; Species Specificity | 1994 |
Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Corpus Striatum; Dioxanes; Hippocampus; Idazoxan; Imidazoles; Male; Mianserin; Mirtazapine; Norepinephrine; Prazosin; Rats; Rats, Wistar; Serotonin; Tetrodotoxin | 1996 |
Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Hippocampus; Locus Coeruleus; Male; Mianserin; Mirtazapine; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Stereoisomerism | 1996 |
Mirtazapine as treatment for serotonin syndrome.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Female; Humans; Mianserin; Mirtazapine; Serotonin Agents | 1996 |
First report of mirtazapine overdose.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Coma; Depressive Disorder; Drug Overdose; Female; Humans; Mianserin; Midazolam; Mirtazapine; Suicide, Attempted | 1996 |
Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Brain; Cerebral Cortex; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Hippocampus; Histamine H1 Antagonists; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Mianserin; Mirtazapine; Norepinephrine; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1996 |
Controversies in the diagnosis and treatment of severe depression.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Severity of Illness Index | 1996 |
Mirtazapine--a new antidepressant.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depression; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine | 1996 |
Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Locus Coeruleus; Male; Mianserin; Mirtazapine; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Synaptic Transmission | 1997 |
Imipramine and mirtazapine are less effective than expected.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Imipramine; Mianserin; Mirtazapine | 1997 |
Neurotransmitters in depression: noradrenaline and serotonin and their interactions.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Mianserin; Mirtazapine | 1997 |
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Selective Serotonin Reuptake Inhibitors | 1997 |
Safety in overdose of mirtazapine: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Confusion; Depressive Disorder; Dothiepin; Drug Overdose; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine | 1997 |
A comparison of the physicochemical and biological properties of mirtazapine and mianserin.
Topics: Animals; Antidepressive Agents, Tricyclic; Biological Availability; Chromatography, High Pressure Liquid; Computer Simulation; Electrochemistry; Feces; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Male; Mianserin; Mirtazapine; Models, Chemical; Norepinephrine; Oxidation-Reduction; Quantum Theory; Radioligand Assay; Receptors, Adrenergic, alpha-1; Serotonin; Structure-Activity Relationship; Vas Deferens | 1997 |
Mirtazapine and ECT combination therapy.
Topics: Aged; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Mianserin; Middle Aged; Mirtazapine | 1997 |
Designing a new generation of antidepressant drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Drug Design; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Rats; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 1997 |
Mirtazapine: pharmacology in relation to adverse effects.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Humans; Mianserin; Mirtazapine; Receptors, Serotonin; Serotonin; Synapses | 1997 |
Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Conditioning, Operant; Fluoxetine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Taste | 1997 |
Mirtazapine revisited.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Humans; Mianserin; Mirtazapine | 1997 |
The pharmacologic rationale for the clinical use of antidepressants.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Psychiatric Status Rating Scales; Receptors, Adrenergic; Receptors, Serotonin; Treatment Outcome | 1997 |
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interactions; Female; Humans; Levodopa; Mianserin; Mirtazapine; Parkinson Disease; Psychoses, Substance-Induced; Suicide, Attempted | 1997 |
Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Rats; Rats, Sprague-Dawley | 1998 |
Are two antidepressant mechanisms better than one?
Topics: Antidepressive Agents; Drug Design; Drug Synergism; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Piperazines; Psychopharmacology; Receptors, Neurotransmitter; Triazoles | 1997 |
Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Direct enantiomeric separation of mianserin and 6-azamianserin derivatives using chiral stationary phases.
Topics: Adrenergic alpha-Antagonists; Amylose; Antidepressive Agents; Cellulose; Chromatography, High Pressure Liquid; Mianserin; Mirtazapine; Serotonin Antagonists; Stereoisomerism | 1998 |
Mirtazapine withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 1998 |
Sexual dysfunction associated with mirtazapine: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Sexual Dysfunctions, Psychological | 1998 |
Hypomania associated with mirtazapine augmentation of sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Serotonin syndrome with mirtazapine-fluoxetine combination.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Depression; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 1998 |
Neurochemical effects of the enantiomers of mirtazapine in normal rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Body Temperature; Injections, Intraperitoneal; Ketanserin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin Antagonists; Stereoisomerism | 1998 |
Mirtazapene: a noradrenergic and specific serotonergic antidepressant.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Mianserin; Mirtazapine | 1998 |
Hypertension during coprescription of mirtazapine and low-dose amitriptyline.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Therapy, Combination; Humans; Hypertension; Male; Mianserin; Middle Aged; Mirtazapine | 1998 |
Suicide attempts with mirtazapine overdose without complications.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Overdose; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Suicide Prevention; Suicide, Attempted | 1998 |
Lack of sexual adverse effects with mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Sexual Dysfunction, Physiological | 1998 |
[Mirtazapine in inpatient treatment of depressed patients].
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Bipolar Disorder; Contraindications; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Admission; Psychiatric Status Rating Scales | 1998 |
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Electrophysiology; Excitatory Amino Acid Agonists; Hippocampus; Inhibition, Psychological; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Oxazoles; Pertussis Toxin; Piperazines; Prosencephalon; Pyramidal Cells; Pyridines; Pyrimidines; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Virulence Factors, Bordetella | 1998 |
[Mirtazapin--fast and strong effects].
Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 1998 |
Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Methysergide; Mianserin; Mirtazapine; Piperazines; Pizotyline; Rats; Rats, Wistar; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Non-fatal mirtazapine overdose.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Overdose; Female; Humans; Hypothermia; Mianserin; Mirtazapine; Suicide, Attempted | 1998 |
Mirtazapine in recurrent brief depression.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Treatment Outcome | 1998 |
Mirtazapine-induced mania in a case of poststroke depression.
Topics: Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Cerebrovascular Disorders; Depression; Humans; Male; Mianserin; Mirtazapine | 1999 |
Mirtazapine and the granulocytes--so far so good.
Topics: Adverse Drug Reaction Reporting Systems; Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; New Zealand; Serotonin Antagonists; World Health Organization | 1999 |
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Clonidine; Dose-Response Relationship, Drug; Evoked Potentials; Hippocampus; Locus Coeruleus; Mianserin; Mirtazapine; Neural Pathways; Neurons; Norepinephrine; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin; Synaptic Transmission | 1998 |
Sexual functioning in depressed outpatients taking mirtazapine.
Topics: Adult; Ambulatory Care; Depressive Disorder, Major; Ejaculation; Female; Humans; Male; Mianserin; Mirtazapine; Orgasm; Patient Dropouts; Personal Satisfaction; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome | 1999 |
[Edema tendency, dyspnea and hypertension in the treatment with mirtazapine (Remeron)].
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Dyspnea; Edema; Female; Histamine H1 Antagonists; Humans; Hypertension; Male; Mianserin; Middle Aged; Mirtazapine | 1999 |
Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias.
Topics: Adrenergic alpha-Antagonists; Aged; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Parkinson Disease | 1999 |
Clinical pharmacology of mirtazapine: revisited.
Topics: Agranulocytosis; Antidepressive Agents, Tricyclic; Anxiety; Depression; Humans; Mianserin; Mirtazapine; Psychomotor Agitation; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders | 1999 |
[Mirtazapine--the new standard].
Topics: Antidepressive Agents, Tricyclic; Depression; Depressive Disorder; Humans; Mianserin; Mirtazapine | 1999 |
Tissue distribution of mirtazapine (Remeron) in postmortem cases.
Topics: Antidepressive Agents, Tricyclic; Autopsy; Bile; Blood Chemical Analysis; Chromatography, Gas; Humans; Kidney; Liver; Mianserin; Mirtazapine; Tissue Distribution; Urine | 1999 |
Distribution of mirtazapine (Remeron) in thirteen postmortem cases.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Autopsy; Chromatography, Gas; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Tissue Distribution | 1999 |
The use of mirtazapine in a patient with chronic pain.
Topics: Accidental Falls; Antidepressive Agents, Tricyclic; Back Pain; Chronic Disease; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 1999 |
Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.
Topics: Animals; Electroencephalography; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Respiration; Serotonin Antagonists; Serotonin Receptor Agonists; Sleep Apnea, Central; Sleep Stages | 1999 |
Does mirtazapine enhance serotonergic neurotransmission in depressed patients?
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prolactin; Serotonin; Synaptic Transmission; Tryptophan | 2000 |
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Citalopram; Discrimination, Psychological; Dopamine; Electrophysiology; Frontal Lobe; Humans; Limbic System; Male; Mianserin; Mirtazapine; Norepinephrine; Pain; Penile Erection; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission | 2000 |
Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
Topics: Antidepressive Agents, Tricyclic; Antimanic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Mianserin; Middle Aged; Mirtazapine; Psychotic Disorders; Recurrence | 2000 |
Hypertensive urgency induced by an interaction of mirtazapine and clonidine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Antihypertensive Agents; Clonidine; Depression; Drug Interactions; Humans; Hypertension; Male; Mianserin; Mirtazapine | 2000 |
Mirtazapine withdrawal causing hypomania.
Topics: Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Female; Humans; Mianserin; Mirtazapine; Substance Withdrawal Syndrome | 1999 |
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
Topics: Adrenergic alpha-Antagonists; Animals; Drug Therapy, Combination; Male; Mianserin; Mirtazapine; Paroxetine; Piperazines; Pyramidal Cells; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
SIADH with multiple antidepressants in a geriatric patient.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Irritable bowel syndrome and mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Colonic Diseases, Functional; Drug Administration Schedule; Female; Humans; Mianserin; Mirtazapine; Treatment Outcome | 2000 |
Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Polysomnography; Psychiatric Status Rating Scales; Sleep Initiation and Maintenance Disorders; Sleep Stages; Treatment Outcome | 2000 |
[Macroglossia and tongue papular injury due to mirtazapine treatment].
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Humans; Macroglossia; Male; Mianserin; Mirtazapine; Skin Diseases, Papulosquamous; Tongue Diseases | 2000 |
Occurrence of mirtazapine-induced delirium in organic brain disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Delirium; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neurocognitive Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Risk Factors | 2000 |
The role of mirtazapine in the pharmacotherapy of depression.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Depressive Disorder; Humans; Mianserin; Mirtazapine; Serotonin Agents; Treatment Outcome | 2000 |
Panic attacks during discontinuation of mirtazepine.
Topics: Antidepressive Agents, Tricyclic; Appendectomy; Dysthymic Disorder; Hernia, Umbilical; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Panic Disorder; Postoperative Complications; Substance Withdrawal Syndrome | 2000 |
Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
Topics: Antidepressive Agents, Tricyclic; Benzoflavones; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxylation; Isoenzymes; Methylation; Mianserin; Microsomes, Liver; Mirtazapine; Oxidation-Reduction; Quinidine; Recombinant Proteins | 2000 |
Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index; United Kingdom | 2000 |
Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism.
Topics: Biotransformation; Cytochrome P-450 Enzyme System; Data Interpretation, Statistical; DNA, Complementary; Humans; Isoenzymes; Kinetics; Mianserin; Microsomes, Liver; Mirtazapine; Predictive Value of Tests; Recombinant Proteins | 2000 |
Treatment of hot flushes with mirtazapine: four case reports.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Female; Hot Flashes; Humans; Mianserin; Middle Aged; Mirtazapine; Receptors, Serotonin; Serotonin Antagonists; Severity of Illness Index | 2000 |
Is the EEG helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Electroencephalography; Humans; Lithium; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine | 2000 |
Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Female; Humans; Male; Mianserin; Mirtazapine; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Stereoisomerism | 2000 |
Determination of mirtazapine in tablets by UV spectrophotometric and derivative spectrophotometric methods.
Topics: Antidepressive Agents, Tricyclic; Calibration; Mianserin; Mirtazapine; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets | 2000 |
Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthesia; Animals; Antidepressive Agents, Tricyclic; Brain; Clonidine; Male; Mianserin; Microdialysis; Mirtazapine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Serotonin | 2000 |
Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs.
Topics: Animals; Antidepressive Agents; Anxiety; Carbolines; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroshock; GABA Antagonists; Imipramine; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Time Factors | 2001 |
Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Citalopram; Discrimination Learning; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors | 2001 |
Treatment of depression in the elderly.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Geriatrics; Humans; Male; Mianserin; Mirtazapine; Prognosis; Risk Assessment; Treatment Outcome | 2001 |
Treatment of cluster headache with mirtazapine.
Topics: Cluster Headache; Histamine H1 Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 1999 |
SSRI and mirtazapine in PTSD.
Topics: Adrenergic alpha-Antagonists; Child; Child Abuse, Sexual; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2001 |
Mirtazapine for neuroleptic-induced akathisia.
Topics: Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Haloperidol; Humans; Male; Mianserin; Mirtazapine; Psychotic Disorders | 2001 |
Does mirtazapine have a more rapid onset than SSRIs?
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Patient Dropouts; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Mitrazapine-associated palinopsia.
Topics: Adult; Afterimage; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Illusions; Mianserin; Mirtazapine | 2001 |
[Depressive disorders. A third have a chronic course].
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Recurrence | 2001 |
Long-term treatment with antidepressant drugs reduces the sensitivity of cortical cholinergic neurons to the activating actions of stress and the anxiogenic drug FG 7142.
Topics: Acetylcholine; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Carbolines; Cholinergic Fibers; GABA Antagonists; Imipramine; Male; Mianserin; Mirtazapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Stress, Physiological | 2001 |
Mirtazapine for excessive masturbation in an adolescent with autism.
Topics: Adolescent; Adrenergic alpha-Antagonists; Autistic Disorder; Benzodiazepines; Drug Therapy, Combination; Humans; Male; Masturbation; Mianserin; Mirtazapine; Olanzapine; Pirenzepine; Remission Induction; Selective Serotonin Reuptake Inhibitors | 2001 |
Subclinical pancreatitis related to mirtazapine - a case report.
Topics: Alcoholism; Amylases; Antidepressive Agents, Tricyclic; Enzymes; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pancreatitis | 2001 |
Mirtazapine and bone marrow suppression: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Bone Marrow Diseases; Depressive Disorder; Female; Humans; Mianserin; Mirtazapine | 2001 |
Mirtazapine for treatment of depression and comorbidities in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Comorbidity; Depression; Female; Humans; Male; Mianserin; Mirtazapine; Sleep Initiation and Maintenance Disorders; Weight Loss | 2001 |
Treatment of mood-congruent psychotic depression with imipramine.
Topics: Adolescent; Adult; Affect; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Imipramine; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychiatric Status Rating Scales; Psychotic Disorders; Treatment Outcome | 2001 |
Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy.
Topics: Antidepressive Agents, Tricyclic; Antineoplastic Agents; Humans; Mianserin; Mirtazapine; Nausea; Sleep Initiation and Maintenance Disorders | 2001 |
Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Dopamine; Electroshock; Extracellular Space; Frontal Lobe; Imipramine; Male; Mianserin; Microdialysis; Mirtazapine; Pregnenolone; Progesterone; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Steroids; Stress, Psychological | 2001 |
Serotonin syndrome induced by fluvoxamine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Adult; Adverse Drug Reaction Reporting Systems; Anorexia Nervosa; Drug Interactions; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tissue Distribution | 2001 |
Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Interactions; Female; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Male; Mianserin; Mirtazapine | 2001 |
Effects of mirtazapine on the levels of exogenous histamine in the plasma of the cat.
Topics: Animals; Antidepressive Agents, Tricyclic; Cats; Female; Histamine; Histamine H1 Antagonists; Injections, Intravenous; Male; Mianserin; Mirtazapine | 2001 |
Peripheral edema associated with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Edema; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2001 |
[Interference in the serotoninergic and noradrenergic system. Faster out of depression].
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2001 |
Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Carbolines; Cerebral Cortex; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Electric Stimulation; GABA Antagonists; Imipramine; Male; Mianserin; Mirtazapine; Norepinephrine; Rats; Receptors, GABA-A; Stress, Physiological | 2002 |
Relative safety of mirtazapine overdose.
Topics: Adult; Antidepressive Agents, Tricyclic; Cathartics; Charcoal; Drug Overdose; Electrocardiography; Humans; Male; Mianserin; Mirtazapine; Sorbitol; Suicide, Attempted; Tachycardia; Treatment Outcome | 2001 |
First report of mirtazapine-induced arthralgia.
Topics: Adult; Antidepressive Agents, Tricyclic; Arthralgia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2001 |
Intravenous mirtazapine in the treatment of depressed inpatients.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Analysis of Variance; Behavior; Depressive Disorder, Major; Female; Humans; Infusions, Intravenous; Male; Mianserin; Middle Aged; Mirtazapine | 2002 |
Comment: serotonin syndrome induced by fluvoxamine and mirtazapine.
Topics: Drug Interactions; Fluvoxamine; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2001 |
Mania associated with mirtazapine augmentation of fluoxetine.
Topics: Adrenergic alpha-Antagonists; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Time Factors | 2002 |
Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2002 |
In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Immobilization; Male; Mianserin; Mirtazapine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Severe serotonin syndrome induced by mirtazapine monotherapy.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Humans; Male; Mianserin; Mirtazapine; Serotonin Syndrome | 2002 |
Serotonin syndrome and atypical antipsychotics.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Pirenzepine; Schizophrenia; Schizotypal Personality Disorder; Serotonin Syndrome; Tramadol | 2002 |
Spectrophotometric, spectrofluorimetric, HPLC and CZE determination of mirtazapine in pharmaceutical tablets.
Topics: Antidepressive Agents; Calibration; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Indicators and Reagents; Mianserin; Mirtazapine; Reproducibility of Results; Solutions; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tablets | 2002 |
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aggression; Animals; Antidepressive Agents, Tricyclic; Binding, Competitive; Cerebral Cortex; Exploratory Behavior; Male; Methoxamine; Mianserin; Mice; Mirtazapine; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1 | 2002 |
Mirtazapine may have the propensity for developing a restless legs syndrome? A case report.
Topics: Depressive Disorder; Electroencephalography; Female; Histamine H1 Antagonists; Humans; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome | 2002 |
Mirtazapine overdose with benign outcome.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Drug Overdose; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Suicide, Attempted; Time Factors | 2002 |
Mirtazapine-induced akathisia.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2002 |
Dystonia induced by mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Dystonia; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2002 |
Urinary incontinence with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Urinary Incontinence | 2002 |
Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Second-Generation; Brain Chemistry; Cerebral Cortex; Chromatography, High Pressure Liquid; Desoxycorticosterone; Electroshock; Fluoxetine; Male; Mianserin; Mirtazapine; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Steroids; Stress, Psychological | 2002 |
Acute and chronic hypertensive headache and hypertensive encephalopathy.
Topics: Acute Disease; Antidepressive Agents; Antihypertensive Agents; Anxiety; Arterioles; Cerebral Arteries; Cerebrovascular Circulation; Chronic Disease; Circadian Rhythm; Depression; Epilepsy, Tonic-Clonic; Female; Headache; Homeostasis; Humans; Hypertension; Hypertensive Encephalopathy; Labetalol; Magnetic Resonance Imaging; Mianserin; Middle Aged; Mirtazapine; Nitroprusside; Norepinephrine; Orgasm; Posture; Spinal Nerve Roots; Vasodilator Agents; Vomiting | 2002 |
Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection. Application to management of acute intoxication.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Mianserin; Mirtazapine; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
Weight change in depressed nursing home patients on mirtazapine.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Homes for the Aged; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nursing Homes; Retrospective Studies; Weight Gain; Weight Loss | 2002 |
Neutropenia associated with mirtazapine use: is a drop in the neutrophil count in a symptomatic older adults a cause for concern?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Mianserin; Mirtazapine; Neutropenia | 2002 |
Mirtazapine-induced hepatotoxicity.
Topics: Antidepressive Agents, Tricyclic; Female; Humans; Liver Cirrhosis; Liver Function Tests; Mianserin; Middle Aged; Mirtazapine | 2002 |
[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Carbon Radioisotopes; Female; Mianserin; Mirtazapine; Swine; Time Factors; Tomography, Emission-Computed | 2002 |
Massive weight gain and hostility force mirtazapine stoppage.
Topics: Adult; Affect; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Hostility; Humans; Mianserin; Mirtazapine; Treatment Refusal; Weight Gain | 2002 |
Functional dyspepsia and mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dyspepsia; Female; Humans; Limbic System; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index | 2002 |
Capgras syndrome responding to the antidepressant mirtazapine.
Topics: Aged; Antidepressive Agents; Capgras Syndrome; Humans; Male; Mianserin; Mirtazapine | 2002 |
Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
Topics: Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Hypersensitivity; Female; Humans; Leukopenia; Mianserin; Middle Aged; Mirtazapine; Neutropenia; Venlafaxine Hydrochloride | 2002 |
The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Narcotic Antagonists; Pain Measurement; Receptors, Opioid; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |
[Rapid treatment effect. An effective antidepressant dissolves on the tongue].
Topics: Administration, Oral; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Humans; Mianserin; Mirtazapine; Sertraline; Treatment Outcome | 2002 |
Biotransformation of mirtazapine by Cunninghamella elegans.
Topics: Antidepressive Agents; Biotransformation; Chromatography, High Pressure Liquid; Circular Dichroism; Cunninghamella; Cyclic N-Oxides; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mianserin; Mirtazapine; Stereoisomerism | 2002 |
Mirtazapine use in two pregnant women: is it safe?
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Trifluoperazine | 2002 |
Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'?
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Mianserin; Mirtazapine; Norepinephrine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Syndrome | 2002 |
Mirtazapine for PTSD nightmares.
Topics: Antidepressive Agents; Dreams; Humans; Mianserin; Mirtazapine; Refugees; Sleep Initiation and Maintenance Disorders; Stress Disorders, Post-Traumatic; Treatment Outcome | 2002 |
In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Clonidine; Cyclopropanes; Depression; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Mirtazapine in Parkinsonian tremor.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Parkinson Disease; Prospective Studies; Statistics, Nonparametric; Tremor | 2002 |
Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lorazepam; Mianserin; Mirtazapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Electroencephalography; Humans; Levodopa; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Parkinsonian Disorders; Polysomnography; REM Sleep Behavior Disorder | 2003 |
Restless legs syndrome induced by mirtazapine.
Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome; Sleep, REM | 2002 |
[Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Genes, Dominant; Humans; Mianserin; Mirtazapine; Pedigree; Restless Legs Syndrome | 2002 |
Re: Mirtazapine in cancer patients.
Topics: Antidepressive Agents, Tricyclic; Depression; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms | 2003 |
Serotonin transporter modulation in blood lymphocytes from patients with major depression.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Second-Generation; Brain; Carrier Proteins; Depressive Disorder, Major; Down-Regulation; Female; Fluoxetine; Humans; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mianserin; Mirtazapine; Nerve Tissue Proteins; Neuroimmunomodulation; Paroxetine; Radioligand Assay; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Up-Regulation | 2002 |
Attenuation of HPA axis hyperactivity and simultaneous clinical deterioration in a depressed patient treated with mirtazapine.
Topics: Adrenocorticotropic Hormone; Antidepressive Agents, Tricyclic; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System | 2001 |
Mirtazapine for treatment-resistant depression: a preliminary report.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Treatment Outcome | 2003 |
Mirtazapine: another drug responsible for drug-induced acute pancreatitis? A letter of warning.
Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Mianserin; Mirtazapine; Pancreatitis | 2003 |
Mirtazapine for pruritus.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Cholestasis; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Pruritus; Renal Insufficiency | 2003 |
Mirtazapine in suicidal Huntington's disease.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Huntington Disease; Mianserin; Mirtazapine; Suicide, Attempted | 2003 |
A non-fatal mirtazapine overdose in a suicide attempt.
Topics: Adult; Antidepressive Agents, Tricyclic; Drug Overdose; Female; Humans; Mianserin; Mirtazapine; Suicide, Attempted; Survival Rate | 2003 |
Glucose dysregulation and mirtazapine-induced weight gain.
Topics: Adult; Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Cocaine-Related Disorders; Depressive Disorder; Diabetes Complications; Diabetes Mellitus; Diagnosis, Dual (Psychiatry); Female; Humans; Mianserin; Mirtazapine; Obesity; Weight Gain | 2003 |
The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Cohort Studies; Depressive Disorder, Major; Drug Prescriptions; England; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pregnancy; Product Surveillance, Postmarketing; Serotonin Antagonists; Surveys and Questionnaires | 2003 |
Linezolid, a monoamine oxidase inhibiting antibiotic, and antidepressants.
Topics: Acetamides; Aged; Anti-Infective Agents; Comorbidity; Depressive Disorder; Drug Interactions; Humans; Linezolid; Male; Mianserin; Mirtazapine; Osteomyelitis; Oxazolidinones; Serotonin Syndrome | 2003 |
Modafinil augmentation of mirtazapine in a failure-to-thrive geriatric inpatient.
Topics: Aged; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cachexia; Central Nervous System Stimulants; Cognition Disorders; Depressive Disorder, Major; Drug Therapy, Combination; Frail Elderly; Hospitalization; Humans; Male; Mianserin; Mirtazapine; Modafinil | 2002 |
Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy.
Topics: Abortion, Induced; Adult; Antidepressive Agents, Tricyclic; Cesarean Section; Female; Humans; Hyperemesis Gravidarum; Infusions, Intravenous; Mianserin; Mirtazapine; Pregnancy; Pregnancy Trimester, Second; Twins | 2003 |
Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report.
Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Diabetic Ketoacidosis; Female; Humans; Hypertriglyceridemia; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Pancreatitis | 2003 |
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Italy; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors | 2003 |
Taurine concentration in human blood peripheral lymphocytes: major depression and treatment with the antidepressant mirtazapine.
Topics: Adolescent; Adult; Depression; Female; Humans; Lymphocytes; Male; Mianserin; Middle Aged; Mirtazapine; Taurine | 2003 |
Epileptiform EEG patterns induced by mirtazapine in both psychiatric patients and healthy volunteers.
Topics: Adult; Antidepressive Agents; Electroencephalography; Epilepsy; Female; Humans; Mental Disorders; Mianserin; Mirtazapine | 2003 |
Determination of mirtazapine in human plasma by liquid chromatography.
Topics: Antidepressive Agents, Tricyclic; Area Under Curve; Humans; Male; Mianserin; Mirtazapine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Chairmen's introduction.
Topics: Antidepressive Agents, Tricyclic; Depression; Humans; Mianserin; Mirtazapine; Patient Compliance; Prevalence | 2003 |
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Cyclohexanols; Doxepin; Drug Resistance, Multiple; Gene Expression; Injections, Subcutaneous; Kidney; Liver; Male; Mianserin; Mice; Mice, Knockout; Mirtazapine; Paroxetine; Point Mutation; Spleen; Venlafaxine Hydrochloride | 2003 |
Mirtazapine-induced hyponatraemia.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2003 |
Influence of mirtazapine on urinary free cortisol excretion in depressed patients.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Sex Factors; Treatment Outcome | 2003 |
[Vasopressin analogue injection as ultimate measure for counteracting severe catecholamine-refractory poisoning by several vasodilators taken with suicidal intent].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiography; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Benzazepines; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Isosorbide Dinitrate; Mesenteric Arteries; Mianserin; Mirtazapine; Poisoning; Suicide, Attempted; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
[Unclear chronic aches. Often depression plays a part therein].
Topics: Acetates; Amines; Analgesics, Opioid; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Back Pain; Chronic Disease; Cyclohexanecarboxylic Acids; Depression; Diagnosis, Differential; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypochondriasis; Mianserin; Mirtazapine; Pain; Somatoform Disorders | 2003 |
Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Clonidine; Drug Administration Schedule; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Parkinsonian Disorders; Recurrence; REM Sleep Behavior Disorder; Treatment Outcome | 2003 |
Influence of mirtazapine on the sexual behavior of male rats.
Topics: Animals; Female; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal | 2004 |
Abnormal prolactin elevation in a schizophrenic patient in treatment with quetiapine and mirtazapine. The role of opioid system.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Drug Interactions; Female; Humans; Mianserin; Mirtazapine; Prolactin; Quetiapine Fumarate; Receptors, Dopamine D2; Schizophrenia | 2003 |
Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment.
Topics: Adult; Analysis of Variance; beta-Adrenergic Receptor Kinases; Blood Platelets; Chi-Square Distribution; Cyclic AMP-Dependent Protein Kinases; Depressive Disorder, Major; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Receptor, Adenosine A2A; Suicide, Attempted | 2004 |
Measurement of total mirtazapine and normirtazapine in plasma/serum by liquid chromatography with fluorescence detection.
Topics: Calibration; Chromatography, High Pressure Liquid; Mianserin; Mirtazapine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2003 |
Oestradiol and mirtazapine restore the disturbed tail-temperature of oestrogen-deficient rats.
Topics: Animals; Body Temperature; Estradiol; Estrogens; Female; Mianserin; Mirtazapine; Ovariectomy; Rats; Rats, Sprague-Dawley | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Mirtazepine overdose and miosis.
Topics: Adult; Antidepressive Agents, Tricyclic; Drug Overdose; Female; Humans; Mianserin; Miosis; Mirtazapine; Treatment Outcome | 2003 |
Therapeutic drug monitoring of the antidepressant mirtazapine and its N-demethylated metabolite in human serum.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sensitivity and Specificity | 2004 |
[Dolichocolon as unwanted effect of treatment with the anti-depressant mirtazapine].
Topics: Adult; Antidepressive Agents, Tricyclic; Colon; Colonic Diseases, Functional; Female; Humans; Mianserin; Mirtazapine; Treatment Outcome | 2004 |
Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.
Topics: Analgesics, Opioid; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Polypharmacy; Serotonin Syndrome; Tramadol; Venlafaxine Hydrochloride | 2004 |
Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Clonidine; Desipramine; Dopamine; Injections, Intraperitoneal; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Occipital Lobe; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2004 |
Mirtazapine: not a dual action antidepressant?
Topics: Antidepressive Agents, Tricyclic; Depression; Humans; Mianserin; Mirtazapine; Serotonin; Synaptic Transmission | 2004 |
Mechanism of action of mirtazapine: dual action or dual effect?
Topics: Antidepressive Agents, Tricyclic; Depression; Humans; Mianserin; Mirtazapine; Serotonin; Serotonin Syndrome | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Comparative toxicity of citalopram and the newer antidepressants after overdose.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Poisoning; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2004 |
[Gynecomastia-galactorrhea during treatment with mirtazapine].
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Male; Mianserin; Mirtazapine; Paroxetine; Risk Factors | 2004 |
Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain Chemistry; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Mianserin; Microdialysis; Mirtazapine; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A | 2004 |
Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
Topics: Adolescent; Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Pruritus | 2004 |
Therapeutic drug monitoring of mirtazapine and its metabolite desmethylmirtazapine by HPLC with fluorescence detection.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sensitivity and Specificity; Spectrometry, Fluorescence | 2004 |
Genetics in pharmacokinetics?
Topics: Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Depressive Disorder; Dose-Response Relationship, Drug; Genotype; Humans; Mianserin; Mirtazapine; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors | 2004 |
Population pharmacokinetic analysis of mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Female; Genotype; Humans; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine | 2004 |
The effects of newer antidepressants on low-density lipoprotein cholesterol levels.
Topics: Antidepressive Agents, Tricyclic; Cholesterol, HDL; Cholesterol, LDL; Confounding Factors, Epidemiologic; Female; Humans; Hypercholesterolemia; Male; Mianserin; Mirtazapine; Research Design; Selection Bias; Sex Factors | 2004 |
Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism.
Topics: Animals; Antidepressive Agents, Tricyclic; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Gene Expression; Hypothalamus; In Vitro Techniques; Male; Mianserin; Mirtazapine; Potassium Chloride; Rats; Rats, Wistar | 2005 |
New method for the chiral evaluation of mirtazapine in human plasma by liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stereoisomerism | 2004 |
Effect of mirtazapine versus fluoxetine on "sleep quality".
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Mianserin; Mirtazapine; Research Design; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders | 2004 |
Altered response to mirtazapine on gene expression profile of lymphocytes from Alzheimer's patients.
Topics: Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Female; Gene Expression Profiling; Humans; Lymphocytes; Male; Mianserin; Mirtazapine; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction | 2004 |
Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS).
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Humans; Male; Mianserin; Mirtazapine; Polysomnography; Sleep Apnea, Central; Sleep Apnea, Obstructive; Treatment Refusal | 2004 |
Mirtazapine-induced shopping spree.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Mianserin; Mirtazapine | 2004 |
Newer antidepressants in pregnancy: prospective outcome of a case series.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Teratogens; Triazoles; Turkey; Venlafaxine Hydrochloride | 2004 |
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
Topics: Adult; Catechol O-Methyltransferase; Depressive Disorder, Major; Female; Humans; Male; Methionine; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Polymorphism, Genetic; Time Factors; Valine | 2005 |
[Motivational therapy can fail here. Sleep disorders in depressions].
Topics: Antidepressive Agents, Tricyclic; Arousal; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Mianserin; Mirtazapine; Motivation; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Wakefulness | 2004 |
Enantioselective determination of the novel antidepressant mirtazapine and its active demethylated metabolite in human plasma by means of capillary electrophoresis.
Topics: Antidepressive Agents; Electrophoresis, Capillary; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stereoisomerism | 2004 |
Impact of the CYP2D6 ultrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers.
Topics: Adult; Area Under Curve; Confidence Intervals; Cytochrome P-450 CYP2D6; Gene Frequency; Genotype; Humans; Male; Metabolic Clearance Rate; Mianserin; Mirtazapine | 2004 |
Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors.
Topics: Depressive Disorder, Major; Female; Histamine H1 Antagonists; Humans; Mianserin; Middle Aged; Mirtazapine; Nausea; Selective Serotonin Reuptake Inhibitors | 2004 |
Mirtazapine and breast-feeding.
Topics: Adult; Antidepressive Agents, Tricyclic; Breast Feeding; Depression, Postpartum; Female; Humans; Infant, Newborn; Mianserin; Milk, Human; Mirtazapine | 2004 |
Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome | 2004 |
Mirtazapine for Charles Bonnet syndrome.
Topics: Antidepressive Agents, Tricyclic; Hallucinations; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Syndrome | 2004 |
Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.
Topics: Acute Disease; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Chronic Disease; Citalopram; Disease Models, Animal; Duloxetine Hydrochloride; Male; Mianserin; Mirtazapine; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2005 |
Low-dose mirtazapine increases genioglossus activity in the anesthetized rat.
Topics: Adrenergic alpha-Antagonists; Anesthetics, Intravenous; Animals; Diaphragm; Dose-Response Relationship, Drug; Electromyography; Male; Mianserin; Mirtazapine; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Tongue; Tracheostomy; Urethane; Vagotomy | 2005 |
Acute reversible dyskinesia induced by mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2005 |
Increased libido with the combined use of venlafaxine and mirtazapine.
Topics: Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Libido; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2005 |
Neurotensin receptor agonists and antagonists for schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Data Interpretation, Statistical; Humans; Mianserin; Mirtazapine; Neurotensin; Peptide Fragments; Piperidines; Pyrazoles; Quinolines; Receptors, Neurotensin; Research Design; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Depressive Disorder; Hepatitis C; Humans; Interferon-alpha; Male; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index; Suicide, Attempted; Time Factors | 2005 |
Study of mirtazapine antidepressant effects in rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Escape Reaction; Male; Mianserin; Mirtazapine; Motor Activity; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Time Factors | 2005 |
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Arousal; Depressive Disorder, Major; Electric Stimulation; Electromagnetic Phenomena; Epilepsy; Evoked Potentials, Motor; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Motor Cortex; Neural Inhibition | 2005 |
Non-lethal mirtazapine overdose with rhabdomyolysis.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Drug Overdose; Humans; Male; Mianserin; Mirtazapine; Rhabdomyolysis | 2005 |
[Mirtazapin and gynecomastia-galactorrhea].
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Galactorrhea; Gynecomastia; Humans; Male; Mianserin; Mirtazapine | 2005 |
Mirtazapine for alcohol dependence: a case report.
Topics: Alcoholism; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Receptors, Serotonin; Treatment Outcome | 2005 |
Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
Topics: Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Cyclohexanols; Electroshock; Extracellular Space; Fluvoxamine; Foot; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2005 |
Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Membrane; Depressive Disorder, Major; Female; Humans; Hydroxyindoleacetic Acid; Kinetics; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mianserin; Middle Aged; Mirtazapine; Nerve Tissue Proteins; Norepinephrine; Paroxetine; Psychiatric Status Rating Scales; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2005 |
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Mirtazapine for chronic urticaria.
Topics: Adrenergic alpha-Antagonists; Adult; Carbon Radioisotopes; Chronic Disease; Female; Humans; Male; Mianserin; Mirtazapine; Urticaria | 2004 |
36-Year-old woman with loss of consciousness, fever, and tachycardia.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Back Pain; Depression; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Neck Pain; Serotonin Syndrome; Tachycardia; Tramadol; Unconsciousness | 2005 |
Management of chemotherapy-induced side-effects.
Topics: Antiemetics; Antineoplastic Agents; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Nausea; Neoplasms; Vomiting | 2005 |
Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass.
Topics: Adrenergic alpha-Antagonists; Adult; Female; Gastric Bypass; Humans; Mianserin; Mirtazapine; Obesity, Morbid; Postoperative Nausea and Vomiting | 2005 |
Splenic norepinephrine depletion following acute stress suppresses in vivo antibody response.
Topics: Animals; Catecholamines; Hemocyanins; Immunoglobulin G; Immunoglobulin M; Immunosuppression Therapy; Injections, Intraperitoneal; Male; Methyltyrosines; Mianserin; Mirtazapine; Norepinephrine; Rats; Rats, Inbred F344; Spleen; Stress, Physiological; Time Factors; Tyrosine | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Sertraline- and mirtazapine-induced severe neutropenia.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Mirtazapine; Neutropenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells.
Topics: Actins; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Blood Cells; Clozapine; Glucose Transporter Type 3; Glucose Transporter Type 4; Glucose Transporter Type 5; Haloperidol; Humans; Mianserin; Mirtazapine; Olanzapine; RNA, Messenger; U937 Cells | 2006 |
Mirtazapine in drug-induced excessive sweating.
Topics: Citalopram; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sweating | 2005 |
Mirtazapine use in resistant hyperemesis gravidarum: report of three cases and review of the literature.
Topics: Adult; Antiemetics; Female; Humans; Hyperemesis Gravidarum; Infant, Newborn; Mianserin; Mirtazapine; Pregnancy | 2005 |
Mirtazapine for akathisia in bipolar disorder.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Serotonin Antagonists | 2005 |
Mirtazapine-induced arthralgia and coagulopathy: a case report.
Topics: Ankle Joint; Antidepressive Agents, Tricyclic; Arthralgia; Ecchymosis; Female; Humans; Knee Joint; Mianserin; Middle Aged; Mirtazapine | 2005 |
Pseudohallucinations associated with moclobemide: a case report.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Hallucinations; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Sertraline | 2005 |
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Community Mental Health Centers; Drug Prescriptions; Drug Utilization; Female; Germany; Hospitals, Psychiatric; Humans; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Piperazines; Practice Patterns, Physicians'; Reboxetine; Rural Health Services; Selective Serotonin Reuptake Inhibitors; Sex Factors; Switzerland; Triazoles; Urban Health Services | 2005 |
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.
Topics: Adult; Amygdala; Antidepressive Agents, Tricyclic; Brain; Cerebrovascular Circulation; Citalopram; Combined Modality Therapy; Depressive Disorder, Major; Female; Functional Laterality; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Oximes; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Thalamus; Tomography, Emission-Computed, Single-Photon; Transcutaneous Electric Nerve Stimulation; Vagus Nerve | 2005 |
Neurologic oral manifestations caused by a new formulation of mirtazapine.
Topics: Administration, Oral; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Extremities; Humans; Ion Channels; Mianserin; Mirtazapine; Mouth; Norepinephrine; Pain; Paresthesia; Product Surveillance, Postmarketing; Receptors, Adrenergic; Receptors, Serotonin; Serotonin; Sweden | 2005 |
Tissue distribution of mirtazapine and desmethylmirtazapine in a case of mirtazapine poisoning.
Topics: Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bile; Brain Chemistry; Forensic Pathology; Gas Chromatography-Mass Spectrometry; Gastrointestinal Contents; Humans; Kidney; Liver; Lung; Male; Mianserin; Mirtazapine; Muscle, Skeletal; Nortriptyline; Sertraline; Suicide; Tissue Distribution | 2006 |
Onset of antidepressant action: a pharmacological question?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Time Factors | 2005 |
Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Sexual Dysfunctions, Psychological | 2005 |
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.
Topics: Adult; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Female; Humans; Image Processing, Computer-Assisted; Male; Mianserin; Middle Aged; Mirtazapine; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2006 |
Enantiomeric separation of mirtazapine and its metabolites by nano-liquid chromatography with UV-absorption and mass spectrometric detection.
Topics: Chromatography, Liquid; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Mianserin; Mirtazapine; Models, Molecular; Quaternary Ammonium Compounds; Spectrophotometry, Ultraviolet; Stereoisomerism | 2005 |
Evaluation of the sensitivity of miniaturized liquid chromatography-electrospray ionization-mass spectrometry for pharmaceutical analysis.
Topics: Chromatography, High Pressure Liquid; Desogestrel; Mianserin; Miniaturization; Mirtazapine; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Surface Properties | 2005 |
Severe chronic urticaria: response to mirtazapine.
Topics: Adrenergic alpha-Antagonists; Aged; Chronic Disease; Female; Humans; Mianserin; Mirtazapine; Remission Induction; Severity of Illness Index; Urticaria | 2005 |
Use of antidepressant combinations: which, when and why? Results of a Spanish survey.
Topics: Antidepressive Agents; Data Collection; Depressive Disorder; Drug Therapy, Combination; Drug Utilization; Humans; Mianserin; Mirtazapine; Practice Patterns, Physicians'; Psychiatry; Selective Serotonin Reuptake Inhibitors; Spain; Surveys and Questionnaires | 2005 |
Does domperidone potentiate mirtazapine-associated restless legs syndrome?
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Domperidone; Dopamine Antagonists; Drug Synergism; Humans; Male; Mianserin; Mirtazapine; Restless Legs Syndrome | 2006 |
Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Antiemetics; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Olanzapine | 2006 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
PET neuroimaging of [11C]mirtazapine enantiomers in pigs.
Topics: Animals; Blood Chemical Analysis; Brain; Carbon Radioisotopes; Female; Injections, Intravenous; Isotope Labeling; Mianserin; Mirtazapine; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Stereoisomerism; Swine; Whole-Body Counting | 2006 |
Changes in weight and glucose tolerance during treatment with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Weight; Depressive Disorder; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Male; Mianserin; Middle Aged; Mirtazapine; Weight Gain | 2006 |
Severe creatine kinase increase during quetiapine and mirtazapine treatment.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Quetiapine Fumarate | 2006 |
Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.
Topics: Amphetamines; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Dose-Response Relationship, Drug; Hippocampus; Imipramine; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; RNA, Messenger; Serotonin Receptor Agonists; Time Factors | 2005 |
Massive creatine kinase elevations with quetiapine: report of two cases.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Creatine Kinase; Depressive Disorder, Major; Dibenzothiazepines; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Pain; Psychotic Disorders; Quetiapine Fumarate | 2006 |
The effect of mirtazapine in patients with chronic pain and concomitant depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Chronic Disease; Depression; Female; Germany; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Prospective Studies; Treatment Outcome | 2006 |
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
[Changes in sexual function in mirtazapine treatment. Primary data of a national, multicenter, prospective observational study in depressed patients].
Topics: Adult; Affect; Aged; Antidepressive Agents, Tricyclic; Coitus; Depressive Disorder; Erectile Dysfunction; Female; Humans; Hungary; Male; Mianserin; Middle Aged; Mirtazapine; Office Visits; Penile Erection; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Surveys and Questionnaires | 2005 |
A suspicious bathtub death in a suicidal patient on mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Asphyxia; Depression; Diagnosis, Differential; Drowning; Female; Forensic Pathology; Humans; Mianserin; Middle Aged; Mirtazapine; Suicide, Attempted | 2006 |
Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain.
Topics: Amitriptyline; Animals; Antidepressive Agents; Corpus Striatum; Gene Expression Regulation; Male; Mianserin; Mirtazapine; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Sertraline; Time Factors; Transcriptional Activation | 2006 |
Mirtazapine in bupropion-induced dyskinesias: a case report.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Dyskinesia, Drug-Induced; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2006 |
Mirtazapine and its enantiomers differentially modulate acute thermal nociception in rats.
Topics: Afferent Pathways; Animals; Antidepressive Agents, Tricyclic; Central Nervous System; Disease Models, Animal; Hot Temperature; Injections, Spinal; Isomerism; Male; Mianserin; Mirtazapine; Molecular Conformation; Nociceptors; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Thermosensing; Treatment Outcome | 2006 |
Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Image Processing, Computer-Assisted; Mianserin; Mirtazapine; Pausinystalia; Positron-Emission Tomography; Swine; Tissue Distribution | 2006 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Risperidone; Serotonin Antagonists; Treatment Outcome | 2006 |
Stress-induced sensitization of the limbic system in ovariectomized rats is partly restored by cyclic 17beta-estradiol administration.
Topics: Amygdala; Animals; Antidepressive Agents; Chronic Disease; Dentate Gyrus; Drug Interactions; Estradiol; Female; Limbic System; Mianserin; Mirtazapine; Ovariectomy; Paraventricular Hypothalamic Nucleus; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stress, Physiological | 2006 |
Mirtazapine-induced hyponatremia in an elderly hospice patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Colonic Neoplasms; Contraindications; Hospices; Humans; Hyponatremia; Male; Mianserin; Mirtazapine | 2006 |
Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.
Topics: Adult; Antiemetics; Depressive Disorder; Humans; Korea; Male; Mianserin; Mirtazapine; Nausea; Vomiting | 2006 |
Compulsive masturbation in infantile autism treated by mirtazapine.
Topics: Adrenergic alpha-Antagonists; Autistic Disorder; Child, Preschool; Compulsive Behavior; Humans; Male; Masturbation; Mianserin; Mirtazapine | 2006 |
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Topics: Adult; Antidepressive Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Female; Fluorobenzenes; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Models, Statistical; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Reproducibility of Results; Serotonin Antagonists; Spectrophotometry, Ultraviolet | 2007 |
Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.
Topics: Action Potentials; Adrenergic Agents; Adrenergic alpha-Antagonists; Animals; Dopamine; Electrochemistry; Globus Pallidus; Ketanserin; Locomotion; Male; Methamphetamine; Mianserin; Microelectrodes; Mirtazapine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 2007 |
[Gynecomastia by mirtazapin].
Topics: Adrenergic alpha-Antagonists; Aged, 80 and over; Antidepressive Agents, Tricyclic; Gynecomastia; Humans; Male; Mianserin; Mirtazapine | 2006 |
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin.
Topics: Adrenergic alpha-2 Receptor Agonists; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Male; Mianserin; Mirtazapine; Oxazoles; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 2006 |
Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Mass Screening; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Personality Assessment; Personality Inventory; Psychiatry; Referral and Consultation; Sick Role; Treatment Outcome | 2006 |
A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Pulmonary Embolism; Rhabdomyolysis; Risperidone; Schizophrenia | 2006 |
Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma.
Topics: Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Lymphoma, T-Cell, Cutaneous; Mianserin; Mirtazapine; Mycosis Fungoides; Pruritus; Sezary Syndrome; Skin Neoplasms | 2006 |
Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.
Topics: Adrenergic alpha-Antagonists; Cytarabine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2006 |
Unrecognised long-lasting tramadol-induced delirium in two elderly patients. A case report.
Topics: Adrenergic alpha-Antagonists; Aged; Analgesics, Opioid; Back Pain; Chronic Disease; Delirium; Drug Interactions; Humans; Male; Mianserin; Mirtazapine; Quality of Life; Time Factors; Tramadol | 2006 |
[Mirtazapine-induced dystonia in a patient with Alzheimer's disease].
Topics: Acute Disease; Adrenergic alpha-Antagonists; Aged; Alzheimer Disease; Dystonia; Female; Humans; Mianserin; Mirtazapine | 2006 |
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Adult; Antidepressive Agents, Tricyclic; Birth Weight; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Longitudinal Studies; Maternal Exposure; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies; Risk Assessment; United Kingdom | 2006 |
Combination pharmacotherapy for adult ADHD.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Mianserin; Middle Aged; Mirtazapine; Sleep Initiation and Maintenance Disorders | 2006 |
Transfer of the antidepressant mirtazapine into breast milk.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Feeding; Depression, Postpartum; Female; Humans; Infant; Infant, Newborn; Mianserin; Milk, Human; Mirtazapine; Pregnancy | 2007 |
Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
Topics: Adult; Anorexia; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors | 2006 |
Recurrent hyponatremia associated with citalopram and mirtazapine.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Differential; Electrolytes; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Recurrence; Sodium | 2006 |
Intractable nausea and vomiting following Roux-en-Y gastric bypass: role of mirtazapine.
Topics: Adult; Antiemetics; Female; Gastric Bypass; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Obesity, Morbid; Postoperative Nausea and Vomiting | 2006 |
Priapism and quetiapine: a case report.
Topics: Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; HIV Seropositivity; Homosexuality, Male; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Priapism; Psychotic Disorders; Quetiapine Fumarate | 2006 |
Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation.
Topics: Animals; Body Temperature Regulation; Dose-Response Relationship, Drug; Female; Hot Flashes; Mianserin; Mirtazapine; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |
[Psychotic symptoms in a case of locked-in syndrome].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain Stem; Cerebral Hemorrhage; Delusions; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Hypertension; Mianserin; Middle Aged; Mirtazapine; Neurologic Examination; Psychotic Disorders; Quadriplegia; Quetiapine Fumarate; Tomography, X-Ray Computed | 2006 |
Dramatic response to chloroquine and mirtazapine for recalcitrant atopic dermatitis.
Topics: Adolescent; Antimalarials; Chloroquine; Dermatitis, Atopic; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine | 2006 |
Therapeutic drug monitoring of mirtazapine, desmethylmirtazapine, 8-hydroxymirtazapine, and mirtazapine-N-oxide by enantioselective HPLC with fluorescence detection.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Drug Monitoring; Fluorescence; Humans; Male; Mianserin; Mirtazapine; Quality Control; Stereoisomerism | 2006 |
Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Drug Interactions; Humans; Lung Transplantation; Mianserin; Mirtazapine; Postoperative Complications; Sleep Initiation and Maintenance Disorders | 2007 |
Effect of acute and repeated treatment with mirtazapine on the immunity of noradrenaline transporter knockout C57BL/6J mice.
Topics: Animals; Antidepressive Agents; Cells, Cultured; Cytokines; Immunity, Cellular; Interleukin-4; Mianserin; Mice; Mice, Inbred C57BL; Mice, Knockout; Mirtazapine; Motor Activity; Norepinephrine Plasma Membrane Transport Proteins | 2006 |
[Compliance in psychiatry: results of a survey of depressed patients using orally disintegrating tablet].
Topics: Administration, Oral; Adult; Age Factors; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Data Collection; Depression; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Physician-Patient Relations; Sex Factors; Surveys and Questionnaires; Tablets; Time Factors | 2006 |
Mirtazapine enantiomers in blood and cerebrospinal fluid.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration Schedule; Humans; Male; Mianserin; Mirtazapine; Severity of Illness Index; Stereoisomerism | 2006 |
Mirtazapine and breastfeeding: maternal and infant plasma levels.
Topics: Adult; Antidepressive Agents, Tricyclic; Breast Feeding; Depressive Disorder; Female; Humans; Infant; Infant, Newborn; Mianserin; Milk, Human; Mirtazapine; Pregnancy; Puerperal Disorders | 2007 |
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Topics: Activities of Daily Living; Administration, Oral; Aged; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder, Major; Dosage Forms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Pilot Projects; Prospective Studies; Quality of Life; Sick Role | 2007 |
Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Venlafaxine Hydrochloride; Weight Gain | 2007 |
Pharmacokinetics of mirtazapine: enantioselective effects of the CYP2D6 ultra rapid metabolizer genotype and correlation with adverse effects.
Topics: Alleles; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Blood Pressure; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Gene Duplication; Genotype; Heart Rate; Humans; Mianserin; Mirtazapine; Stereoisomerism | 2007 |
Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Drug Overdose; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Poison Control Centers; Retrospective Studies; Substance-Related Disorders; Tachycardia; Unconsciousness | 2007 |
The antidepressant mirtazapine-induced cytosolic Ca2+ elevation and cytotoxicity in human osteosarcoma cells.
Topics: Antidepressive Agents, Tricyclic; Bone Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Cytosol; Fura-2; Humans; Mianserin; Mirtazapine; Osteosarcoma; Time Factors; Type C Phospholipases | 2006 |
Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine.
Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Opportunistic Infections; Organophosphonates; Sarcoidosis | 2007 |
STAR*D level IV methodology.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Research Design; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Cessation of complex visual hallucinations during treatment with mirtazapine.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Hallucinations; Humans; Mianserin; Middle Aged; Mirtazapine | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Cannabinoid hyperemesis: marijuana puts patients in hot water.
Topics: Abdominal Pain; Adult; Antidepressive Agents, Tricyclic; Cannabinoids; Cognitive Behavioral Therapy; Depressive Disorder, Major; Humans; Male; Marijuana Abuse; Mianserin; Mirtazapine; Vomiting | 2007 |
Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Electroshock; Epilepsies, Myoclonic; Male; Mianserin; Mice; Mirtazapine; Pentylenetetrazole; Random Allocation; Seizures | 2007 |
Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Female; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine | 2007 |
Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Cachexia; Humans; Mianserin; Mirtazapine; Nausea; Neoplasms; Olanzapine; Ondansetron; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2007 |
Enantioselective separation of the novel antidepressant mirtazapine and its main metabolites by CEC.
Topics: Antidepressive Agents; Capillary Electrochromatography; Humans; Mianserin; Mirtazapine; Stereoisomerism; Vancomycin | 2007 |
Mirtazapine for depression and comorbidities in older patients with cancer.
Topics: Aged; Antidepressive Agents, Tricyclic; Antiemetics; Comorbidity; Depression; Humans; Mianserin; Mirtazapine; Neoplasms | 2007 |
Treatment resistant hyperemesis gravidarum in a patient with type 1 diabetes mellitus: neonatal withdrawal symptoms after successful antiemetic therapy with mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Diabetes Mellitus, Type 1; Drug Resistance; Female; Humans; Hyperemesis Gravidarum; Infant, Newborn; Male; Mianserin; Mirtazapine; Pre-Eclampsia; Pregnancy; Respiration Disorders; Substance Withdrawal Syndrome; Tachycardia; Tremor | 2008 |
The management of insomnia in the older adult.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Baths; Exercise; Humans; Hypnotics and Sedatives; Indenes; Male; Mianserin; Mirtazapine; Pyridines; Relaxation Therapy; Sleep Initiation and Maintenance Disorders; Trazodone; Zolpidem | 2007 |
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
Topics: Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Polycythemia Vera; Selective Serotonin Reuptake Inhibitors | 2007 |
Mirtazapine for anorexia nervosa with depression.
Topics: Adolescent; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Body Weight; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Family Therapy; Female; Humans; Mianserin; Mirtazapine; Patient Care Team; Suicide; Suicide Prevention | 2007 |
Can prefrontal theta cordance differentiate between depression recovery and dissimulation?
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Fatal Outcome; Female; Humans; Mianserin; Mirtazapine; Prefrontal Cortex; Retrospective Studies; Suicide; Theta Rhythm | 2007 |
Comments on "Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder".
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Gene Expression; Genetic Variation; Humans; Linkage Disequilibrium; Mianserin; Mirtazapine; Pharmacogenetics; Polymorphism, Genetic; Promoter Regions, Genetic; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2008 |
Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression.
Topics: Antidepressive Agents, Tricyclic; Asian People; Depressive Disorder, Major; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polymorphism, Genetic | 2007 |
Outcomes after isolated mirtazapine (Remeron) supratherapeutic ingestions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Child; Drug Overdose; Humans; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Poison Control Centers; Poisoning; Retrospective Studies; Treatment Outcome | 2008 |
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride | 2007 |
Enantioselective analysis of mirtazapine and its two major metabolites in human plasma by liquid chromatography-mass spectrometry after three-phase liquid-phase microextraction.
Topics: Chromatography, Liquid; Circular Dichroism; Humans; Mianserin; Mirtazapine; Molecular Structure; Stereoisomerism; Tandem Mass Spectrometry; Temperature | 2008 |
Effects of systemic administration of mirtazapine on respiratory muscle activity in sleeping rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Electroencephalography; Electromyography; Kinetics; Male; Mianserin; Mirtazapine; Neck Muscles; Rats; Rats, Sprague-Dawley; Respiratory Muscles; Sleep; Sleep, REM | 2008 |
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles | 2008 |
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Polycythemia Vera; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists | 2008 |
Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
Topics: Adrenergic Uptake Inhibitors; Adult; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Thiophenes; Treatment Outcome | 2008 |
Mirtazapine associated with recurrent pancreatitis - a case report.
Topics: Abdominal Pain; Adult; Amylases; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Humans; Lipase; Male; Mianserin; Mirtazapine; Pancreatitis | 2008 |
A case of mirtazapine-induced spontaneous orgasms in a female patient.
Topics: Antidepressive Agents, Tricyclic; Anxiety; Depressive Disorder; Female; Hospitals, Psychiatric; Humans; Libido; Mianserin; Middle Aged; Mirtazapine; Orgasm; Outpatient Clinics, Hospital; Sexual Dysfunction, Physiological; Withholding Treatment | 2009 |
[Differentiated approach to the therapy of endogenous anxious depression].
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Radioisotopes; Depression; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Cytokines; Denervation; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Hyperalgesia; Interleukin-10; Interleukin-1beta; Male; Mianserin; Mirtazapine; Neural Pathways; Neuralgia; NF-kappa B; Pain Measurement; Rats; Rats, Sprague-Dawley; Spinal Nerves; Tumor Necrosis Factor-alpha | 2008 |
Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Employment; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Piperazines; Quinolones; Schizophrenia, Paranoid; Social Behavior | 2008 |
Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
Topics: Antidepressive Agents, Tricyclic; Asian People; Case-Control Studies; Depressive Disorder, Major; Female; Genotype; Heterozygote; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2007 |
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Mirtazapine precipitated seizures: a case report.
Topics: Anticonvulsants; Antidepressive Agents; Drug Interactions; Electroencephalography; Epilepsies, Partial; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Seizures | 2008 |
Mirtazapine in the treatment of adolescent anorexia nervosa. Case-control study.
Topics: Adolescent; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Drug Administration Schedule; Female; Humans; Mianserin; Mirtazapine | 2008 |
Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Tricyclic; Case-Control Studies; Cognition; Depression; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neuropsychological Tests; Prefrontal Cortex; Psychometrics; Treatment Outcome | 2007 |
Mirtazapine treatment in a subject with autistic disorder and fetishism.
Topics: Adolescent; Autistic Disorder; Fetishism, Psychiatric; Follow-Up Studies; Humans; Male; Mianserin; Mirtazapine; Sexual Behavior; Stereotyped Behavior; Treatment Outcome | 2008 |
Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Humans; Mianserin; Mirtazapine; Propranolol; Receptors, Serotonin; Serotonin Antagonists | 2008 |
Restless legs syndrome as side effect of second generation antidepressants.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prospective Studies; Reboxetine; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors | 2008 |
Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.
Topics: Adrenergic alpha-Antagonists; Aged; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 2009 |
Neonatal recurrent prolonged hypothermia associated with maternal mirtazapine treatment during pregnancy.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Body Temperature Regulation; Female; Follow-Up Studies; Humans; Hypothermia; Infant, Newborn; Infant, Premature; Male; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Recurrence; Twins, Monozygotic | 2008 |
Successful antidepressive treatment with mirtazapine following lung transplantation.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Humans; Lung Transplantation; Male; Mianserin; Mirtazapine | 2008 |
Employing mirtazapine to aid benzodiazepine withdrawal.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Humans; Male; Mianserin; Midazolam; Mirtazapine; Substance Withdrawal Syndrome | 2008 |
Contents of general practitioner-patient consultations in the treatment of depression.
Topics: Counseling; Depressive Disorder; Humans; Mianserin; Mirtazapine; Patient Education as Topic; Physician-Patient Relations; Physicians, Family; Psychotherapeutic Processes; Referral and Consultation; Treatment Outcome | 2008 |
Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Mianserin; Mirtazapine; Morphine; Morphine Dependence; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance Withdrawal Syndrome | 2008 |
[Integrative therapy of a patient with complex psychosomatic complaints].
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Dyspepsia; Female; Humans; Integrative Medicine; Materia Medica; Mianserin; Mirtazapine; Psychophysiologic Disorders; Psychotherapy; Treatment Outcome | 2008 |
Mirtazapine-induced akathisia.
Topics: Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Male; Mianserin; Mirtazapine | 2008 |
Mirtazapine relieves postdural puncture headache.
Topics: Female; Humans; Mianserin; Middle Aged; Mirtazapine; Post-Dural Puncture Headache | 2008 |
A case of chronic drug-induced neutropenia.
Topics: Anti-Anxiety Agents; Anti-Infective Agents; Anxiety Disorders; Chronic Disease; Female; Humans; Metronidazole; Mianserin; Middle Aged; Mirtazapine; Neutropenia | 2008 |
Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Carcinoma; Cell Line, Tumor; Female; Fluoxetine; Male; Mianserin; Mice; Mice, Inbred BALB C; Mice, Nude; Mirtazapine; Neoplasm Transplantation; Pancreatic Neoplasms | 2008 |
Mirtazapine associated with profound hyponatremia: two case reports.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Hyponatremia; Male; Mianserin; Middle Aged; Mirtazapine; Probability | 2008 |
Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Hypertension; Injections, Intraperitoneal; Male; Mianserin; Mirtazapine; Propranolol; Rats; Rats, Inbred SHR | 2008 |
[General practice psychotherapy for depression].
Topics: Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Family Practice; Humans; Mianserin; Mirtazapine; Psychotherapy, Brief; Referral and Consultation; Treatment Outcome | 2008 |
Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Tricyclic; Dehydroepiandrosterone Sulfate; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2009 |
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Discrimination, Psychological; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Reinforcement, Psychology; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Factors potentiating the risk of mirtazapine-associated restless legs syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Antiemetics; Depression; Drug Synergism; Female; Humans; Male; Medical Records Systems, Computerized; Mianserin; Middle Aged; Mirtazapine; Restless Legs Syndrome; Retrospective Studies; Risk Factors; Young Adult | 2008 |
Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Bipolar Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain Measurement; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Sleep Deprivation; Treatment Outcome | 2008 |
Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Idazoxan; Imidazoles; Male; Mianserin; Mirtazapine; Morphine; Rats; Rats, Sprague-Dawley; Spine; Yohimbine | 2008 |
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis.
Topics: Electrophoresis, Capillary; Humans; Hydrolysis; Mianserin; Mirtazapine; Temperature | 2008 |
Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference.
Topics: Adrenergic alpha-Antagonists; Animals; Blotting, Western; Central Nervous System Stimulants; Conditioning, Operant; Cues; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Male; Memory; Methamphetamine; Mianserin; Mirtazapine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Signal Transduction; Taste | 2009 |
Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Therapy, Combination; Gliclazide; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Mianserin; Mirtazapine | 2008 |
Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.
Topics: Adult; Anorexia Nervosa; Benzodiazepines; Calcinosis; Combined Modality Therapy; Dominance, Cerebral; Humans; Life Change Events; Male; Mediodorsal Thalamic Nucleus; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Psychotherapy; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
Mirtazapine induced nightmares in an adult male.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Dreams; Humans; Male; Mianserin; Mirtazapine; Sleep; Young Adult | 2009 |
An immunocapture/scintillation proximity analysis of G alpha q/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Amphetamines; Animals; Cerebral Cortex; Clozapine; GTP-Binding Protein alpha Subunits, Gq-G11; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Scintillation Counting; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Mirtazapine-induced manic switch in adolescent unipolar depression.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lithium Carbonate; Mianserin; Mirtazapine; Psychiatric Status Rating Scales | 2008 |
Protective effect of mirtazapine on indomethacin-induced ulcer in rats and its relationship with oxidant and antioxidant parameters.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Antioxidants; Famotidine; Glutathione; Indomethacin; Male; Malondialdehyde; Mianserin; Mirtazapine; Oxidative Stress; Oxidoreductases; Rats; Rats, Wistar; Stomach; Stomach Ulcer | 2009 |
No influence of dialysis on mirtazapine - a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Biotransformation; Depressive Disorder; Dialysis Solutions; Female; Humans; Mianserin; Mirtazapine; Renal Dialysis; Renal Insufficiency | 2008 |
Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Smoking; Stereoisomerism | 2009 |
Optimal use of antidepressants: when to act?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic | 2009 |
Antidepressant medications, neuroleptics, and prominent eye movements during NREM sleep.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Eye Movement Measurements; Eye Movements; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Pyridines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Young Adult; Zolpidem | 2009 |
Racemic intrathecal mirtazapine but not its enantiomers acts anti-neuropathic after chronic constriction injury in rats.
Topics: Analgesics; Animals; Antidepressive Agents; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Mianserin; Mirtazapine; Neuralgia; Pain Threshold; Physical Stimulation; Rats; Rats, Wistar; Stereoisomerism | 2009 |
Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Conditioning, Classical; Fear; Male; Mianserin; Mirtazapine; Prazosin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1 | 2009 |
A possible case of Capgras syndrome after a right anterior cerebral artery cerebrovascular accident treated successfully with mirtazapine.
Topics: Adrenergic alpha-Antagonists; Antipsychotic Agents; Capgras Syndrome; Electroencephalography; Female; Humans; Infarction, Anterior Cerebral Artery; Mianserin; Middle Aged; Mirtazapine; Piperazines; Thiazoles; Tomography, X-Ray Computed | 2008 |
Status epilepticus in a patient treated with olanzapine and mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychotic Disorders; Status Epilepticus | 2009 |
A case study of delayed serotonin syndrome: lessons learned.
Topics: Adrenergic alpha-Antagonists; Aged; Assisted Living Facilities; Drug Interactions; Female; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Time Factors | 2009 |
Development and validation of a reversed-phase HPLC method for separation and simultaneous determination of process-related substances of mirtazapine in bulk drugs and formulations.
Topics: Acetonitriles; Antidepressive Agents, Tricyclic; Buffers; Chromatography, High Pressure Liquid; Drug Contamination; Ethylamines; Hydrogen-Ion Concentration; Mianserin; Mirtazapine; Pharmaceutical Preparations; Sensitivity and Specificity; Temperature | 2009 |
Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anorexia Nervosa; Anti-Ulcer Agents; Antidepressive Agents, Tricyclic; Bundle-Branch Block; Comorbidity; Electrocardiography; Female; Humans; Mianserin; Mirtazapine; Pancytopenia; Pantoprazole | 2009 |
Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
Topics: Aged; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder; Drug Interactions; Female; Humans; Hypotension; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mianserin; Mirtazapine; Tacrolimus | 2009 |
Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; HIV-1; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Mianserin; Mirtazapine; Virus Internalization | 2009 |
Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.
Topics: Adolescent; Adrenergic alpha-Antagonists; Autistic Disorder; Child; Female; Humans; Male; Masturbation; Mianserin; Mirtazapine; Sexual Behavior | 2009 |
MAOA gene polymorphisms and response to mirtazapine in major depression.
Topics: Adult; Aged; Apolipoproteins E; Depressive Disorder, Major; DNA; Female; Humans; Male; Mianserin; Middle Aged; Minisatellite Repeats; Mirtazapine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Polymorphism, Genetic; Psychiatric Status Rating Scales; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2009 |
Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Receptors, Adrenergic, alpha-2; Weight Gain | 2009 |
Mirtazapine and hyperpigmentation.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Female; Humans; Hyperpigmentation; Mianserin; Mirtazapine | 2009 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Mirtazapine-associated hyponatremia in an elderly patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Hypertension; Hyponatremia; Mianserin; Mirtazapine; Severity of Illness Index; Time Factors | 2009 |
Neopterin and C-reactive protein in the course of Stevens-Johnson syndrome: report of a case.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Biopsy; C-Reactive Protein; Depression; Drug Therapy, Combination; Female; Humans; Lamotrigine; Mianserin; Middle Aged; Mirtazapine; Neopterin; Selective Serotonin Reuptake Inhibitors; Sertraline; Stevens-Johnson Syndrome; Triazines | 2009 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2010 |
High mirtazapine plasma levels in infant after breast feeding: case report and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Breast Feeding; Depressive Disorder; Female; Humans; Infant; Male; Mianserin; Milk, Human; Mirtazapine | 2009 |
[11C]Mirtazapine binding in depressed antidepressant nonresponders studied by PET neuroimaging.
Topics: Adult; Antidepressive Agents, Tricyclic; Brain; Carbon Radioisotopes; Depressive Disorder, Major; Drug Resistance; Female; Humans; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Positron-Emission Tomography; Protein Binding | 2009 |
[Simultaneous determination of clozapine, olanzapine and mirtazapine in human plasma by LC-MS/MS].
Topics: Benzodiazepines; Chromatography, Liquid; Clozapine; Forensic Toxicology; Humans; Mianserin; Mirtazapine; Olanzapine; Tandem Mass Spectrometry | 2009 |
An open-label study of mirtazapine as treatment for combat-related PTSD.
Topics: Antidepressive Agents, Tricyclic; Australia; Combat Disorders; Dose-Response Relationship, Drug; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2009 |
Interaction of glia activation and neurotransmission in hippocampus of neuropathic rats treated with mirtazapine.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Astrocytes; Glial Fibrillary Acidic Protein; Hippocampus; Hyperalgesia; Interleukin-1beta; Male; Mianserin; Mirtazapine; Neuroglia; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tumor Necrosis Factor-alpha | 2009 |
Musical hallucination in a patient after cochlear implantation.
Topics: Aged; Cochlear Implantation; Deafness; Female; Hallucinations; Humans; Mianserin; Mirtazapine; Music | 2009 |
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
Topics: Adult; Aged; Benzodiazepines; Cytochrome P-450 CYP1A2; Depressive Disorder; Female; Genotype; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Pharmacogenetics; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Schizophrenia; Smoking; Weight Gain | 2010 |
A fatal case involving extremely high levels of ethylene glycol without elevation of its metabolites or crystalluria.
Topics: Antidepressive Agents; Bupropion; Drug Overdose; Ethylene Glycol; Forensic Toxicology; Glycolates; Glyoxylates; Humans; Mianserin; Mirtazapine; Osmolar Concentration; Oxalic Acid; Suicide; Vitreous Body | 2009 |
Stevens-Johnson syndrome due to mirtazapine - first case.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Humans; Male; Mianserin; Mirtazapine; Patch Tests; Stevens-Johnson Syndrome | 2009 |
Cortisol metabolism in depressed patients and healthy controls.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cortisone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Mianserin; Middle Aged; Mirtazapine; Tetrahydrocortisol; Tetrahydrocortisone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Trait anxiety and defensive functioning in relation to antidepressant treatment outcome.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Female; Humans; Imipramine; Male; Mianserin; Middle Aged; Mirtazapine; Patient Selection; Personality Assessment; Psychiatric Status Rating Scales; Regression Analysis; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2009 |
Progressive multifocal leukoencephalopathy - experimental options.
Topics: Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors | 2009 |
[Mirtazapine-associated hepatotoxicity].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Drug Interactions; Duloxetine Hydrochloride; Humans; Kidney Failure, Chronic; Male; Mianserin; Middle Aged; Mirtazapine; Nephrosclerosis; Thiophenes | 2010 |
[Psycho- and pharmacotherapy of depressions. So you combine correctly].
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Area Under Curve; Depressive Disorder; Female; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Inpatients; Male; Mianserin; Middle Aged; Mirtazapine | 2010 |
Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.
Topics: Adiponectin; Adult; Aged; Antidepressive Agents; Blood Glucose; Body Mass Index; Chi-Square Distribution; Citalopram; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Insulin; Insulin Resistance; Leptin; Mianserin; Middle Aged; Mirtazapine; Patient Selection; Pilot Projects; Waist Circumference | 2009 |
Neurotrophic factors in serum following ECT: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride | 2009 |
[Serotonin syndrome after administration of mirtazapine in a critical care unit].
Topics: Aged; Antidepressive Agents, Tricyclic; Critical Care; Humans; Intensive Care Units; Male; Mianserin; Mirtazapine; Serotonin Syndrome | 2009 |
Prescribing a sedative antidepressant for patients at work or on sick leave under conditions of routine care.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Employment; Female; Humans; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Sick Leave; Workplace | 2010 |
Mirtazapine intoxication in a child.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Charcoal; Child, Preschool; Female; Histamine H1 Antagonists; Humans; Lethargy; Mianserin; Mirtazapine; Treatment Outcome; Turkey | 2012 |
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Kinetics; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Signal Processing, Computer-Assisted | 2010 |
Enantioselective analysis of mirtazapine, demethylmirtazapine and 8-hydroxy mirtazapine in human urine after solid-phase microextraction.
Topics: Antidepressive Agents, Tricyclic; Buffers; Chromatography, Liquid; Humans; Hydrogen-Ion Concentration; Mianserin; Mirtazapine; Osmolar Concentration; Reproducibility of Results; Solid Phase Microextraction; Stereoisomerism; Tandem Mass Spectrometry | 2010 |
Acute antipsychotic-induced akathisia revisited.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
Topics: Anorexia Nervosa; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2011 |
Mirtazapine treatment of periodic catatonia in organic mental disorder: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Catatonia; Humans; Male; Mianserin; Mirtazapine; Neurocognitive Disorders | 2010 |
Mania associated with mirtazepine treatment and mixed depression.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2010 |
Does night-time cortisol excretion normalize in the long-term course of depression?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Time Factors; Venlafaxine Hydrochloride | 2010 |
Combining antidepressant medications: a good idea?
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2010 |
Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Topics: Drugs, Generic; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Secondary Prevention; Therapeutic Equivalency; Valproic Acid | 2010 |
Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Depressive Disorder, Major; Dreams; Hallucinations; Haloperidol; Humans; Male; Mianserin; Mirtazapine; Psychotic Disorders; REM Sleep Behavior Disorder; Sleep; Sleep, REM; Wakefulness | 2010 |
Effectiveness of mirtazapine in the treatment of postherpetic neuralgia.
Topics: Adrenergic alpha-Antagonists; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Neuralgia, Postherpetic; Pain Measurement; Treatment Outcome | 2010 |
Sertraline-induced serotonin syndrome followed by mirtazapine reaction.
Topics: Adult; Antidepressive Agents; Cyproheptadine; Depressive Disorder, Major; Humans; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Treatment Outcome | 2010 |
Bupropion, bayesian logic and serotonin toxicity.
Topics: Animals; Bupropion; Dopamine Uptake Inhibitors; Humans; Mianserin; Mirtazapine; Serotonin; Serotonin Syndrome | 2010 |
New onset multimodal hallucinations associated with mirtazapine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Hallucinations; Humans; Male; Mianserin; Middle Aged; Mirtazapine | 2010 |
Ameliorating effects of mirtazapine on visceral hypersensitivity in rats with neonatal colon sensitivity.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Gastric Emptying; Gastrointestinal Transit; Intestine, Small; Irritable Bowel Syndrome; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley | 2010 |
The association between serotonin 2C receptor polymorphisms and weight gain and eating behavior in patients using mirtazapine: a prospective follow-up study.
Topics: Adult; Aged; Feeding Behavior; Female; Follow-Up Studies; Haplotypes; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polymorphism, Genetic; Prospective Studies; Receptor, Serotonin, 5-HT2C; Weight Gain | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Blotting, Western; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Depressive Disorder; Disease Models, Animal; Dopamine; Glutathione; Glutathione Transferase; Hypothalamus; Liver; Male; Mianserin; Mirtazapine; Norepinephrine; Rats; Rats, Sprague-Dawley | 2010 |
Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome.
Topics: Animals; Body Temperature; Disease Models, Animal; Fever; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Syndrome | 2010 |
Mirtazapine-associated urinary retention.
Topics: Aged, 80 and over; Depressive Disorder, Major; Humans; Male; Mianserin; Mirtazapine; Urinary Retention | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.
Topics: Antidepressive Agents; Cyclohexanols; Databases, Factual; Drug Costs; Humans; Lithium Compounds; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Spain; Suicide; Venlafaxine Hydrochloride | 2010 |
Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Fatty Acids, Omega-3; Fluoxetine; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Swimming; Time Factors | 2010 |
Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct.
Topics: Antifungal Agents; Benzylamines; Brain Neoplasms; Clotrimazole; Cyclams; Drug Synergism; Glioblastoma; Heterocyclic Compounds; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Receptors, CXCR4; Signal Transduction | 2010 |
Delayed-onset mirtazapine-related leukopenia and rechallenge.
Topics: Adult; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Leukopenia; Mianserin; Mirtazapine; Stress Disorders, Post-Traumatic; Time Factors | 2010 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
A case of mirtazapine-associated hair loss.
Topics: Alopecia; Antidepressive Agents, Tricyclic; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Taiwan | 2010 |
PROMISCUOUS: a database for network-based drug-repositioning.
Topics: Amantadine; Antidepressive Agents, Tricyclic; Databases, Factual; Dopamine Agents; Drug Repositioning; Memantine; Mianserin; Mirtazapine; Pharmaceutical Preparations; Protein Interaction Mapping; Proteins | 2011 |
Mirtazapine alters cue-associated methamphetamine seeking in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Cues; Drug Interactions; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Self Administration | 2011 |
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Severity of Illness Index; Venlafaxine Hydrochloride | 2010 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Evaluation of a QT nomogram for risk assessment after antidepressant overdose.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Drug Overdose; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Mianserin; Mirtazapine; Nomograms; Retrospective Studies; Risk Assessment; Torsades de Pointes; Venlafaxine Hydrochloride | 2010 |
Embryotoxicity of mirtazapine: a study using Chick Embryotoxicity Screening Test.
Topics: Abnormalities, Drug-Induced; Animals; Antidepressive Agents, Tricyclic; Chick Embryo; Depression; Dose-Response Relationship, Drug; Embryonic Development; Female; Humans; Mianserin; Mirtazapine; Models, Animal; Pregnancy; Pregnancy Complications; Risk Factors; Teratogens | 2010 |
Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Blotting, Western; Cerebral Cortex; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Infusion Pumps; Male; Mianserin; Mirtazapine; Neurons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reverse Transcriptase Polymerase Chain Reaction; Serotonin; Synaptic Transmission | 2011 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
A case of crying seizures.
Topics: Adult; Crying; Female; Humans; Mianserin; Mirtazapine; Seizures | 2011 |
Rapid weight gain during mirtazapine treatment.
Topics: Humans; Male; Mianserin; Mirtazapine; Time Factors; Treatment Outcome; Weight Gain; Young Adult | 2011 |
Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
Topics: Antidepressive Agents, Tricyclic; Body Weight; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Melatonin; Mianserin; Middle Aged; Mirtazapine; Perimenopause; Quality of Life; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2011 |
Vitamin B6 treatment of oedema induced by mirtazapine and isocarboxazid.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Edema; Humans; Isocarboxazid; Mianserin; Mirtazapine; Vitamin B 6 | 2011 |
Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dibenzothiazepines; Drug Therapy, Combination; Fatal Outcome; Female; Haloperidol; Humans; Mianserin; Middle Aged; Mirtazapine; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Risk Factors; Serotonin Syndrome | 2011 |
Measuring Caenorhabditis elegans life span in 96 well microtiter plates.
Topics: Animals; Antidepressive Agents, Tricyclic; Caenorhabditis elegans; Drug Evaluation, Preclinical; Longevity; Mianserin; Mirtazapine; Models, Animal | 2011 |
Mirtazapine in combination with perospirone synergistically enhances dopamine release in the rat prefrontal cortex via 5-HT1A receptor activation.
Topics: Animals; Depression; Disease Models, Animal; Dopamine; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Isoindoles; Male; Mianserin; Microdialysis; Mirtazapine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT1 Receptor Agonists; Thiazoles | 2011 |
Evaluation of polysaccharide-based chiral stationary phases in quality control of (S)-mirtazapine.
Topics: Amylose; Cellulose; Chromatography, High Pressure Liquid; Mianserin; Mirtazapine; Phenylcarbamates; Stereoisomerism | 2012 |
[Mirtazapine and hyperemesis gravidarum].
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Hyperemesis Gravidarum; Mianserin; Mirtazapine; Pregnancy; Treatment Outcome | 2012 |
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Infusion Pumps, Implantable; Ketanserin; Male; Methamphetamine; Mianserin; Mirtazapine; Ondansetron; Pergolide; Rats; Rats, Sprague-Dawley | 2011 |
Visual trails: do the doors of perception open periodically?
Topics: Anticonvulsants; Antidepressive Agents; Female; Fructose; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mianserin; Middle Aged; Mirtazapine; Perceptual Disorders; Piperazines; Topiramate; Trazodone; Triazoles; Visual Perception | 2011 |
[Mediastinal fibrosis and mirtazapin].
Topics: Antidepressive Agents, Tricyclic; Female; Fibrosis; Humans; Mediastinum; Mianserin; Middle Aged; Mirtazapine; Superior Vena Cava Syndrome | 2011 |
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2011 |
Enantiomeric separation of mirtazapine and its metabolite in rat plasma by reverse polar ionic liquid chromatography using fluorescence and polarimetric detectors connected in series.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Linear Models; Mianserin; Mirtazapine; Rats; Rats, Wistar; Reproducibility of Results; Spectrometry, Fluorescence; Stereoisomerism | 2011 |
Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: a pilot study.
Topics: Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Dogs; Half-Life; Male; Metabolic Clearance Rate; Mianserin; Mirtazapine; Pilot Projects | 2012 |
Mirtazapine-induced hepatocellular-type liver injury.
Topics: Antidepressive Agents, Tricyclic; Chemical and Drug Induced Liver Injury; Depressive Disorder, Major; Hepatocytes; Humans; Liver Function Tests; Male; Mianserin; Mirtazapine; Republic of Korea; Young Adult | 2011 |
The acute effects of mirtazapine on pain related behavior in healthy animals.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Arginine; Behavior, Animal; Cyproheptadine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Hippocampus; In Vitro Techniques; Male; Mianserin; Mice; Mirtazapine; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 2011 |
Mirtazapine induced mania in a woman with major depression in the absence of features of bipolarity.
Topics: Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Mianserin; Mirtazapine | 2011 |
[Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Postoperative Complications; Transplantation, Homologous | 2011 |
Complexity analysis of spontaneous brain activity: effects of depression and antidepressant treatment.
Topics: Age Factors; Antidepressive Agents; Brain; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Net; Sex Factors | 2012 |
Treatment of depression as part of end-of-life care.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamous Cell; Depression; Drug Therapy, Combination; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Mianserin; Mirtazapine; Paroxetine; Terminal Care | 2008 |
Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hyponatremia; Male; Mianserin; Middle Aged; Mirtazapine; Republic of Korea; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride; Young Adult | 2011 |
Antidepressant treatment in Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Mirtazapine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Drug Administration Schedule; Male; Methamphetamine; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lymphopenia; Magnetic Resonance Imaging; Mefloquine; Mianserin; Mirtazapine; Multiple Sclerosis; Neuroimaging; Reference Values; Treatment Outcome | 2011 |
Intolerance to mirtazapine in advanced cancer.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Disorders of Excessive Somnolence; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Prospective Studies; Quality of Life; Treatment Outcome | 2011 |
A fatal case of simultaneous ingestion of mirtazapine, escitalopram, and valproic acid.
Topics: Aged; Autopsy; Citalopram; Fatal Outcome; Female; Forensic Toxicology; Humans; Mianserin; Mirtazapine; Suicide; Valproic Acid | 2011 |
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.
Topics: Antimalarials; Antiviral Agents; Biopsy; Brain; Hemianopsia; Histamine H1 Antagonists; Histological Techniques; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Immunosuppression Therapy; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Polyomavirus Infections; Sarcoidosis; Treatment Outcome; Withholding Treatment | 2012 |
An audit to compare patient factors (age, sex, social background & associated physical diagnoses) in people with refractory depression in a Bedfordshire Community Mental Health Team (BCMHT) being augmented with (A) mirtazepine, (B) atypical antipsychotics
Topics: Adult; Age Distribution; Alcoholism; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Combined Modality Therapy; Community Mental Health Services; Depressive Disorder; Drug Therapy, Combination; Family Conflict; Female; Health Status; Humans; Male; Medical Audit; Mianserin; Mirtazapine; Sex Distribution; Socioeconomic Factors; Substance-Related Disorders; Suicidal Ideation; United Kingdom | 2011 |
An audit to compare the efficacy of treatment (as indicated by discharge rates and reduction in suicidality) among patients with refractory depression in a Bedfordshire Community Mental Health Team receiving augmentation therapy with either mirtazepine or
Topics: Adult; Age Distribution; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Combined Modality Therapy; Community Mental Health Services; Depressive Disorder; Humans; Male; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Patient Discharge; Sex Distribution; Suicidal Ideation; Treatment Outcome; United Kingdom | 2011 |
Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
Topics: Antibodies, Monoclonal, Humanized; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Mirtazapine; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange; Treatment Outcome; Young Adult | 2011 |
Effect of mirtazapine on oxidative stress created in rat kidneys by ischemia-reperfusion.
Topics: Animals; Kidney; Male; Mianserin; Mirtazapine; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury | 2012 |
[Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics].
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Autopsy; Benzodiazepines; Death, Sudden, Cardiac; Drug Therapy, Combination; Eosinophilia; Forensic Pathology; Forensic Toxicology; Humans; Male; Mianserin; Mirtazapine; Myocarditis; Myocardium; Olanzapine; Piperazines; Quinolones; Risk Factors | 2011 |
What do psychiatrists talk about with their depressed patients parallel to prescribing an antidepressant?
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Combined Modality Therapy; Depression; Depressive Disorder; Female; Germany; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Education as Topic; Psychiatry; Psychotherapy; Young Adult | 2011 |
Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation.
Topics: Animals; Antidepressive Agents, Tricyclic; Biological Availability; Chemical Phenomena; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Drug Compounding; Drug Stability; Glutaral; Half-Life; Hot Temperature; Injections, Intramuscular; Male; Metabolic Clearance Rate; Mianserin; Microscopy, Electron, Scanning; Microspheres; Mirtazapine; Rats; Rats, Wistar | 2011 |
FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Dose-Response Relationship, Drug; Doxepin; Evidence-Based Medicine; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Sleep Initiation and Maintenance Disorders; Trazodone; Trimipramine | 2011 |
Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Korea; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Outpatients; Paroxetine; Retrospective Studies; Venlafaxine Hydrochloride | 2011 |
Effects of mirtazapine on sleep disturbance under neuropathic pain-like state.
Topics: Animals; Disease Models, Animal; Histamine H1 Antagonists; Hyperalgesia; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Neuralgia; Pain Measurement; Receptors, Histamine H1; Sciatic Nerve; Sleep Wake Disorders; Wakefulness | 2012 |
Mirtazapine relieves limb paralysis of unknown etiology: a three-year case follow-up.
Topics: Adrenergic alpha-Antagonists; Extremities; Female; Humans; Longitudinal Studies; Mianserin; Mirtazapine; Pain Measurement; Paralysis | 2011 |
[Low-dose mirtazapine improved nausea and appetite loss during S-1 therapy].
Topics: Aged, 80 and over; Anorexia; Antimetabolites, Antineoplastic; Drug Combinations; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Nausea; Neoplasm Staging; Oxonic Acid; Pancreatic Neoplasms; Tegafur | 2012 |
Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Antidepressants differentially modify the extinction of an aversive memory task in female rats.
Topics: Animals; Antidepressive Agents; Anxiety; Avoidance Learning; Extinction, Psychological; Female; Fluoxetine; Maze Learning; Memory; Mianserin; Mirtazapine; Nortriptyline; Psychomotor Performance; Rats; Rats, Wistar | 2012 |
A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
Topics: Animals; Brain; Cyclopropanes; Dopamine; Drug Combinations; Extracellular Fluid; Male; Mianserin; Microdialysis; Milnacipran; Mirtazapine; Norepinephrine; Rats; Rats, Wistar; Serotonin | 2012 |
Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus.
Topics: Cognition Disorders; Histamine H1 Antagonists; HIV Infections; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Mianserin; Middle Aged; Mirtazapine | 2012 |
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Methotrexate; Mianserin; Middle Aged; Mirtazapine; Organophosphonates; Prednisolone; Receptor, Serotonin, 5-HT2A; Sarcoidosis; Serotonin Antagonists | 2012 |
Prolonged QTc interval and torsades de pointes induced by citalopram.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depression; Drug Substitution; Electrocardiography; Female; Heart Conduction System; Humans; Mianserin; Mirtazapine; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Time Factors; Torsades de Pointes | 2012 |
Hydrophilic interaction liquid chromatography/positive ion electrospray mass spectrometry for the quantification of deferasirox, an oral iron chelator, in human plasma.
Topics: Acetates; Acetonitriles; Adult; Benzoates; beta-Thalassemia; Chromatography, Liquid; Deferasirox; Female; Humans; Hydrophobic and Hydrophilic Interactions; Linear Models; Male; Methanol; Mianserin; Mirtazapine; Spectrometry, Mass, Electrospray Ionization; Triazoles | 2012 |
Differential effects of the antidepressant mirtazapine on amphetamine- and dizocilpine-induced PPI deficits.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antidepressive Agents; Dizocilpine Maleate; Female; Inhibition, Psychological; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating | 2012 |
Coma blisters with hypoxemic respiratory failure.
Topics: Amitriptyline; Anti-Bacterial Agents; Blister; Coma; Diazepam; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Oxycodone; Oxygen; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pneumonia, Aspiration; Quadriplegia; Respiratory Insufficiency; Treatment Outcome; Young Adult | 2012 |
N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
Topics: Acetylcysteine; alpha-Tocopherol; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Animal; Fluvoxamine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Motor Activity; Obsessive-Compulsive Disorder | 2012 |
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride | 2012 |
A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.
Topics: Adult; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Clonazepam; Delayed-Action Preparations; Delusions; Dibenzothiazepines; Drug Monitoring; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Neutropenia; Polypharmacy; Quetiapine Fumarate; Suicidal Ideation; Treatment Outcome; Valproic Acid | 2012 |
Reversal of SSRI-associated urinary retention with mirtazapine augmentation.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Urinary Retention | 2012 |
Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Brain Chemistry; Brain-Derived Neurotrophic Factor; Depression; Dopamine; Drug Synergism; Drug Therapy, Combination; Extracellular Fluid; Gene Expression Regulation; Male; Mianserin; Mirtazapine; Morpholines; Organ Specificity; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Reboxetine; RNA, Messenger | 2012 |
Classifying responders and non-responders; does it help when there is evidence of differentially responding patient groups?
Topics: Amitriptyline; Antidepressive Agents; Chi-Square Distribution; Clinical Trials as Topic; Computer Simulation; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Models, Statistical; Psychiatric Status Rating Scales; Sample Size; Treatment Outcome | 2012 |
[Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].
Topics: Alleles; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Colitis, Ulcerative; Combined Modality Therapy; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Genetic Carrier Screening; Humans; Liver; Male; Mesalamine; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine; Patient Admission | 2012 |
Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.
Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Multiple Myeloma; Organophosphonates; Postoperative Complications; Transplantation, Autologous | 2011 |
Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Analgesics; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clopenthixol; Fluoxetine; Histamine Antagonists; Humans; Limit of Detection; Linear Models; Methotrimeprazine; Methylphenidate; Mianserin; Mirtazapine; Pharmaceutical Preparations; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cachexia; Carcinoma; Cell Line, Tumor; Deoxycytidine; Eating; Gemcitabine; Humans; Mianserin; Mice; Mice, Inbred BALB C; Mice, Nude; Mirtazapine; Nutritional Status; Pancreatic Neoplasms; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Important interaction between mirtazapine and ondansetron.
Topics: Aged; Antidepressive Agents, Tricyclic; Antiemetics; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Mianserin; Mirtazapine; Ondansetron | 2012 |
Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.
Topics: Adrenergic alpha-Antagonists; Adult; DNA, Viral; Fatal Outcome; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lung Diseases; Male; Mianserin; Mirtazapine; Radiography; Sarcoidosis | 2012 |
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.
Topics: Aged, 80 and over; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome; Venlafaxine Hydrochloride | 2012 |
Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: case report of an adolescent.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dissociative Identity Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Risperidone | 2012 |
Tinnitus treatment with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tinnitus | 2012 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Antidepressants and unresponsive episodes in the elderly.
Topics: Age Factors; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depression; Guidelines as Topic; Humans; Male; Mianserin; Mirtazapine; Risk Assessment; Stupor; Treatment Outcome | 2012 |
Mirtazapine inhibits tumor growth via immune response and serotonergic system.
Topics: Adrenergic alpha-Antagonists; Animals; Autoradiography; Colonic Neoplasms; Genes, Reporter; Immunity, Innate; Immunocompromised Host; Injections, Subcutaneous; Interferon-gamma; Interleukin-12; Luciferases; Male; Mianserin; Mice; Mice, Inbred BALB C; Mice, SCID; Mirtazapine; Neoplasm Transplantation; Serotonin Plasma Membrane Transport Proteins; Survival Rate; T-Lymphocytes; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2012 |
Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine.
Topics: Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Cisplatin; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Kidney Diseases; Male; Malondialdehyde; Mianserin; Mirtazapine; Peroxidase; Rats; Rats, Wistar | 2012 |
The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Conditioning, Operant; Cues; Disease Models, Animal; Male; Mianserin; Mirtazapine; Morphine; Morphine Dependence; Motor Activity; Rats; Rats, Sprague-Dawley; Reward | 2012 |
Studies on the metabolism of five model drugs by fungi colonizing cadavers using LC-ESI-MS/MS and GC-MS analysis.
Topics: Absidia; Amitriptyline; Aspergillus; Biotransformation; Cadaver; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Gliocladium; Hydroxylation; Methylation; Metoprolol; Mianserin; Mirtazapine; Mortierella; Oxidation-Reduction; Pharmaceutical Preparations; Promethazine; Pyridines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Zolpidem | 2012 |
What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Parkinson Disease | 2012 |
A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.
Topics: Animals; Automation; Biotransformation; Buspirone; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation, Preclinical; Half-Life; Humans; Mianserin; Microsomes, Liver; Mirtazapine; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Verapamil | 2012 |
Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Ethylene Glycols; Female; Homovanillic Acid; Humans; Male; Methionine; Mianserin; Middle Aged; Mirtazapine; Phenols; Polymorphism, Genetic; Psychiatric Status Rating Scales; Statistics, Nonparametric; Valine; Young Adult | 2012 |
[Case of successful management with mirtazapine for prolonged pain after esophagectomy].
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Esophageal Neoplasms; Esophagectomy; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neuralgia; Pain, Intractable; Pain, Postoperative; Thoracotomy; Time Factors; Treatment Outcome | 2012 |
Challenges in management of complex panic disorder in a palliative care setting.
Topics: Anti-Anxiety Agents; Anxiety; Breathing Exercises; Comorbidity; Death; Dibenzothiazepines; Eye Movement Desensitization Reprocessing; Female; Humans; Hypnosis; Lung Neoplasms; Mianserin; Middle Aged; Mirtazapine; Palliative Care; Panic Disorder; Quetiapine Fumarate; Stress Disorders, Post-Traumatic; Terminal Care | 2012 |
Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
Topics: Adult; Aged; Biomarkers; Depressive Disorder, Major; Female; Humans; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Mirtazapine; Saliva; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2013 |
[Mirtazapine versus other antidepressive agents for depression].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Depressive Disorder; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2012 |
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease.
Topics: Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Depressive Disorder; Female; Hallucinations; Humans; Mianserin; Middle Aged; Mirtazapine; Parkinson Disease; Treatment Outcome | 2013 |
Antidepressant use in underweight older adults.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Appetite; Body Mass Index; Body Weight; Depressive Disorder, Major; Duloxetine Hydrochloride; Hospitals, University; Humans; Inservice Training; Mianserin; Mirtazapine; Practice Patterns, Physicians'; Retrospective Studies; Thinness; Thiophenes | 2012 |
Mirtazapine-induced massive dyslipidaemia in an elderly woman.
Topics: Aged; Antidepressive Agents, Tricyclic; Dyslipidemias; Female; Humans; Mianserin; Mirtazapine | 2013 |
Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Histamine H1 Antagonists; Immunoenzyme Techniques; Male; Methylnitronitrosoguanidine; Mianserin; Mirtazapine; Rats; Rats, Wistar; Stomach Neoplasms | 2012 |
Simultaneous determination of 5 psychotropic drugs of various types in an autopsy case of acute multiple drug poisoning.
Topics: Adult; Amoxapine; Chlorpromazine; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Gastrointestinal Contents; Humans; Mianserin; Mirtazapine; Psychotropic Drugs; Pyridines; Sertraline; Solid Phase Extraction; Zolpidem | 2013 |
Molecular structure, FT-IR, FT-Raman, NMR studies and first order molecular hyperpolarizabilities by the DFT method of mirtazapine and its comparison with mianserin.
Topics: Anisotropy; Hydrochloric Acid; Magnetic Resonance Spectroscopy; Mianserin; Mirtazapine; Models, Molecular; Molecular Conformation; Quantum Theory; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermodynamics; Vibration | 2013 |
Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain.
Topics: Animals; Antineoplastic Agents; Antioxidants; Brain; Cisplatin; DNA Damage; Glutathione; Guanine; Male; Malondialdehyde; Mianserin; Mirtazapine; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Superoxide Dismutase | 2013 |
Road traffic accidents: more than just whiplash?
Topics: Accidents, Traffic; Antidepressive Agents; Drug Therapy, Combination; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Sertraline; Stress Disorders, Post-Traumatic; Whiplash Injuries | 2013 |
Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Female; Humans; Mianserin; Mirtazapine; Nausea; Panic Disorder; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sleep Initiation and Maintenance Disorders | 2013 |
Influence of body mass index on the choice of therapy for depression and follow-up care.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Choice Behavior; Cohort Studies; Depression; Female; Fluoxetine; Follow-Up Studies; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Obesity; Paroxetine; Psychotherapy; Young Adult | 2013 |
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming | 2012 |
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperkinesis; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for antibody-mediated rejection.
Topics: Antibodies, Monoclonal, Murine-Derived; Cognition Disorders; Fatal Outcome; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Plasmapheresis; Rituximab | 2013 |
Chronic administration of duloxetine and mirtazapine downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice.
Topics: Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Behavior, Animal; Cerebral Cortex; Down-Regulation; Duloxetine Hydrochloride; Female; Hippocampus; Mianserin; Mice; Mirtazapine; Nerve Growth Factors; Thiophenes; Up-Regulation | 2013 |
Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Entorhinal Cortex; Frontal Lobe; Histamine Agonists; Histamine H1 Antagonists; Male; Mianserin; Microdialysis; Mirtazapine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-2; Serotonin | 2013 |
Mirtazapine-induced galactorrhea: a case report.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Galactorrhea; Humans; Mianserin; Mirtazapine | 2013 |
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Topics: Adrenal Cortex Hormones; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Fatal Outcome; Gene Rearrangement; HIV; HIV Infections; Humans; Immunity, Innate; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Middle Aged; Mirtazapine | 2013 |
The effect of mirtazapine on cisplatin-induced oxidative damage and infertility in rat ovaries.
Topics: Animals; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Female; Infertility, Female; Mianserin; Mirtazapine; Ovary; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Treatment Outcome | 2013 |
Visual and auditory hallucinations associated with citalopram treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Drug Substitution; Drug Therapy, Combination; Hallucinations; Humans; Male; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2013 |
Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Cardiovascular Diseases; Cross-Sectional Studies; Depressive Disorder; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prevalence; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Veterans | 2013 |
New onset alcohol dependence linked to treatment with selective serotonin reuptake inhibitors.
Topics: Alcoholism; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Substitution; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2013 |
Effects of low-dose mirtazapine on driving performance in healthy volunteers.
Topics: Adrenergic alpha-Antagonists; Adult; Automobile Driving; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Healthy Volunteers; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychomotor Performance; Reaction Time | 2013 |
Repeated administration of mirtazapine attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B up-regulation in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Hyperalgesia; Mianserin; Mirtazapine; Organoplatinum Compounds; Oxaliplatin; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spine; Up-Regulation | 2013 |
Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2014 |
Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Topics: Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Female; Hallucinations; Humans; Mianserin; Mirtazapine; Parkinson Disease; Psychotic Disorders; Treatment Outcome | 2013 |
Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Dogs; Duloxetine Hydrochloride; Fluoxetine; Humans; Imipramine; Madin Darby Canine Kidney Cells; Mianserin; Mirtazapine; Thiophenes; Transfection | 2013 |
Inhibitory effect of antidepressants on B16F10 melanoma tumor growth.
Topics: Animals; Antidepressive Agents; Cell Proliferation; Desipramine; Fluoxetine; Interleukin-10; Male; Melanoma, Experimental; Mianserin; Mice; Mice, Inbred C57BL; Mirtazapine; T-Lymphocytes; Tumor Cells, Cultured | 2013 |
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
Side effects of interferon therapy in adolescent melanoma.
Topics: Adolescent; Adrenergic alpha-Antagonists; Depression; Humans; Immunologic Factors; Interferon-alpha; Male; Melanoma; Mianserin; Mirtazapine | 2014 |
[Antidepressant treatment associated hyponatremia -- case report].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Does use of tetracyclic antidepressant-mirtazapine reduce cancer risk in depression patients?
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Case-Control Studies; Chi-Square Distribution; Comorbidity; Depression; Female; Humans; Incidence; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Sex Factors; Taiwan; Young Adult | 2013 |
Linking Clostridium difficile infection with depression.
Topics: Antidepressive Agents; Clostridioides difficile; Clostridium Infections; Depression; Fluoxetine; Humans; Mianserin; Mirtazapine; Risk Factors | 2013 |
Mirtazapine overdose is unlikely to cause major toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Critical Care; Databases, Factual; Drug Overdose; Electrocardiography; Female; Glasgow Coma Scale; Humans; Hypertension; Long QT Syndrome; Male; Mianserin; Middle Aged; Mirtazapine; Tachycardia; Young Adult | 2014 |
Impact of antidepressants on cytokine production of depressed patients in vitro.
Topics: Adult; Antidepressive Agents; CD40 Antigens; Citalopram; Cytokines; Depression; Female; Humans; Interleukin-17; Interleukin-1beta; Interleukin-2; Interleukin-22; Interleukin-4; Interleukin-6; Interleukins; Male; Mianserin; Middle Aged; Mirtazapine; Muromonab-CD3; Tumor Necrosis Factor-alpha | 2013 |
Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Antiviral Agents; Brain; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mianserin; Mirtazapine; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2014 |
Mirtazapine associated tender pitting pedal oedema.
Topics: Antidepressive Agents, Tricyclic; Edema; Female; Foot; Humans; Mianserin; Middle Aged; Mirtazapine | 2014 |
Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Brain; Cognition; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone | 2013 |
A pilot study to evaluate symptom-oriented selection of antidepressants in patients with cancer.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Feasibility Studies; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neoplasms; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2014 |
Anxiolytic-like effect of mirtazapine mediates its effect in the median raphe nucleus.
Topics: Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Behavior, Animal; Conditioning, Psychological; Fear; Hippocampus; Male; Mianserin; Mirtazapine; Motor Activity; Raphe Nuclei; Rats; Rats, Sprague-Dawley | 2013 |
Antinociceptive effects of mirtazapine, pregabalin, and gabapentin after chronic constriction injury of the infraorbital nerve in rats.
Topics: Adrenergic alpha-Antagonists; Amines; Analgesics; Animals; Cranial Nerve Injuries; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Facial Pain; Gabapentin; gamma-Aminobutyric Acid; Injections, Spinal; Male; Mianserin; Mirtazapine; Neuralgia; Nociceptive Pain; Orbit; Pain Threshold; Pregabalin; Rats; Rats, Sprague-Dawley; Time Factors; Touch | 2014 |
Reduction of parkinsonism and psychosis with mirtazapine: a case report.
Topics: Aged; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Parkinsonian Disorders; Psychotic Disorders | 2014 |
Potential role of mirtazapine in underweight older adults.
Topics: Aged; Antidepressive Agents, Tricyclic; Appetite; Body Weight; Humans; Mianserin; Mirtazapine; Quality of Life; Thinness; Weight Loss | 2014 |
[Use of psychotropic drugs in patients with chronic pain].
Topics: Chronic Pain; Cortisone; Depression; Guillain-Barre Syndrome; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotropic Drugs; Sleep Wake Disorders | 2014 |
Prokinetic effects of mirtazapine on gastrointestinal transit.
Topics: Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Colon; Disease Models, Animal; Dogs; Female; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Transit; Gastroparesis; Intestine, Small; Mianserin; Mirtazapine; Pressure; Rectum; Time Factors | 2014 |
Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dopamine D2 Receptor Antagonists; Female; Histamine H1 Antagonists; Hospitals, Psychiatric; Humans; Israel; Male; Mianserin; Middle Aged; Mirtazapine; Off-Label Use; Piperazines; Quinolones; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
[Effectiveness of mirtazapine for digestive symptoms in palliative care - retrospective study of 50 cases].
Topics: Adult; Aged; Aged, 80 and over; Feeding and Eating Disorders; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Neoplasms; Palliative Care; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2014 |
Enantioselective separation of mirtazapine and its metabolites by capillary electrophoresis with acetonitrile field-amplified sample stacking and its application.
Topics: Acetonitriles; Administration, Oral; Antidepressive Agents, Tricyclic; beta-Cyclodextrins; Biotransformation; Buffers; Chemical Fractionation; Cyclic N-Oxides; Electrophoresis, Capillary; Humans; Limit of Detection; Male; Mianserin; Mirtazapine; Reproducibility of Results; Stereoisomerism | 2014 |
Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
Topics: Aged; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Atrial Fibrillation; Bradycardia; Diagnostic Imaging; Drug Interactions; Electrocardiography; Humans; Long QT Syndrome; Male; Mianserin; Mirtazapine; Propafenone; Seizures; Sleep Initiation and Maintenance Disorders | 2014 |
Studies on drug metabolism by fungi colonizing decomposing human cadavers. Part II: biotransformation of five model drugs by fungi isolated from post-mortem material.
Topics: Amitriptyline; Biotransformation; Cadaver; Fungi; Humans; Metoprolol; Mianserin; Mirtazapine; Promethazine; Pyridines; Zolpidem | 2015 |
Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Epistasis, Genetic; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2014 |
Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine.
Topics: Abdominal Pain; Adrenergic alpha-Antagonists; Adult; Antiemetics; Female; Gastric Emptying; Gastroparesis; Humans; Mianserin; Mirtazapine; Nausea; Serotonin 5-HT1 Receptor Antagonists; Treatment Outcome; Virus Diseases; Vomiting | 2014 |
Mirtazapine: rhabdomyolysis.
Topics: Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Pharmacovigilance; Rhabdomyolysis | 2014 |
Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.
Topics: Cytarabine; Disease Progression; Female; Humans; JC Virus; Leukemia, Lymphocytic, Chronic, B-Cell; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Treatment Failure | 2014 |
Suppression of metastasis by mirtazapine via restoration of the Lin-7C/β-catenin pathway in human cancer cells.
Topics: Adrenergic alpha-Antagonists; Animals; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Melanoma; Membrane Proteins; Mianserin; Mice, Inbred BALB C; Mice, Nude; Mirtazapine; Neoplasm Metastasis; Neoplasms; Receptor, Serotonin, 5-HT2C; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Disease Models, Animal; Feasibility Studies; Male; Mianserin; Mice; Mice, Inbred C57BL; Mirtazapine; MPTP Poisoning; Treatment Outcome | 2014 |
Serotonin toxicity after addition of mirtazapine to escitalopram.
Topics: Adult; Antidepressive Agents; Citalopram; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome | 2014 |
Does mirtazapine interfere with naturalistic diabetes treatment?
Topics: Antidepressive Agents, Tricyclic; Blood Glucose; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Triglycerides | 2014 |
Progressive multifocal leukoencephalopathy in a patient with pre-clinical primary biliary cirrhosis.
Topics: Aged; Brain; Disease Progression; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Liver Cirrhosis, Biliary; Mefloquine; Mianserin; Mirtazapine; Treatment Outcome | 2014 |
Acute hepatitis after starting pinaverium bromide in a patient taking mirtazapine.
Topics: Acute Disease; Biopsy; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Gastroesophageal Reflux; Hepatitis; Histamine H1 Antagonists; Humans; Irritable Bowel Syndrome; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Parasympatholytics | 2014 |
Therapeutic drug monitoring of mirtazapine in a routine outpatient setting in Asian psychiatric patients.
Topics: Adrenergic alpha-Antagonists; Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Outpatients; Psychiatric Status Rating Scales; Republic of Korea; Retrospective Studies; Treatment Outcome | 2014 |
Mirtazapine associated with drug-related thrombocytopenia: a case report.
Topics: Antidepressive Agents, Tricyclic; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Thrombocytopenia | 2014 |
Distribution pattern of mirtazapine and normirtazapine in blood and CSF.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Blood-Brain Barrier; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine | 2015 |
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
Topics: Amino Acids; Animals; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Down-Regulation; Female; Humans; Ketanserin; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prefrontal Cortex; Radioligand Assay; Rats, Sprague-Dawley; Reboxetine; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; RNA, Messenger; Tritium; Xanthenes | 2014 |
The in vitro genotoxic and cytotoxic effects of remeron on human peripheral blood lymphocytes.
Topics: Adrenergic alpha-Antagonists; Adult; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Male; Mianserin; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mirtazapine; Mitosis; Mitotic Index; Risk Assessment; Serotonin Antagonists; Sister Chromatid Exchange; Time Factors; Young Adult | 2015 |
Sleep-related eating disorder associated with mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Feeding and Eating Disorders; Female; Humans; Mianserin; Mirtazapine; Sleep Wake Disorders; Young Adult | 2014 |
[Electroconvulsion therapy for neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Neuroleptic Malignant Syndrome; Olanzapine | 2014 |
Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Circadian Rhythm; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Sleep Deprivation; Surveys and Questionnaires; Time Factors; Young Adult | 2014 |
Mirtazapine for new daily persistent headache-associated chronic nausea.
Topics: Chronic Disease; Female; Headache; Histamine H1 Antagonists; Humans; Mianserin; Middle Aged; Mirtazapine; Nausea | 2015 |
Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrestins; beta-Arrestin 1; beta-Arrestins; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Treatment Outcome; Young Adult | 2015 |
Toxic leukoencephalopathy in the intensive care unit.
Topics: Adult; Amphetamines; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Ascorbic Acid; Brain; Clonazepam; Diagnosis, Differential; Dibenzothiazepines; Fatal Outcome; Humans; Intensive Care Units; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Oxycodone; Quadriplegia; Quetiapine Fumarate; Solvents; Tomography, X-Ray Computed; Ubiquinone; Vitamin E; Young Adult | 2014 |
[Pediatric bipolar disorder - case report of a bipolar patient with disease onset in childhood and adolescence: implications for diagnosis and therapy].
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Bipolar Disorder; Child; Diagnosis, Differential; Dibenzothiazepines; Humans; Hypnotics and Sedatives; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Social Behavior; Treatment Outcome | 2014 |
Use of antidepressants and association with elective termination of pregnancy: population based case-control study.
Topics: Abortion, Induced; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studies; Denmark; Depression; Drug Administration Schedule; Female; Finland; Humans; Maternal Age; Mianserin; Mirtazapine; Norway; Pregnancy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Social Class; Ultrasonography, Prenatal | 2015 |
Treatment of depression in an adolescent with cardiomyopathy and arrhythmia.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Anxiety; Cardiomyopathy, Hypertrophic; Depression; Electrocardiography; Glycogen Storage Disease Type IIb; Humans; Male; Mianserin; Mirtazapine; Weight Loss; Wolff-Parkinson-White Syndrome | 2015 |
Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Fear; Lithium; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Frontal Lobe; Injections, Intraperitoneal; Mianserin; Microdialysis; Mirtazapine; Norepinephrine; Piperazines; Pyridines; Rats; Risperidone; Serotonin | 2014 |
Transcranial magnetic stimulation as an antidepressant alternative in a patient with Brugada syndrome and recurrent syncope.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brugada Syndrome; Bupropion; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Electrocardiography; Humans; Male; Mianserin; Mirtazapine; NAV1.5 Voltage-Gated Sodium Channel; Nortriptyline; Syncope; Transcranial Magnetic Stimulation | 2014 |
Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Genotype; Humans; Male; Metabolic Clearance Rate; Mianserin; Microsomes, Liver; Middle Aged; Mirtazapine | 2015 |
Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine.
Topics: Antidepressive Agents; Delayed-Action Preparations; Drug Liberation; Kinetics; Lactic Acid; Methylene Chloride; Mianserin; Microspheres; Mirtazapine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents | 2016 |
Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse.
Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Carcinoma, Ductal, Breast; Female; Histamine Antagonists; Humans; Mianserin; Mirtazapine; Pruritus; Serotonin Antagonists; Skin Neoplasms; Treatment Outcome; Triple Negative Breast Neoplasms | 2016 |
Mirtazapine in pregnancy and lactation: data from a case series.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Tricyclic; Breast Feeding; Cohort Studies; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third | 2015 |
Mirtazapine-induced restless legs syndrome treated with pramipexole.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Female; Humans; Mianserin; Mirtazapine; Pramipexole; Restless Legs Syndrome | 2015 |
[Urinary incontinence induced by the antidepressants - case report].
Topics: Antidepressive Agents; Diagnosis, Differential; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Urinary Incontinence, Stress | 2015 |
Successful treatment of gastroparesis with the antidepressant mirtazapine: a case report.
Topics: Aged; Antidepressive Agents; Gastroparesis; Humans; Male; Mianserin; Mirtazapine; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Mirtazapine | 2014 |
Protective effect of mirtazapine and hesperidin on cyclophosphamide-induced oxidative damage and infertility in rat ovaries.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Cyclophosphamide; Female; Glutathione Peroxidase; Hesperidin; Infertility, Female; Malondialdehyde; Mianserin; Mirtazapine; Nitric Oxide; Ovary; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Superoxide Dismutase | 2015 |
An unusual presentation of dose dependent SIADH secondary to mirtazapine therapy.
Topics: Aged; Antidepressive Agents; Citalopram; Depression; Dose-Response Relationship, Drug; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine | 2015 |
Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.
Topics: Antidepressive Agents, Tricyclic; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Citrates; Crystallization; Crystallography, X-Ray; Dicarboxylic Acids; Kinetics; Mianserin; Mirtazapine; Models, Molecular; Molecular Structure; Oxalates; Powder Diffraction; Solubility; Tartrates; Technology, Pharmaceutical; Temperature; Thermogravimetry; Water | 2015 |
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Birth Weight; Case-Control Studies; Depressive Disorder; Female; Gestational Age; Humans; Mianserin; Mirtazapine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Selective Serotonin Reuptake Inhibitors | 2015 |
Effect of mirtazapine on rat bone tissue after orchidectomy.
Topics: Adrenergic alpha-Antagonists; Alkaline Phosphatase; Animals; Antidepressive Agents, Tricyclic; Biomechanical Phenomena; Bone and Bones; Bone Density; Compressive Strength; Male; Mianserin; Mirtazapine; Orchiectomy; Osteoprotegerin; Rats, Wistar | 2015 |
Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Topics: Animals; Antidepressive Agents; Arrestins; beta-Arrestins; Cell Proliferation; CHO Cells; Cricetulus; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Fibroblasts; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gi-Go; HEK293 Cells; Humans; Lysophospholipids; Mianserin; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptor, IGF Type 1; Receptors, Lysophosphatidic Acid; Signal Transduction; Transcriptional Activation | 2015 |
Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
Topics: Antiviral Agents; Common Variable Immunodeficiency; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Viremia | 2015 |
Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Hypothalamic Hormones; Hypothalamus; Male; Melanins; Mianserin; Mirtazapine; Pituitary Hormones; Sex Factors; Treatment Outcome | 2015 |
Neuromyotonia with polyneuropathy, prominent psychoorganic syndrome, insomnia, and suicidal behavior without antibodies: a case report.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Second-Generation; Electromyography; Humans; Immunoglobulins, Intravenous; Isaacs Syndrome; Male; Mianserin; Mirtazapine; Polyneuropathies; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Venlafaxine Hydrochloride | 2015 |
Antidepressant action via the nitric oxide system: A pilot study in an acute depressive model induced by arginin.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Arginine; Cyclopropanes; Depression; Fluoxetine; Male; Mianserin; Milnacipran; Mirtazapine; Nitric Oxide; Nitric Oxide Synthase; Pilot Projects; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2015 |
Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Comorbidity; Cooperative Behavior; Delirium; Depressive Disorder; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Interdisciplinary Communication; Interferon alpha-2; Interferon-alpha; Male; Mianserin; Middle Aged; Mirtazapine; Physician's Role; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uridine Monophosphate | 2015 |
Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Case-Control Studies; Citalopram; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Female; Gene-Environment Interaction; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Vascular Endothelial Growth Factor A; Venlafaxine Hydrochloride | 2015 |
Mirtazapine toxicity in cats: retrospective study of 84 cases (2006-2011).
Topics: Animals; Appetite Stimulants; Cat Diseases; Cats; Drug-Related Side Effects and Adverse Reactions; Female; Male; Mianserin; Mirtazapine; Poison Control Centers; Retrospective Studies; United States | 2016 |
Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catalase; Fluoxetine; Histamine H1 Antagonists; Life Expectancy; Longevity; Mianserin; Mirtazapine; Oxidative Stress; Peroxiredoxins; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Superoxide Dismutase; Synaptic Transmission | 2015 |
Pharmacological and psychosomatic treatments for an elderly patient with severe nausea and vomiting in reaction to postoperative stress.
Topics: Aged; Amoxapine; Anti-Anxiety Agents; Antidepressive Agents; Antiemetics; Benzodiazepines; Bromazepam; Clomipramine; Combined Modality Therapy; Female; Humans; Mianserin; Mirtazapine; Nausea; Olanzapine; Physical Therapy Modalities; Postoperative Complications; Psychotherapy; Stomach Neoplasms; Stress, Psychological; Vomiting | 2015 |
Mirtazapine-induced acute angle closure.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocular Pressure; Mianserin; Mirtazapine | 2015 |
Effect of lipid emulsion during resuscitation of a patient with cardiac arrest after overdose of chlorpromazine and mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cardiopulmonary Resuscitation; Chlorpromazine; Depression; Drug Overdose; Emulsions; Fat Emulsions, Intravenous; Female; Heart Arrest; Humans; Mianserin; Mirtazapine; Phospholipids; Soybean Oil; Young Adult | 2015 |
Use of mirtazapine in functional vomiting.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Mianserin; Mirtazapine; Nausea; Vomiting | 2016 |
Effects of Mirtazapine on Patients Undergoing Naturalistic Diabetes Treatment: A Follow-Up Study Extended From 6 to 12 Months.
Topics: Adult; Antidepressive Agents, Tricyclic; Diabetes Mellitus; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Treatment Outcome; Weight Gain | 2015 |
[FOCAL MOTOR SEIZURES AND STATUS EPILEPTICUS PROVOKED BY MIRTAZAPINE].
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Electroencephalography; Epilepsy, Partial, Motor; Humans; Levetiracetam; Male; Mianserin; Mirtazapine; Piracetam; Status Epilepticus; Video Recording | 2015 |
Pharmacological management of borderline personality disorder in a pregnant woman with a previous history of alcohol addiction: a case report.
Topics: Adult; Alcoholism; Borderline Personality Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Mianserin; Mirtazapine; Pregnancy; Pregnancy Outcome | 2015 |
Antidepressant Prescription Pattern in the Presence of Medical Co-morbidity: REAP-AD 2013 Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Asia; Child; Citalopram; Comorbidity; Depression; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Practice Patterns, Physicians'; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Young Adult | 2015 |
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.
Topics: Animals; Antidepressive Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Male; Mianserin; Mirtazapine; Rats; Risperidone; Social Behavior | 2015 |
Mirtazapine for Choking Phobia: Report of a Pediatric Case.
Topics: Airway Obstruction; Antidepressive Agents, Tricyclic; Child; Female; Humans; Mianserin; Mirtazapine; Phobic Disorders | 2015 |
Formulation studies for mirtazapine orally disintegrating tablets.
Topics: Acrylates; Administration, Oral; Chemistry, Pharmaceutical; Drug Compounding; Excipients; Hardness; Mianserin; Mirtazapine; Polymers; Solubility; Tablets; Taste | 2016 |
Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Genotype; Humans; Japan; Male; Mianserin; Middle Aged; Mirtazapine; Pharmacogenetics; Young Adult | 2015 |
Mirtazapine-Associated Hypertriglyceridemia and Hyperglycemia.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Humans; Hyperglycemia; Hypertriglyceridemia; Male; Mianserin; Mirtazapine | 2015 |
[Cognitive dysfunction in major depression].
Topics: Attention; Cognition Disorders; Depressive Disorder, Major; Drug Therapy, Combination; Executive Function; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Rehabilitation, Vocational; Stress, Psychological; Venlafaxine Hydrochloride | 2015 |
Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.
Topics: Animals; Antidepressive Agents; Atrophy; Breath Tests; Cerebral Cortex; Desipramine; GABAergic Neurons; gamma-Aminobutyric Acid; Heart Rate; Humans; Methyl-CpG-Binding Protein 2; Mianserin; Mice; Mirtazapine; Rett Syndrome; Seizures; Somatosensory Cortex | 2016 |
[A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy].
Topics: Aged; Anticoagulants; Drug Interactions; Hemorrhage; Humans; Male; Mianserin; Mirtazapine; Prothrombin; Warfarin | 2015 |
Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Sarcoidosis; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Comparative Evaluation of Partial α2 -Adrenoceptor Agonist and Pure α2 -Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Alcoholism; Animals; Anxiety; Behavior, Animal; Clonidine; Depression; Dose-Response Relationship, Drug; Male; Memory; Mianserin; Mice; Mirtazapine; Receptors, Adrenergic; Substance Withdrawal Syndrome | 2016 |
Mirtazapine, in orodispersible form, for patients with preoperative psychological distress: A pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Preoperative Period; Propensity Score | 2016 |
Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Central Nervous System Sensitization; Cocaine; Dopamine Uptake Inhibitors; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Serotonin Agents | 2016 |
New antidepressant use in older adults: a Canadian population-based study (1997-2013).
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Manitoba; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Trazodone; Venlafaxine Hydrochloride | 2017 |
Search for fungi-specific metabolites of four model drugs in postmortem blood as potential indicators of postmortem fungal metabolism.
Topics: Aged; Amitriptyline; Biotransformation; Cardiovascular Agents; Central Nervous System Agents; Chromatography, Liquid; Female; Fungi; Humans; Male; Metoprolol; Mianserin; Middle Aged; Mirtazapine; Postmortem Changes; Pyridines; Tandem Mass Spectrometry; Zolpidem | 2016 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
Mirtazapine exerts an anxiolytic-like effect through activation of the median raphe nucleus-dorsal hippocampal 5-HT pathway in contextual fear conditioning in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Conditioning, Psychological; Dopamine; Dorsal Raphe Nucleus; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Hippocampus; Male; Mianserin; Mirtazapine; Motor Activity; Neural Pathways; Piperazines; Pyridines; Random Allocation; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists | 2016 |
Combined treatment with subchronic lithium and acute intracerebral mirtazapine microinjection into the median raphe nucleus exerted an anxiolytic-like effect synergistically.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Drug Synergism; Extracellular Space; Fear; Lithium; Male; Mianserin; Microinjections; Mirtazapine; Neurons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2016 |
["Alice in wonderland syndrome", a precursor of depressive disorder with melancholic characteristics].
Topics: Aged; Alice in Wonderland Syndrome; Antidepressive Agents, Second-Generation; Antimanic Agents; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Mianserin; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Head shaking in the forced swim test: A robust but unexplored sex difference.
Topics: Adrenalectomy; Aging; Animals; Behavior, Animal; Castration; Corticosterone; Female; Head; Male; Mianserin; Mirtazapine; Movement; Rats; Rats, Inbred Strains; Sex Characteristics; Species Specificity; Swimming; Testosterone | 2017 |
Antidepressants and the risk of hyponatremia: a Danish register-based population study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Denmark; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Incidence; Male; Mianserin; Middle Aged; Mirtazapine; Registries; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride | 2016 |
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Corpus Striatum; Delay Discounting; Dopamine Agonists; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Mianserin; Mirtazapine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation; Rats, Sprague-Dawley; Risk-Taking; Self Stimulation | 2016 |
Unsteady Gait and Dizziness.
Topics: Accidental Falls; Anticonvulsants; Cervical Cord; Clonazepam; Dizziness; Epidural Neoplasms; Gait Disorders, Neurologic; Humans; Laminectomy; Lamotrigine; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Oxycodone; Spinal Cord Compression; Triazines | 2016 |
Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.
Topics: Adult; Biomarkers; Cell Proliferation; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Integrin beta3; Male; Mianserin; Middle Aged; Mirtazapine; Monocytes; Paroxetine; Peptide Fragments; Serotonin Plasma Membrane Transport Proteins | 2016 |
An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Alcohol Drinking; Alcohol-Related Disorders; Antipsychotic Agents; Disorders of Excessive Somnolence; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Quetiapine Fumarate; Treatment Outcome | 2016 |
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |
Childhood Sleep Terror and Mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Child; Humans; Male; Mianserin; Mirtazapine; Night Terrors; Treatment Outcome; Vomiting | 2016 |
Progressive multifocal leukoencephalopathy with bilateral middle cerebellar peduncle lesions confirmed by repeated CSF-JC virus tests and coexistence of JC virus granule cell neuronopathy. Report of a case.
Topics: Aged; Cerebellum; Cerebrospinal Fluid; Corneal Dystrophies, Hereditary; Diagnosis, Differential; DNA, Viral; Drug Therapy, Combination; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Mianserin; Mirtazapine; Polymerase Chain Reaction; Retinal Degeneration; Virology | 2016 |
JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7.
Topics: Aged; Ataxia; Chronic Disease; Hamartoma Syndrome, Multiple; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Interleukin-7; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lymphopenia; Male; Malformations of Cortical Development, Group I; Mefloquine; Methylprednisolone; Mianserin; Mirtazapine; Recombinant Proteins | 2017 |
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Disease Progression; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Mirtazapine; Multimodal Imaging; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines | 2017 |
[Aggression and restlessness following baclofen overdose: the narrow line between intoxication and withdrawal symptoms].
Topics: Adult; Aggression; Alcoholism; Baclofen; Delirium; Drug Overdose; GABA-B Receptor Agonists; Humans; Male; Mianserin; Mirtazapine; Psychomotor Agitation; Respiratory Insufficiency; Substance Withdrawal Syndrome; Young Adult | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Development of a novel ultrasonic-assisted magnetic dispersive solid-phase microextraction method coupled with high performance liquid chromatography for determination of mirtazapine and its metabolites in human urine and water samples employing experimen
Topics: Adsorption; Aniline Compounds; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Factor Analysis, Statistical; Fresh Water; Graphite; Healthy Volunteers; Humans; Magnets; Mianserin; Mirtazapine; Nanocomposites; Oxides; Solid Phase Microextraction; Sonication; Water Pollutants, Chemical | 2016 |
Serotonin Syndrome Following an Uncomplicated Orthopedic Surgery in a Patient With Post-Traumatic Stress Disorder.
Topics: Adult; Citalopram; Diskectomy; Drug-Related Side Effects and Adverse Reactions; Humans; Low Back Pain; Male; Mianserin; Mirtazapine; Orthopedic Procedures; Serotonin Receptor Agonists; Serotonin Syndrome; Stress Disorders, Post-Traumatic; Veterans | 2016 |
A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy.
Topics: Aged, 80 and over; Astrocytes; Brain; Cerebrospinal Fluid; Drug Therapy, Combination; Humans; Immunocompromised Host; JC Virus; Kidney Failure, Chronic; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Mianserin; Mirtazapine; Renal Dialysis; Treatment Outcome | 2016 |
Mirtazapine-associated peripheral oedema.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Edema; Female; Humans; Lower Extremity; Mianserin; Mirtazapine | 2016 |
Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Mirtazapine; Orgasm; Schizophrenia; Sexual Dysfunctions, Psychological; Treatment Outcome | 2017 |
Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women.
Topics: Accidental Falls; Aged, 80 and over; Antidepressive Agents; Bupropion; Female; Frail Elderly; Humans; Mianserin; Mirtazapine; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Trazodone | 2016 |
Poisoning suicide with ingestion of the pyrethroids alpha-cypermethrin and deltamethrin and the antidepressant mirtazapine: A case report.
Topics: Antidepressive Agents; Central Nervous System Depressants; Ethanol; Humans; Insecticides; Male; Mianserin; Middle Aged; Mirtazapine; Nitriles; Pyrethrins; Suicide | 2017 |
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Mianserin; Mirtazapine; Motor Activity; MPTP Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced | 2017 |
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Bupropion; Citalopram; Cluster Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Sleep; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2017 |
Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment.
Topics: Animals; Antidepressive Agents; Brain; Cyclopropanes; Depressive Disorder, Major; Down-Regulation; Drug Administration Schedule; Male; Mianserin; Milnacipran; Mirtazapine; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; RNA, Messenger | 2017 |
Metoclopramide-induced Serotonin Syndrome.
Topics: Adult; Antiemetics; Bipolar Disorder; Drug Interactions; Female; Humans; Metoclopramide; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2017 |
Topical ketamine-amitriptyline-lidocaine for chronic pruritus: A retrospective study assessing efficacy and tolerability.
Topics: Aged; Amines; Amitriptyline; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Lidocaine; Male; Mianserin; Mirtazapine; Pain Measurement; Pruritus; Retrospective Studies | 2017 |
Mirtazapine Induces Nightmares in Depressed Patients.
Topics: Antidepressive Agents, Tricyclic; Depression; Dreams; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Young Adult | 2017 |
Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Topics: Acrylates; Administration, Oral; Antidepressive Agents, Tricyclic; Caco-2 Cells; Drug Compounding; Drug Liberation; Excipients; Humans; Mianserin; Mirtazapine; Polymers; Solubility; Tablets; Taste | 2018 |
Mirtazapine attenuates cocaine seeking in rats.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Antidepressive Agents, Tricyclic; Cocaine; Conditioning, Operant; Drug-Seeking Behavior; Extinction, Psychological; Food; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Time Factors | 2017 |
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry | 2017 |
Mirtazapine for symptom control in refractory gastroparesis.
Topics: Adult; Aged; Aged, 80 and over; Female; Gastroparesis; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Young Adult | 2017 |
Mirtazapine and ketanserin alter preference for gambling-like schedules of reinforcement in rats.
Topics: Animals; Choice Behavior; Decision Making; Gambling; Ketanserin; Male; Mianserin; Mirtazapine; Rats; Reinforcement Schedule; Reward; Self Stimulation | 2017 |
Mirtazapine-induced steatosis
.
Topics: Adrenergic alpha-2 Receptor Antagonists; Antidepressive Agents, Tricyclic; Biopsy; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Humans; Jaundice; Liver; Liver Function Tests; Mianserin; Middle Aged; Mirtazapine | 2017 |
Navigating Undiagnosed Dissociative Identity Disorder in the Inpatient Setting: A Case Report.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Antipsychotic Agents; Cognitive Behavioral Therapy; Dissociative Identity Disorder; Female; Hospitalization; Humans; Inpatients; Mianserin; Mirtazapine; Risperidone; Sertraline; Treatment Outcome | 2017 |
Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Time Factors | 2017 |
Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.
Topics: Adrenergic alpha-Antagonists; Adult; Antimalarials; Biopsy; Brain; DNA, Viral; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mianserin; Mirtazapine; Reproducibility of Results; Treatment Outcome | 2017 |
Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone.
Topics: Animals; Antidepressive Agents, Tricyclic; Antioxidants; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Depressive Disorder; Disease Models, Animal; Drug Combinations; Glutathione; Hippocampus; Lipid Peroxidation; Male; Mianserin; Mice; Mirtazapine; Nitrites; Thioctic Acid | 2017 |
Mirtazapine fatal poisoning.
Topics: Antidepressive Agents, Tricyclic; Chromatography, Liquid; Humans; Male; Mass Spectrometry; Mianserin; Middle Aged; Mirtazapine; Suicide | 2017 |
Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
Topics: Animals; Antioxidants; Collagen; Glutathione; Hepatic Stellate Cells; Hypertension, Portal; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Mianserin; Mice; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidative Stress; Phosphorylation; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Smad3 Protein; Thioacetamide; Transforming Growth Factor beta1 | 2017 |
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists | 2017 |
Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model.
Topics: Animals; Antidepressive Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Liver; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2017 |
Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats.
Topics: Animals; Dose-Response Relationship, Drug; Extinction, Psychological; Locomotion; Male; Mianserin; Mirtazapine; Nicotine; Rats; Rats, Wistar | 2017 |
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Bupropion; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-17; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; T-Lymphocytes; Venlafaxine Hydrochloride | 2017 |
Synergistic interactions between mirtazapine and prazosin prevent the induction and expression of behavioral sensitization to cocaine in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Anesthetics, Local; Animals; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Locomotion; Male; Mianserin; Mirtazapine; Prazosin; Rats; Rats, Wistar | 2017 |
Protective effects of mirtazapine and chrysin on experimentally induced testicular damage in rats.
Topics: Acid Phosphatase; Animals; Caspase 3; Flavonoids; Glutathione; Male; Malondialdehyde; Mianserin; Mirtazapine; Protective Agents; Proto-Oncogene Proteins c-kit; Rats; Testis; Tumor Necrosis Factor-alpha | 2017 |
Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.
Topics: Adrenergic alpha-Antagonists; Cerebellar Ataxia; Disease Progression; Dysarthria; Fatal Outcome; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2017 |
Translating the HAM-D into the MADRS and vice versa with equipercentile linking.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic | 2018 |
Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Databases, Factual; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polypharmacy; Venlafaxine Hydrochloride | 2018 |
Effects of the antidepressant mirtazapine and zinc on nicotinic acetylcholine receptors.
Topics: Animals; Antidepressive Agents; Interneurons; Membrane Potentials; Mianserin; Mirtazapine; Neurons; Nicotinic Antagonists; Oocytes; Rats, Sprague-Dawley; Receptors, Nicotinic; Zinc | 2018 |
Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline.
Topics: Antidepressive Agents; Brain; Calibration; Cause of Death; Chromatography, Liquid; Citalopram; Drug Overdose; Duloxetine Hydrochloride; Forensic Toxicology; Humans; Linear Models; Mianserin; Mirtazapine; Reference Standards; Reproducibility of Results; Sertraline; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2018 |
Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats.
Topics: Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Cues; Drug-Seeking Behavior; Male; Mianserin; Mirtazapine; Rats; Rats, Wistar; Time Factors | 2018 |
Intractable hyperemesis gravidarum in a patient with type 1 diabetes.
Topics: Antiemetics; Cesarean Section; Diabetes Mellitus, Type 1; Female; Gestational Age; Humans; Hyperemesis Gravidarum; Infant, Newborn; Infant, Small for Gestational Age; Male; Mianserin; Mirtazapine; Off-Label Use; Parenteral Nutrition, Total; Pregnancy; Young Adult | 2017 |
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
Topics: Aged; Antidepressive Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cohort Studies; Databases, Factual; Depression; Disease-Free Survival; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Mianserin; Middle Aged; Mirtazapine; Proportional Hazards Models; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Tachyphylaxis to the Sedative Action of Mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Conscious Sedation; Depression; Dose-Response Relationship, Drug; Female; Humans; Mianserin; Mirtazapine; Tachyphylaxis | 2018 |
Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; France; Humans; Male; Mianserin; Military Personnel; Mirtazapine; Quetiapine Fumarate; Rhabdomyolysis; Stress Disorders, Post-Traumatic | 2018 |
[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Topics: Adult; Brain; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Risperidone; Time Factors; Treatment Outcome | 2018 |
[Antipsychotic induced rhabdomyolysis].
Topics: Adult; Antipsychotic Agents; Humans; Male; Mianserin; Mirtazapine; Rhabdomyolysis; Stress Disorders, Post-Traumatic | 2018 |
Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bupropion; Comorbidity; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Hospitalization; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Proportional Hazards Models; Quetiapine Fumarate; Retrospective Studies; Young Adult | 2018 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locomotion; Male; Mianserin; Mirtazapine; Rats; Recognition, Psychology; Risperidone; Serotonin | 2018 |
8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine.
Topics: Age Factors; Alleles; Anti-Anxiety Agents; Asian People; Cytochrome P-450 CYP2D6; Genotype; Glucuronides; Humans; Hydroxylation; Japan; Mental Disorders; Mianserin; Mirtazapine; Smoking | 2019 |
[Serotonin syndrome shortly after the administration of low-dose mirtazapine].
Topics: Aged; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome | 2020 |
Evidence of repeated mirtazapine poisoning in children by hair analysis.
Topics: Antidepressive Agents; Child; Child Abuse; Chromatography, Liquid; Forensic Toxicology; Hair; Humans; Mass Spectrometry; Mianserin; Mirtazapine | 2021 |
The Hunger for Mirtazapine: A Discontinuation Syndrome.
Topics: Appetite; Depressive Disorder, Major; Humans; Hunger; Male; Mianserin; Middle Aged; Mirtazapine | 2021 |
[Antidepressants - stimulators for the release of norepinephrine and serotonin (history of creation, study of neurochemical effects and classification)].
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Norepinephrine; Serotonin | 2021 |
Mirtazapine for agitation in dementia: moving forward.
Topics: Antidepressive Agents; Dementia; Humans; Mianserin; Mirtazapine | 2021 |
Sertraline-Induced Urinary Retention Reversed by Mirtazapine in an Adolescent.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Sertraline; Urinary Retention | 2022 |
Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study.
Topics: Benzodiazepines; Denmark; Drug Prescriptions; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Male; Melatonin; Mianserin; Mirtazapine; Olanzapine; Pregabalin; Promethazine; Quetiapine Fumarate; Substance-Related Disorders | 2023 |
Mirtazapine-Induced Hyponatremia in a Patient with Systemic Mastocytosis and Generalized Anxiety Disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Humans; Hyponatremia; Mastocytosis, Systemic; Mianserin; Mirtazapine | 2023 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |